WO2014165275A1 - Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure - Google Patents
Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure Download PDFInfo
- Publication number
- WO2014165275A1 WO2014165275A1 PCT/US2014/025059 US2014025059W WO2014165275A1 WO 2014165275 A1 WO2014165275 A1 WO 2014165275A1 US 2014025059 W US2014025059 W US 2014025059W WO 2014165275 A1 WO2014165275 A1 WO 2014165275A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wound
- layer
- lip
- tissue
- filler
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 60
- 206010052428 Wound Diseases 0.000 title claims description 723
- 208000027418 Wounds and injury Diseases 0.000 title claims description 718
- 239000000463 material Substances 0.000 claims abstract description 227
- 239000000945 filler Substances 0.000 claims abstract description 188
- 230000007246 mechanism Effects 0.000 claims abstract description 94
- 210000003195 fascia Anatomy 0.000 claims abstract description 60
- 239000006260 foam Substances 0.000 claims description 101
- 210000000056 organ Anatomy 0.000 claims description 38
- 239000000853 adhesive Substances 0.000 claims description 27
- 230000001070 adhesive effect Effects 0.000 claims description 27
- 230000003187 abdominal effect Effects 0.000 claims description 21
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 12
- 239000006261 foam material Substances 0.000 claims description 9
- 239000003106 tissue adhesive Substances 0.000 claims description 8
- 239000003292 glue Substances 0.000 claims description 4
- 108010003992 parietex Proteins 0.000 claims description 4
- 239000010410 layer Substances 0.000 description 284
- 210000001519 tissue Anatomy 0.000 description 188
- 230000000087 stabilizing effect Effects 0.000 description 132
- 238000004873 anchoring Methods 0.000 description 31
- 239000012530 fluid Substances 0.000 description 28
- 239000011159 matrix material Substances 0.000 description 17
- 239000011148 porous material Substances 0.000 description 16
- 238000009581 negative-pressure wound therapy Methods 0.000 description 15
- 238000000418 atomic force spectrum Methods 0.000 description 14
- 238000006073 displacement reaction Methods 0.000 description 10
- 238000003780 insertion Methods 0.000 description 10
- 230000037431 insertion Effects 0.000 description 10
- 229920000642 polymer Polymers 0.000 description 10
- 229920001296 polysiloxane Polymers 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- 239000003381 stabilizer Substances 0.000 description 9
- 210000001835 viscera Anatomy 0.000 description 9
- 229920002635 polyurethane Polymers 0.000 description 8
- 239000004814 polyurethane Substances 0.000 description 8
- 210000000683 abdominal cavity Anatomy 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 230000036961 partial effect Effects 0.000 description 7
- 210000004303 peritoneum Anatomy 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 230000001464 adherent effect Effects 0.000 description 6
- 210000000416 exudates and transudate Anatomy 0.000 description 6
- 229920005570 flexible polymer Polymers 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 208000002847 Surgical Wound Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 210000000577 adipose tissue Anatomy 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 230000002500 effect on skin Effects 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- -1 polyethylene Polymers 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000008733 trauma Effects 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 206010063560 Excessive granulation tissue Diseases 0.000 description 3
- 208000004210 Pressure Ulcer Diseases 0.000 description 3
- 229920001247 Reticulated foam Polymers 0.000 description 3
- 208000031737 Tissue Adhesions Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 210000001126 granulation tissue Anatomy 0.000 description 3
- 230000037313 granulation tissue formation Effects 0.000 description 3
- 239000004800 polyvinyl chloride Substances 0.000 description 3
- 210000002151 serous membrane Anatomy 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- 230000009278 visceral effect Effects 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- 210000003489 abdominal muscle Anatomy 0.000 description 2
- 210000003815 abdominal wall Anatomy 0.000 description 2
- 239000012790 adhesive layer Substances 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000009519 contusion Effects 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000009950 felting Methods 0.000 description 2
- 229920002457 flexible plastic Polymers 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 206010058808 Abdominal compartment syndrome Diseases 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 206010056340 Diabetic ulcer Diseases 0.000 description 1
- 208000035874 Excoriation Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000002623 Intra-Abdominal Hypertension Diseases 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 206010028885 Necrotising fasciitis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010048625 Skin maceration Diseases 0.000 description 1
- 208000000558 Varicose Ulcer Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000012569 microbial contaminant Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 201000007970 necrotizing fasciitis Diseases 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000007460 surgical drainage Methods 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000001066 surgical stoma Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000010388 wound contraction Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01021—Non-adhesive bandages or dressings characterised by the structure of the dressing
- A61F13/01029—Non-adhesive bandages or dressings characterised by the structure of the dressing made of multiple layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
- A61F13/022—Adhesive bandages or dressings with fluid retention members having more than one layer with different fluid retention characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/05—Bandages or dressings; Absorbent pads specially adapted for use with sub-pressure or over-pressure therapy, wound drainage or wound irrigation, e.g. for use with negative-pressure wound therapy [NPWT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/915—Constructional details of the pressure distribution manifold
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/916—Suction aspects of the dressing specially adapted for deep wounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00544—Plasters form or structure
- A61F2013/00553—Plasters form or structure with detachable parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00795—Plasters special helping devices
- A61F2013/00842—Plasters special helping devices for tearing off dressing of desired size
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/04—Skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1021—Abdominal cavity
Definitions
- Embodiments described herein relate to devices and methods that can be used to treat a wound with negative pressure. Particular embodiments can also be useful to aid in wound closure, for example in abdominal wounds or following fasciotomy procedures.
- the embodiments described herein can be used to assist in the treatment of wounds with negative pressure.
- the embodiments can be particularly useful in treating large wounds, such as abdominal wounds and/or for fasciotomy procedures, where closure and approximation of the wound edges is challenging.
- Certain embodiments described herein are directed to an elongated layer of material and a lip to be placed in contact with a wound and the elongated layer of material to be wrapped around a wound filler, their methods of use and systems incorporating the same, wherein the wound filler lip is configured to be positioned beneath the fascia.
- some embodiments described herein are directed to the closure of the wound and the use of attachment mechanisms on the elongate layer and lip to attach to the wound surface.
- an apparatus for wound treatment comprises an elongate layer of material configured to be placed in contact with a wound.
- the elongate layer is capable of being formed into an annular shape.
- a lip extends outwardly from the elongate layer when the layer is arranged in an annular shape, wherein the lip is capable of being positioned beneath the fascia of a patient.
- the elongate layer can be made of foam.
- the lip can be made of foam.
- the elongate layer may have an inner surface and an outer surface and a thickness therebetween, wherein the thickness of the layer is less than a height of the inner and outer surfaces.
- the inner surface of the elongate layer can be configured to be attached to a wound filler.
- the inner surface of the layer can have means for attaching the inner surface of the layer to the wound filler.
- the outer surface of the layer can be configured to attach to a wound surface.
- the outer surface can have means for attaching the outer surface of the layer to the wound surface.
- the lip can have means for attaching the lip to the fascia.
- the outer surface of the layer can have means for attaching the outer surface of the layer to the wound surface that is different from the means for attaching the lip to the fascia.
- a plurality of fingers can be extending outwardly from the lip.
- the fingers can be covered by a slitted organ protection layer.
- the fingers can comprise a foam material different from the material of the strip.
- the foam material for the fingers can comprise foam in some embodiments having a porosity between 200 ppi to 60 ppi.
- the layer and lip can form a generally L-shaped cross-section.
- the layer can have a first end and a second end and a means for attaching the first and second ends together.
- the apparatus for wound treatment in some embodiments can further comprise a wound filler, wherein the elongate layer described above can surround the wound filler.
- the wound filler can comprise foam.
- An organ protection layer can be configured to be positioned over a wound beneath the wound filler.
- One or more foam layers can be configured to be positioned above and/or below the wound filler.
- a wound cover can be configured to be placed over a wound.
- the apparatus may also comprise a connection for connecting the wound cover to a source of negative pressure.
- a negative pressure source can be configured to be connected to the wound cover to provide negative pressure to a wound.
- a method of treating a wound using the apparatus can comprise applying negative pressure to the wound through a wound cover positioned over the wound.
- a wound filler can be positioned within the wound, wherein the wound filler is surrounded by the elongate layer of material and the lip is positioned beneath the fascia.
- the wound can be an abdominal wound.
- an organ protection layer is positioned over the wound and the wound filler is then positioned within the wound.
- an apparatus for wound treatment comprises a wound filler configured to collapse horizontally within a wound.
- a securing material can be configured to surround the wound filler, the securing material comprises an elongate layer configured to be placed in contact with the wound, and a lip extending outwardly from elongate layer.
- the lip is capable of being positioned beneath the fascia of a patient.
- the elongate layer and the lip are integrated as a single piece and form a generally L-shaped cross-section.
- the apparatus further comprises a wound cover configured to be placed over a wound.
- an inner surface of the layer can be configured to be attached to the wound filler.
- the inner surface can have means for attaching the inner surface of the layer to the wound filler.
- the means for attaching the inner surface of the layer to the wound filler comprise an attachment mechanism selected from the group consisting of a barb, an adhesive, Velcro, hooks of Velcro, mushroom shaped hooks of Velcro, a hooked shape, a staggered hook, a staggered barb, and any combination thereof.
- an outer surface of the layer can be configured to be attached to a wound surface.
- the outer surface can have means for attaching the outer surface of the layer to the wound surface.
- the means for attaching the outer surface of the layer to the wound surface is selected from the group consisting of a barb, an adhesive, Velcro, hooks of Velcro, mushroom shaped hooks of Velcro, a hooked shape, a staggered hook, a staggered barb, and any combination thereof.
- the lip can have means for attaching the lip to the fascia.
- the means for attaching the lip to the fascia comprise an attachment mechanism selected from the group consisting of a barb, an adhesive, Velcro, hooks of Velcro, mushroom shaped hooks of Velcro, a hooked shape, a staggered hook, a staggered barb, and any combination thereof.
- the means for attaching the lip to the fascia comprise a lateral attachment mechanism, the lateral attachment mechanism extending outwardly from a front surface of the lip.
- the apparatus for wound treatment further comprising a plurality of fingers extending outwardly from the lip.
- the apparatus for wound treatment can further comprise an organ protection layer configured to be positioned over a wound beneath the wound filler.
- the apparatus for wound treatment can further comprise one or more foam layers configured to be positioned above and/or below the wound filler.
- the apparatus for wound treatment can further comprise a connection for connecting the wound cover to a source of negative pressure.
- the apparatus for wound treatment further comprising a negative pressure source configured to be connected to the wound cover to provide negative pressure to the wound.
- a method of treating a wound using the apparatus of any one of the preceding claims comprising applying negative pressure to the wound through the wound cover positioned over the wound with the wound filler positioned within the wound, wherein the wound filler is surrounded by the elongate layer and the lip is positioned beneath the fascia; and wherein the wound filler collapses horizontally under negative pressure.
- Figure 1 illustrates an embodiment of a negative pressure treatment system.
- Figure 2A illustrates an embodiment of a wound securing material comprising an elongate layer.
- Figure 2B illustrates a cross sectional view of the wound securing material of Figure 2 A, showing an elongate layer with a lip having an L-shaped cross-section.
- Figure 2C is a perspective view the wound securing material of Figure 2A arranged in an angular shape.
- Figures 2D-2E illustrate side views of the wound securing material of Figure 2A arranged in an annular shape, with slits shown.
- Figure 3A illustrates an embodiment of a wound securing material with an elongate layer of material, a lip, and a plurality of fingers extending outwardly from the lip.
- Figure 3B illustrates an embodiment of a wound securing material with an elongate layer, a lip, and fingers surrounded by an organ protection layer.
- Figure 4 illustrates a top view of an embodiment of a wound securing material.
- Figure 5 illustrates a top view of an embodiment of a wound securing material with fingers.
- Figures 6A illustrate a partial cross sectional view of an embodiment of a negative pressure wound therapy system comprising a wound securing material with an elongate layer and a lip.
- Figures 6B illustrate a partial cross sectional view of an embodiment of a negative pressure wound therapy system comprising a wound securing material with an elongate layer, a lip, and fingers.
- Figures 6C illustrate a partial cross sectional view of another embodiment of a negative pressure wound therapy system, wherein a wound securing material comprises attachment mechanisms.
- Figures 6D is an enlarged view of an embodiment of a wound securing material positioned within a wound comprising attachment mechanisms.
- Figure 7 illustrates a top view of an embodiment of a wound filler and wound securing material placed within a wound.
- Figures 8A-H illustrate a partial cross sectional view of embodiments of a negative pressure wound therapy system comprising a wound securing material with an elongate layer and a lip.
- Figures 8I-K are an enlarged view of an embodiment of a wound securing material positioned within a wound comprising various attachment mechanisms.
- Figure 9A illustrates a cross sectional view of a pad and wound filler at a surgical site in accordance with a preferred embodiment of the invention.
- Figure 9B illustrates a top view of a wound filler and a tissue adhesion device.
- Figure 9C shows a detailed perspective of a surgical drainage system in accordance with a preferred embodiment of the invention.
- Figures 10 illustrates a cross-sectional view of a wound drain and closure system used for a surgically treated pressure ulcer in accordance with a preferred embodiment of the invention.
- Figure 1 1 A illustrates an enlarged view of an embodiment of the tissue anchor system.
- Figure 1 IB is a cross sectional view of the tissue grasping surface of the wound closure device.
- Figure 1 1 C is a side view of a tissue grasping surface, illustrating different tissue anchors for different types of tissue (Ti, T 2 ) and the respective force profiles for the anchors, including the maximum force applied during vacuum closure (Fi) and the force required to remove the anchors from the tissue (F 2 ) without damaging the tissue.
- Figure 1 1D illustrates different designs for a tissue anchor of the invention.
- Figure HE illustrates an enlarged view of tissue anchor elements on the peripheral surface of an oval shaped wound closure device.
- Figure 12A is a schematic illustration of a wound closure device positioned within a wound showing the different force profile around the margin of the wound according to one embodiment.
- Figure 12B illustrates the wound closure device of Figure 12A after a period of wound closure and healing, with the original configuration of the wound and wound closure device indicated in phantom.
- Figures 13A-B illustrate a wound closure device closing a wound.
- Fig. 14 illustrates an embodiment of a negative pressure treatment system.
- Figs. 15A-F illustrate multiple views of an embodiment of a stabilizing structure.
- Figs. 15G-15I illustrate multiple views of another embodiment of a stabilizing structure.
- Fig. 16 illustrates an embodiment of a ring that can surround a stabilizing structure.
- Fig. 17 illustrates an embodiment of a stabilizing structure with surrounding anchoring and foam layers.
- Figs. 18A-D illustrate another embodiment of a stabilizing structure with surrounding anchoring and foam layers.
- Fig. 19 illustrates an embodiment of an open abdominal wound.
- Fig. 20 illustrates an embodiment of a step in a method of treating a wound.
- Fig. 21 illustrates an embodiment of a step in a method of treating a wound
- FIGs. 22A-C illustrate an embodiment of steps of a method of treating a wound.
- Figs. 23A-C illustrate an embodiment of steps of a method of treating a wound.
- Fig. 24 illustrates an embodiment of steps of a method of treating a wound.
- FIGs. 25A-G illustrate an embodiment of steps of a method of treating a wound.
- Embodiments disclosed in this section or elsewhere in this specification relate to apparatuses and methods of treating a wound with reduced pressure, including pump and wound dressing components and apparatuses.
- the embodiments including the wound fillers described herein may be used in combination with a negative pressure system comprising a drape or wound cover placed over the filler.
- a vacuum source such as a pump, may be connected to the cover, for example, through one or more tubes connected to an aperture or port made in or under the cover.
- the apparatuses and components comprising the wound overlay and packing materials, if any, are sometimes collectively referred to herein as dressings.
- wound is to be broadly construed and encompasses open and closed wounds in which skin is torn, cut or punctured, or where trauma causes a contusion, or any other superficial or other conditions or imperfections on the skin of a patient or otherwise that benefit from reduced pressure treatment.
- a wound is thus broadly defined as any damaged region of tissue where fluid may or may not be produced.
- wounds include, but are not limited to, acute wounds, chronic wounds, surgical incisions and other incisions, subacute and dehisced wounds, traumatic wounds, flaps and skin grafts, lacerations, abrasions, contusions, burns, diabetic ulcers, pressure ulcers, stoma, surgical wounds, trauma and venous ulcers or the like.
- the components of the negative pressure treatment system described herein can be particularly suited for incisional wounds that exude a small amount of wound exudate.
- reduced or negative pressure levels such as -X mmHg
- pressure levels that are below standard atmospheric pressure, which corresponds to 760 mmHg (or 1 atm, 29.93 inHg, 101.325 kPa, 14.696 psi, etc.).
- a negative pressure value of -X mmHg reflects absolute pressure that is X mmHg below 760 mmHg or, in other words, an absolute pressure of (760- X) mmHg.
- negative pressure that is "less” or “smaller” than -X mmHg corresponds to pressure that is closer to atmospheric pressure (e.g.,—40 mmHg is less than - 60 mmHg).
- Negative pressure that is "more” or “greater” than -X mmHg corresponds to pressure that is further from atmospheric pressure (e.g., -80 mmHg is more than -60 mmHg).
- the negative pressure range for some embodiments of the present disclosure can be approximately -80 mmHg, or between about -20 mmHg and -200 mmHg. Note that these pressures are relative to normal ambient atmospheric pressure. Thus, -200 mmHg would be about 560 mmHg in practical terms.
- the pressure range can be between about -40 mmHg and - 150 mmHg.
- a pressure range of up to -75 mmHg, up to -80 mmHg or over -80 mmHg can be used.
- a pressure range of below -75 mmHg can be used.
- a pressure range of over approximately -100 mmHg, or even -150 mmHg can be supplied by the negative pressure apparatus.
- the negative pressure range can be as small as about -20 mmHg or about -25 mmHg, which may be useful to reduce fistulas.
- increased wound contraction can lead to increased tissue expansion in the surrounding wound tissue. This effect may be increased by varying the force applied to the tissue, for example by varying the negative pressure applied to the wound over time, possibly in conjunction with increased tensile forces applied to the wound via embodiments of the wound closure devices.
- negative pressure may be varied over time for example using a sinusoidal wave, square wave, and/or in synchronization with one or more patient physiological indices (e.g., heartbeat).
- a wound site 1 10 illustrated here as an abdominal wound site, may benefit from treatment with negative pressure.
- abdominal wound sites may be a result of, for example, an accident or due to surgical intervention.
- medical conditions such as abdominal compartment syndrome, abdominal hypertension, sepsis, or fluid edema may require decompression of the abdomen with a surgical incision through the abdominal wall to expose the peritoneal space, after which the opening may need to be maintained in an open, accessible state until the condition resolves.
- Other conditions may also necessitate that an opening— particularly in the abdominal cavity— remain open, for example if multiple surgical procedures are required (possibly incidental to trauma), or there is evidence of clinical conditions such as peritonitis or necrotizing fasciitis.
- wounds that have exhibited positive response to treatment by the application of negative pressure include infected open wounds, decubitus ulcers, dehisced incisions, partial thickness burns, and various lesions to which flaps or grafts have been attached. Consequently, the application of negative pressure to a wound site 1 10 can be beneficial to a patient.
- an organ protection layer 105 which may be cut to size to be placed over the wound site 1 10.
- the organ protection layer 105 can be a material which will not adhere to the wound site or the exposed viscera in close proximity.
- the organ protection layer is permeable.
- the organ protection layer 105 can be provided with openings, such as holes, slits, or channels, to allow the removal of fluids from the wound site 1 10 or the transmittal of negative pressure to the wound site 1 10. Additional embodiments of the organ protection layer 105 are described in further detail below.
- a tissue protection layer can be used instead of or in addition to the organ protection layer to protect surrounding tissues near the wound site.
- a tissue protection layer can be used in place of the organ protection layer if the wound closure device is used over non-abdominal wounds.
- the tissue protection layer can be used with the organ protection layer to protect the surrounding organs and tissues.
- Certain embodiments of the negative pressure treatment system 101 may also use one or more foam layers 102 and 104 that may be cut to size (e.g., into an oval shape) to fit within the wound.
- a foam layer 104 can be disposed over the organ protection layer 105.
- the foam layer 104 can be configured to be positioned below a wound filler 103 and above the organ protection layer.
- one or more foam layers can be configured to be positioned above and/or below a wound filler 103.
- the wound filler 103 is positioned over the foam layer 104
- a foam layer 102 is positioned over the wound filler 103.
- one or both of these foam layers are optional, and may not be used at all.
- the foam layer(s) above and/or below the wound filler 103 can protect the wound cover and assist in fluid flow.
- the foam can have a thickness of the range of 1 mm to 20 mm (or about 1 mm to about 20 mm), for example between 5 mm and 15 mm(or about 5 mm to about 15 mm).
- Certain embodiments of the negative pressure treatment system 101 may also use wound filler 103, which can be disposed over the wound contact layer 105 and/or over the foam layer 104.
- the wound filler 103 can be cut into an appropriate shape to fit within a wound, e.g., an oval shape.
- the wound filler illustrated in Figure 1 has portions that can be removed to provide an appropriate size for fitting within the wound.
- This wound filler 103 can be constructed from a porous material, for example foam, that is soft, resiliently flexible, and generally conformable to the wound site 1 10.
- a foam can include an open-celled and reticulated foam made, for example, of a polymer.
- Suitable foams include foams composed of, for example, polyurethane, silicone, and polyvinyl alcohol.
- this wound filler 103 can channel wound exudate and other fluids through itself when negative pressure is applied to the wound.
- Some wound fillers 103 may include preformed channels or openings for such purposes.
- the wound filler may include a material or materials that are more compressible in a horizontal plane than in a vertical dimension. Such materials may compress horizontally as negative pressure is applied to cause the wound edges to draw closer together, while maintaining relatively rigid to prevent vertical collapse of the wound cover 107 described below.
- wound fillers Examples of wound fillers that may be used are described in Application Serial No. 13/365,615, titled “Negative Pressure Wound Closure Device,” filed February 3, 2012, published as US 2012/0209227, incorporated by reference herein. Additional wound filler materials and characteristics may be used as described in International Application No. PCT/US2013/050698, titled “Negative Pressure Wound Closure Device,” filed July 16, 2013, incorporated by reference herein.
- the wound closure devices and treatment methods of horizontally compressing material and/or stabilizing structures to be incorporated into wound closure devices will be described in further detail below with respect to Figures 14-25G.
- the negative pressure treatment system 101 may comprise an additional wound filler material 200 that facilitates securement of the wound filler 103 to the wound.
- This material 200 will be hereinafter referred to as wound securing material 200.
- the wound securing material 200 may comprise an elongate strip of material 210 that may be formed in an annular shape and sized to fit over the outer dimension of the wound filler 103.
- the wound securing material 200 may be placed in the wound before or with the wound filler 103.
- the wound securing material 200 can be configured to be placed in contact with the wound edges, such that the wound securing material is between the wound edge and the wound filler material 103.
- the wound securing material 200 can have a lip 216 extending outwardly when the wound securing material is in an annular shape.
- the wound securing material 200 can have a plurality of fingers 217 protruding outwardly from the lip.
- the lip and the fingers can be positioned beneath the fascia of the patient in order to secure the wound filler within the wound. Additional embodiments of the wound securing material 200 are described in further detail below.
- a wound cover 107 is used to seal the wound site 1 10.
- the wound cover 107 can be at least partially liquid impermeable, such that at least a partial negative pressure may be maintained at the wound site.
- Suitable materials for the wound cover 107 include, without limitation, synthetic polymeric materials that do not significantly absorb aqueous fluids, including polyolefms such as polyethylene and polypropylene, polyur ethanes, polysiloxanes, polyamides, polyesters, and other copolymers and mixtures thereof.
- the materials used in the wound cover may be hydrophobic or hydrophilic. Examples of suitable materials include Transeal® available from DeRoyal and OpSite® available from Smith & Nephew.
- the wound cover in certain embodiments are at least partly breathable, such that water vapor is able to pass through without remaining trapped under the dressing.
- An adhesive layer may be provided on at least a portion the underside of the wound cover 107 to secure the wound cover to the skin of the patient, although certain embodiments may instead use a separate adhesive or adhesive strip.
- a release layer may be disposed over the adhesive layer to protect it prior to use and to facilitate handling the wound cover 107; in some embodiments, the release layer may be composed of multiple sections.
- the negative pressure system 101 can be connected to a source of negative pressure, for example a pump 1 14.
- a pump 1 14 is the Renasys EZ pump available from Smith & Nephew.
- the wound cover 107 may be connected to the source of negative pressure 1 14 via a conduit 1 12.
- the conduit 1 12 may be connected to a port 1 13 situated over an aperture 109 in the wound cover 107, or else the conduit 1 12 may be connected directly through the aperture 109 without the use of a port.
- the conduit may pass underneath the wound cover and extend from a side of the wound cover.
- U.S. Patent No. 7,524,315 discloses other similar aspects of negative pressure systems and is hereby incorporated by reference in its entirety and should be considered a part of this specification.
- a container or other storage unit 1 15 may be interposed between the source of negative pressure 1 14 and the conduit 1 12 so as to permit wound exudate and other fluids removed from the wound site to be stored without entering the source of negative pressure.
- Certain types of negative pressure sources for example, peristaltic pumps— may also permit a container 1 15 to be placed after the pump 1 14.
- Some embodiments may also use a filter to prevent fluids, aerosols, and other microbial contaminants from leaving the container 1 15 and/or entering the source of negative pressure 1 14.
- FIG. 1 may also include a shut-off valve or occluding hydrophobic and/or oleophobic filter in the container to prevent overflow; other embodiments may include sensing means, such as capacitive sensors or other fluid level detectors that act to stop or shut off the source of negative pressure should the level of fluid in the container be nearing capacity.
- sensing means such as capacitive sensors or other fluid level detectors that act to stop or shut off the source of negative pressure should the level of fluid in the container be nearing capacity.
- At the pump exhaust it may also be preferable to provide an odor filter, such as an activated charcoal canister.
- Figures 2A-2E illustrate embodiments of the wound securing material 200 with a lip that may be used in the negative pressure systems and methods as described herein. As compared to Figure 1 , the securing material 200 in Figures 2A-2E do not include fingers, which are shown in the embodiment of Figures 3A-3B.
- Figure 2A illustrates an embodiment of the securing material 210 as an elongate layer or strip 210 that may have a straight or substantially straight length between ends 214 and 215 before use, and which may be cut to an appropriate length to be sized around wound filler 103.
- the ends 214, 215 can be joined to form an angular shape and can be attached through an attachment mechanism such as an adhesive, gripper or barbs, Velcro, hooks of Velcro, mushroom shaped hooks of Velcro, or other attachment mechanism known in the art.
- an attachment mechanism such as an adhesive, gripper or barbs, Velcro, hooks of Velcro, mushroom shaped hooks of Velcro, or other attachment mechanism known in the art.
- the wound securing material may be pre-formed into an annular shape to fit different sizes of wound fillers.
- the wound securing material 200 can have a lip 216, an inner surface 21 1 , an outer surface 212, and a thickness 213 therebetween.
- the elongate layer 210 can have a height of the inner and outer surface 21 1 , 212 that is greater than its thickness 213.
- the inner surface 21 1 of the elongate layer can be configured to attach to the wound filler 103.
- the wound securing material 200 including the lip 216 and the elongate layer 210 can stabilize the wound filler and/or wound closure device in position within the wound.
- the elongate layer can have a lip forming an L- shaped cross-section as illustrated in Figure 2A-E.
- Figure 2B illustrates a cross sectional view of an embodiment of an elongate layer with a lip 216 having an L-shaped cross-section.
- the elongate layer can be in the form of a strip without a lip.
- the elongate layer can be used in the same way as described with reference to the elongate layer with a lip herein however a portion of the elongate layer is not disposed beneath the fascia.
- Figure 2D-2E illustrates an embodiment of an elongate layer 220 arranged in an annular shape with slits shown.
- the lip 216 can have slits or cut outs 221 that allow for the bending of the elongate layer into the angular shape formation as illustrated in Figure 2A- 2E.
- the wound securing material 200 of Figure 2A can be made of foam.
- the wound securing material 200 can be formed of any material that can transmit negative pressure and/or fluid.
- the material can be a felted open reticulated foam having a porosity in the range of 60 ppi (or about 60 ppi) or less, 50 ppi (or about 50 ppi) or less, 40 ppi (or about 40 ppi) or less, 30 ppi (or about 30 ppi) or less, 20 ppi (or about 20 ppi) or less, or 10 ppi (or about 10 ppi) or less.
- the foam can be compressed with heat and/or pressure to form the more rigid felted foam.
- the material can be a felted, 10-60 ppi (or about 10 to about 60 ppi) open reticulated foam, such as one that has been compressed with heat and/or pressure to form the more rigid felted foam.
- Such a foam may supply little barbs that can help attach the material to the tissue better.
- the felting can be important to increase the rigidity of the foam but leave a structure that can still act as a manifold for exudates and the vacuum.
- the results of felting are a more dense structure, and therefore the resulting surface can be less open for tissue ingrowth.
- the foam can have a finer pore size, e.g., 60 ppi to 200 ppi (or about 60 ppi to about 200 ppi), or greater than 60 ppi (or about 60 ppi), to minimize granulation tissue formation.
- a finer pore size e.g., 60 ppi to 200 ppi (or about 60 ppi to about 200 ppi), or greater than 60 ppi (or about 60 ppi), to minimize granulation tissue formation.
- the wound securing material 200 can be made of materials that do not adhere to the wound site.
- the non-adherent material can assist in wound closure without adhering to the tissue within the wound site.
- the non-adherent material can prevent injury to the wound tissue when the wound closure device is removed from the wound site.
- the wound securing material 200 can be a porous or non-porous material.
- the wound securing material 200 can be a flexible covering, such as a mesh film, that is secured to the outer perimeter surface of the wound filler 103 and can expand and contract with the expansion and contraction of the wound filler 103.
- the wound securing material 200 can be a mesh film or a composite polyester mesh film, such as the ParietexTM mesh from Covidien (Mansfield, MA).
- the inner surface 21 1 may be configured to attached to the wound filler through any suitable attachment mechanism such as an adhesive, gripper or barbs, Velcro, hooks of Velcro, mushroom shaped hooks of Velcro, or other attachment mechanism known in the art.
- the elongate layer 210 is supplied with a means of attachment integrated within the inner surface 21 1.
- the inner surface 21 1 can be prepared prior to insertion into the body cavity with the attachment means.
- the elongate layer 210 may also have an outer surface 212 configured to attach to the wound surface.
- the outer surface 212 can be configured to attach to the wound surface through any suitable tissue attachment mechanism such as an adhesive, gripper or barbs, tissue grabbers known in the art, glue, suturing, Parietex, or other tissue attachment mechanism known in the art.
- the outer surface 212 can have barbs that may help attach to the tissue, such as backward facing barbs that can anchor into the tissue when the barbs are pulled in the direction that closes the wound cavity but can be released when pushed in the opposite direction, and can provide a closing force on the wound.
- the barbs can be polymer, glass, metal, fine hair like structures, and/or other barbs known in the art.
- the barbs may be smooth rod like projections.
- the barbs may have a rough surface or spiked surface to increase adhesion.
- the length of the barbs can be in the range of 0.1 mm to 5 mm (or about 0.1 mm to about 5 mm), for example 5 mm (or about 5 mm), 4 mm (or about 4 mm), 3 mm (or about 3 mm), 2 mm (or about 2 mm), or 1 mm (or about 1 mm).
- the spacing of the barbs can be in the range of 0.1 mm to 10 mm (or about 0.1 mm to about 10 mm), for example 10 mm (or about 10 mm), 8 mm (or about 8 mm), 6 mm (or about 6 mm), 4 mm (or about 4 mm), 2 mm (or about 2 mm), or 1 mm (or about 1 mm).
- the elongate layer 210 is supplied with a means of attachment integrated within the outer surface 212. In some embodiments, the elongate layer 210 outer surface 212 can be prepared prior to insertion into the body cavity with the attachment means.
- the lip 216 can attach to the base 232 of the outer surface 212 or be formed with the elongate layer 210 to form a generally L-shaped cross- section as illustrated in Figure 2B.
- the lip 216 can be made of the same or a different foam material as that described above.
- the lip can be formed of other material known in the art appropriate for contacting the wound or fascia of a patient.
- the lip 216 can be formed of material that can transmit negative pressure and/or fluid.
- the lip 216 can be a non-porous material.
- the lip 216 can be a porous material.
- the lip can be made of materials that do not adhere to the wound site.
- the non-adherent material can assist in wound closure without adhering to the tissue within the wound site.
- the non-adherent material can prevent injury to the wound tissue when the wound closure device is removed from the wound site.
- the lip 216 can be a flexible material, for example a flexible polymer material. As the lip extends outward from the wound filler the lip 216 can have varying rigidity, for example near the wound filler the lip 216 can be rigid and as the lip extends outward radially the lip material can increase in flexibility and/or decrease in strength.
- the lip 216 can have a top surface 218, a bottom surface 219, and a thickness therebetween as illustrated in Figure 2B. Additionally, the lip 216 can have a front or outward surface 231.
- the lip 216 can have an upper surface 218 that can be configured to attach to the wound site.
- the lip can have a means for attaching the lip to the fascia.
- the upper surface 218 can be attached to the wound site through a tissue attachment mechanism such as an adhesive, gripper or barbs, tissue grabbers known in the art, glue, suturing, Parietex, or other tissue attachment mechanism known in the art.
- the barbs may be smooth rod like projections. Alternatively, in some embodiments, the barbs may have a rough surface or spiked surface to increase adhesion.
- the lip 216 can have barbs, such as backward facing barbs, that may help attach to the tissue or anchor the lip into the fascia when the barbs are pulled in the direction that closes the wound cavity but can be released when pushed in the opposite direction, and can provide a closing force on the wound.
- the barbs can be polymer, glass, metal, fine hair like structures, and/or other barbs known in the art.
- the length of the barbs can be in the range of 0.1 mm to 5 mm (or about 0.1 mm to about 5 mm), for example 5 mm (or about 5 mm), 4 mm (or about 4 mm), 3 mm (or about 3 mm), 2 mm (or about 2 mm), or 1 mm (or about 1 mm).
- the spacing of the barbs can be in the range of 0.1 mm to 10 mm (or about 0.1 mm to about 10 mm), for example 10 mm (or about 10 mm), 8 mm (or about 8 mm), 6 mm (or about 6 mm), 4 mm (or about 4 mm), 2 mm (or about 2 mm), or 1 mm (or about 1 mm).
- the lip 216 is supplied with a means of attachment integrated within the upper surface 218.
- the lip 216 upper surface 218 can be prepared prior to insertion into the body cavity with the attachment means.
- the surface of the lip that the barbs protrude from may be smooth to limit the formation of granulation tissue on the fascia.
- the tissue attachment mechanism on the lip 216 can be the same tissue attachment mechanism as used on the other components of the device. In other embodiments, the tissue attachment mechanism on the lip 216 can be of a different type than is used on the other components of the device.
- the wound securing material can comprise an elongate layer such as a tape, with or without a lip.
- the tape can surround the wound filler when in use.
- the tape can contain adhesive, barbs, Velcro, hooks of Velcro, mushroom shaped hooks of Velcro, or other attachment mechanism known in the art on both sides.
- the tape can have adhesive, barbs, Velcro, hooks of Velcro, mushroom shaped hooks of Velcro, or other attachment mechanism known in the art on the tissue facing side and an adhesive or other attachment mechanism known in the art on the wound filler facing side.
- the barbs may be smooth rod like projections.
- the barbs may have a rough surface or spiked surface to increase adhesion.
- the length of the barbs can be in the range of 0.1 mm to 5 mm (or about 0.1 mm to about 5 mm), for example 5 mm (or about 5 mm), 4 mm (or about 4 mm), 3 mm (or about 3 mm), 2 mm (or about 2 mm), or 1 mm (or about 1 mm).
- the spacing of the barbs can be in the range of 0.1 mm to 10 mm (or about 0.1 mm to about 10 mm), for example 10 mm (or about 10 mm), 8 mm (or about 8 mm), 6 mm (or about 6 mm), 4 mm (or about 4 mm), 2 mm (or about 2 mm), or 1 mm (or about 1 mm).
- the barbs on the tape can be different sizes and shapes. In some embodiments, the barbs on the tape can be of the same size and shape.
- Figure 3A illustrates an embodiment of a wound securing material 200 comprising an elongate layer of material 210 with a lip 216 and a plurality of fingers 217 extending outwardly from the lip.
- the lip can have one or more outwardly extending fingers 217 protruding from the end of the lip 216.
- the plurality of outwardly extending fingers 217 can be protruding from the end of the front surface 231 of the lip 216 as illustrated in Figure 3 A.
- the fingers 217 can each have a distal end 240 and a proximal end 241 and a length extending from the distal end 240 to the proximal end 241.
- the proximal end 241 of each finger 217 can be attached to the front surface 231 of the lip 216.
- the lip 216 is formed with fingers 217 protruding from the front surface 231 of the lip 216.
- the finger 217 can be a foam material.
- the fingers 217 can comprise a foam material different from the material used for the elongate layer, the lip, and/or other components of the device.
- the fingers can comprise a foam material similar or the same as the material used for the elongate layer, the lip, and/or other components of the device, or any other foam described herein.
- the foam used for the fingers can be compressed as described herein.
- the foam material used for the fingers 217 can be a foam having a porosity in the range of 60 ppi to 200 ppi (or about 60 ppi to about 200 ppi), or greater than 60 ppi (or about 60 ppi) to minimize granulation tissue formation. .
- the fingers or even portions of the wound securing material such as the lip 216 can be made of a 3D fabric instead of foam, for example a knitted or woven spacer fabric (such as a knitted polyester 3D fabric, Baltex 7970®, or Gehring 879®) or a nonwoven fabric.
- the fingers or wound securing material can comprise other materials that can remain porous when compressed, including non-woven materials and/or other materials described herein or known in the art.
- the fingers 217 can be formed from a non-porous material. Additionally, in some embodiments, the fingers 217 can be a flexible material, for example a flexible polymer material.
- the fingers 217 can have varying a rigidity, for example near the lip 216 at the proximal end 241 the fingers 217 can be rigid, but as the fingers 217 extends outward radially from the lip 216 the fingers 217 can increase in flexibility and/or decrease in strength and the distal end 240 can be flexible.
- the fingers 217 can have varying thickness, for example the thickness of the fingers can be reduced along the length of the fingers 217 and the proximal end 241 can be thicker than the distal end 240.
- the fingers can be branched and/or contain cross members, for example cross members can extend from one finger to another finger thereby connecting the fingers.
- the fingers 217 can vary in the width, for example the fingers 217 can widen as it extends outward radially from the lip 216 and the distal end 240 can be wider than the proximal end 241. The widening of the finger can allow for greater fluid removal.
- the fingers 217 can be helpful to drain the abdomen because they are in contact with the wound site and/or extend into the rear of the abdomen.
- the fingers 217 can assist in securing the lip 216 during use as the fingers 217 can be inserted between the fascia and the internal organs as described further below.
- the fingers 217 can extend into the rear of the abdomen thus draining fluid from the majority of the abdominal cavity. For example, the fluid may travel along the length of the fingers towards the point of application of negative pressure thereby draining fluid from the abdominal cavity.
- the surface of the fingers 217 can be in contact with the interior of the wound site and body cavity. Such interaction of the finger 217 surface with the interior of the body may cause the formation of granulation tissue.
- the fingers 217 can be formed from a foam with a porosity in the range of 60 ppi to 200 ppi (or about 60 ppi to about 200 ppi) to prevent granulation of tissue.
- Figure 3B illustrates an embodiment of a wound securing material with fingers as described with reference to Figure 3A, but the fingers as illustrated in Figure 3B can be surrounded by an organ protection layer 305.
- the fingers 217 can be encapsulated by an organ protection layer 305 that has a plurality of fluid drainage openings or slits that prevents granulation tissue and other undesired interactions between the fingers and the body cavity interior.
- the organ protection layer 305 surrounding the fingers 217 can be microporous or semipermeable, for example a dialysis membrane.
- the organ protection layer 305 may serve to increase strength of the fingers 217 and thereby reduce the chance of parts being left in the body due to tearing during removal.
- Figure 4 illustrates the top view of an embodiment of a wound securing material 200 similar to Figures 2C comprising an elongate layer 210 formed into or having an annular shape with an outwardly extending lip 216 and slits 221.
- Figure 5 illustrates the top view of an embodiment similar to Figures 3A-3B of a wound securing material 200 formed into or having an annular shape with fingers 217 extending outwardly from the lip 216.
- the elongate layer 210 of Figure 2A including the lip 216 is bent into an angular shape and the first end 214 and end second end 215 are attached, the elongate layer can form an annular shape as illustrated in the top view shown in Figure 4.
- Figures 6A-6C illustrate a cross sectional view of the negative pressure system 101 with the components described with respect to Figure 1 as applied to a wound.
- Figure 6A illustrates a cross sectional view of the wound securing material 200 similar to the Figure 2A-E embodiments within the wound area.
- an organ protection layer 105 can be positioned in the wound site as shown in Figure 6A.
- the organ protection layer 105 can extend radially beyond the foam layer 104 and the outer ends 602 of the organ protection layer can be inserted beneath the abdominal wall 601.
- the organ protection layer can have a length in the range of 900 mm (or about 900 mm) or less, 800 mm (or about 800 mm) or less, 700 mm (or about 700 mm) or less, and 600 mm (or about 600 mm) or less.
- foam layer 104 can be provided above the organ protection layer 105.
- the foam layer 104 can be a foam as described herein or other foam known in the art.
- the foam can have a thickness in the range of 1 mm to about 20 mm (or about 1 mm to about 20 mm), for example 15 mm (or about 15 mm) or less, 10 mm (or about 10 mm) or less, or 5 mm (or about 5 mm) or less.
- the outer perimeter or boundary of the foam 104 will not extend beyond the front surface 231 of the lip 216 of the wound securing material 210.
- the foam layer 104 will extend to the front surface 231 of the lip 216.
- the foam 104 will not protrude out under the tissue 600 of the wound site. In some embodiments, the foam 104 can extend beyond the front surface 231 of the lip 216 as shown in Figure 8A. In some embodiments, the foam layer 104 can be at least partially surrounded by the elongate layer 210 and/or lip 216 of the wound securing material 200 as illustrated in Figure 6C-6D.
- the wound filler 103 can be placed above the foam layer 104 and below the foam layer 102.
- the wound filler can be a wound filler as described herein or other foam known in the art.
- the wound filler can have a thickness of the range of 5 mm to 40 mm (or about 5 mm to about 40 mm), for example 40 mm (or about 40 mm) or less, 30 mm (or about 30 mm) or less, or 10 mm (or about 10 mm).
- the wound filler can have a thickness on the lower end of the range for use in neonatal applications.
- the wound filler 104 can be used in combination with other wound filler stacked within the wound site for larger or deeper wounds.
- additional wound filler can also be surrounded by an additional wound securing material as described herein.
- the additional wound securing material surrounding the wound fillers stacked above the bottom wound filler can be an elongate layer without finger protrusions.
- the additional elongate layers surrounding the wound fillers stacked above the bottom wound filler can be an elongate layer without a lip.
- the wound filler can be surrounded by the elongate layer 210.
- the elongate layer 210 can have a lip 216.
- the elongate layer 210 and lip 216 can be any embodiment of an elongate layer and/or lip as described herein.
- the lip 216 of the elongate layer 210 can extend under the tissue 600.
- the lip 216 can be inserted beneath the layer of tissue 600 in which a closing force is desired to close the wound cavity.
- the lip can extend beneath the deep fascia, subserous fascia, serous membrane, peritoneum, or any other layer between the dermal layers and the viscera.
- the lip can preferably be placed beneath the peritoneum.
- the use of the lip may therefore facilitate maintaining and retaining the wound filler at the correct vertical level within the wound.
- the lip can have a length in some embodiments between 5 mm and 60 mm (or about 5 mm and about 60 mm), for example 60mm (or about 60 mm) or less, 50 mm (or about 50 mm) or less, 40 mm (or about 40 mm) or less, 30 mm (or about 30 mm) or less, or 10 mm (or about 10 mm) or less.
- the attachment mechanisms on the lip 216 can thus be used to facilitate movement of the fascia as the wound closes.
- the elongate layer 210 with the lip 216 surrounds the wound filler 103.
- the wound filler 103 can be wrapped with and attached to the elongate layer 210 with the lip 216 prior to insertion of the unit into the body cavity.
- the elongate layer 210 with the lip 216 and the wound filler 103 can be one integral piece of material.
- the elongate layer 210 with the lip 216 can be cut and shaped into the appropriate size for the wound site 1 10 and then placed within the wound site. Then the wound filler 103 can be placed within and attached to the inner surface 21 1 of the elongate layer 210 with the lip 216.
- the inner surface 21 1 of the elongate layer 210 can contact the wound filler 103 and the outer surface of the elongate layer 212 and the lip can contact the interior of the wound site.
- the inner surface 21 1 and the wound filler 103 can be attached through the attachment means described herein and other attachment means known in the art.
- a foam layer 102 can be provided above the wound filler 103.
- the foam layer 102 can comprise a foam as described herein or other foam known in the art.
- the foam can have a thickness in the range of 1 mm to about 20 mm (or about 1 mm to about 20 mm), for example 15 mm (or about 15 mm) or less, 10 mm (or about 10 mm) or less, or 5 mm (or about 5 mm) or less.
- the outer boundary of the foam 102 will not extend beyond the outer surface 212 of the elongate layer 210. In some embodiments, the foam 102 will extend to the outer surface 212.
- the foam 102 can extend beyond the outer surface 212 as shown in Figure 8A. In some embodiments, the foam 102 can be at least partially surrounded by the elongate layer 210 and/or lip 216 as illustrated in Figure 6C-6D.
- the foam layer 102 is covered by a wound cover 107.
- the wound cover 107 can include all embodiments of a wound cover described herein and other wound covers known in the art.
- a port 1 13 and a conduit 1 12 may be used to connect the wound cover to a source of negative pressure as described above.
- Figure 6B illustrates a cross sectional view similar to that described in Figure 6A, however, Figure 6B illustrates the elongate layer 210 with fingers 217 as described with respect to Figure 3 protruding outwardly from the lip.
- the fingers 217 can have a length in the range of 100 mm to about 300 mm (or about 100 mm to about 300 mm), for example, 250 mm (or about 250 mm) or less, 200 mm (or about 200 mm) or less, or 150 mm (or about 150 mm) or less.
- the lip 216 and fingers 217 can be inserted beneath the layer of tissue 600 in which a closing force is desired to close the wound cavity.
- the lip and fingers 217 can extend beneath the deep fascia, subserous fascia, serous membrane, peritoneum, or any other layer between the dermal layers and the viscera.
- the lip can preferably be placed beneath the peritoneum.
- Figure 6C illustrates an alternative embodiment of a cross sectional view of the elongate layer within the wound area similar to that described with reference to Figure 6A.
- Figure 6C further illustrates an elongate layer 210 and with an attachment mechanism 700 for attachment of the elongate layer to the wound filler material.
- the attachment mechanism 700 can be achieved through any of the means described herein and other attachment mechanisms known in the art.
- Figure 6C further illustrates an attachment mechanism 701 for attachment of the elongate layer outer surface 212 to the wound site.
- the attachment mechanism 701 can be achieved through any of the means described herein and other attachment mechanisms known in the art.
- Figure 6D illustrates an elongate layer 210 with an attachment mechanism 702.
- the outer surface 212 of the elongate layer can be attached to the wound site through tissue attachment means described herein and other tissue attachment means known in the art.
- the upper surface 218 of the lip 216 can be attached to the wound site through tissue attachment means described herein and other tissue attachment means known in the art.
- the attachment mechanism 702 can be achieved through any of the means described herein and other attachment mechanisms known in the art.
- the attachment mechanisms 700, 701 , and 702 can utilize the same attachment means. Alternatively, in some embodiments, the attachment mechanisms 700, 701 , and 702 can utilize different attachment means.
- the lip 216 can extend outwardly into the wound cavity.
- the top surface of the lip 216 can be situated under the peritoneum or fascia of the patient.
- the lip 216 can be inserted into the wound site 1 10 by the medical professional or user manipulating the lip 216 with their fingers to get the lip 216 under the peritoneum.
- the optional tissue attachment mechanism on the top surface of the lip can adhere the lip to the wound site and secure the lip 216 as shown in Figure 6D.
- the secure connection of the elongate material 210 through the secure connection of the lip 216 to the wound site 1 10 can ensure the correct positioning of the wound filler 103 attached to the inner surface 21 1 of the elongate material 210.
- the lip 216 can assist in providing structural stability to the device and prevent the wound filler or device from coming out of the wound site. Additionally, the barb or grippers on the lip 216 may also produce traction to pull the bottom of the wound together.
- the bottom surface of the lip 216 can be in contact with a bottom foam layer 104 and/or an organ protection layer 105, depending on the components used and the dimensions of those components.
- Figure 7 illustrates a top view of a wound filler 103 inserted into a wound 1 10 with a wound securing material 200 such as described in Figures 3A-3B surrounding the wound filler.
- the front surface 231 of the lip 216 and the fingers 217 are illustrated in phantom lining to depict that the lip 216 and the fingers 217 are located radially outward from the wound edge and placed underneath the fascia.
- Figures 8A-H illustrate a partial cross sectional view of embodiments of a negative pressure wound therapy system comprising a wound securing material with an elongate layer and a lip.
- the negative pressure wound therapy systems comprising a wound securing material illustrated in Figures 8A-B are similar to the system described with reference to Figure 6A.
- Figures 8A-B further illustrate the foam 102 extending beyond the elongate layer 210 and in contact with the top surface of the tissue.
- Figure 8B illustrates an embodiment comprising two wound filler materials 103 separated by an additional foam layer 160.
- the two wound filler materials 103 and the additional foam 160 can be surrounded by the elongate layer 210 and lip 216.
- Figures 8C-D illustrate embodiments of negative pressure wound therapy systems comprising a wound securing material similar to that described with reference to Figure 6 A.
- Figures 8C-D further illustrate the foam layers 102, 104 at least partially surrounded by the elongate layer 210 and/or lip 216.
- Figure 8B illustrates an embodiment comprising two wound filler materials 103 separated by an additional foam layer 160.
- the two wound filler materials 103 and the additional foam 160 can be surrounded by the elongate layer 210 and lip 216.
- Figures 8E-F illustrate embodiments of negative pressure wound therapy systems comprising a wound securing material similar to that described with reference to Figures 8A-B. Figures 8E-F further illustrate the use of grippers and/or attachment mechanisms 700, 701 as described with reference to Figure 6C.
- Figures 8G-H illustrate embodiments of negative pressure wound therapy systems comprising a wound securing material similar to that described with reference to Figures 8C-D. Figures 8G-H further illustrate further illustrate the use of grippers and/or attachment mechanisms 700, 701 as described with reference to Figure 6C.
- Figures 8I-K are enlarged views of embodiments of a wound securing material positioned within a wound comprising attachment mechanisms 701 , 700.
- the attachment mechanisms 701 can be mushroom grippers as illustrated in Figure 81.
- the attachment mechanisms 701 can be incline grippers as illustrated in Figure 8 J.
- the attachment mechanisms 701 can be hook grippers as illustrated in Figure 8K.
- the elongate material 210 can be in the form of a strip without a lip.
- the elongate layer without a lip can have fingers that extend directly from the outer surface 212 of the elongate material 210. These fingers extending directly from the elongate layer can contact the tissue and be placed beneath the fascia and/or any other layer or configuration as described herein.
- the fingers 217 extending directly from the elongate layer 210 without the lip can support and secure the wound securing material 200 and provide the functionality of the elongate layer with the lip as described herein.
- the elongate material 210 can have more than one lip 216 extending outwardly from the elongate material.
- the elongate layer can have two separate lip regions extending outwardly from the outer surface of the elongate layer that can be positioned at different depths in the wound. For example, one lip can extend laterally from the elongate layer and can be placed between the abdominal cavity and the fascia while a second lip can be positioned between the fascia and overlying tissue.
- the elongate material 210 and lip 216 are preferably integrally formed or attached to one another such that the elongate material and lip are integrated into a single piece to be placed in the wound simultaneously.
- the elongate material may also be pre-attached to any of the wound fillers described herein, such that the wound filler, elongate material and lip are placed in the wound simultaneously.
- Figure 9A-9C illustrate another embodiment where a wound 1900 is treated using a wound filler in a negative pressure region 1918 that is a separate element from an underlying pad 1925 that extends laterally beyond the edges of the wound filler 1918.
- the pad 1925 in Figure 9A is illustrated as being positioned between the fascia and overlying tissue, but in other embodiments, the pad 1925 may be positioned underneath the fascia.
- the pad 1925 also need not be a separate element from the filler 1918, and may be attached to the filler or be formed integral with the filler. It will further be appreciated that features of the pad 1925, such as the drain tubes, apertures and tissue anchors described further below, can also be incorporated into the lip 216 that may be integral with the elongate material 210 described above.
- Illustrated in Fig. 9A is a wound incision 1900 in which tissue regions 1906, 1908 have been separated to access an underlying tissue region 1902 for treatment.
- the lateral displacement of regions 1906, 1908 from their respective positions overlying region 1902 has caused further separation between the displaced regions 1906, 1908 and the underlying structure.
- the underlying structure can be the large and small intestines, which can be subject to infection and/or elevated fluid pressure.
- the system can optionally include three components, the pad 1907 positioned between the abdominal cavity 1902 and the fascia that can be used to permit sliding movement and utilize negative pressure, secondly, a pad 1925, described in greater detail hereinafter, positioned between the fascia and overlying tissue and, thirdly, the wound filler 1918.
- the negative pressure region of the wound filler 1918 can be in fluid communication with the underlying layer of the pad 1925, which extends laterally to sections 1914 and 1916 which are situated between overlying tissue 1906, 1908, respectively, and the underlying abdominal muscle and fascia structure 191 1 , 1909.
- One or both sides of the sections 1914, 1916 can have tissue anchors as described herein.
- Dotted line 1921 indicates a region through which negative pressure is applied to all three layers.
- the compressible wound filler 1918 is inserted followed by the wound cover 1905 and the port 1940 and conduit 1942.
- the pad 1907 operates to drain fluid 1910 from the abdominal cavity by negative pressure through pad 1925 and wound filler 1918.
- the wound filler 1918 can be integral to or attached to the underlying layers.
- the wound filler 1918 can be integral to the pad 1925.
- the wound filler 1918 can be integral to or attached to both pad 1925 and pad 1907.
- the system does not include the pad 1925.
- the wound filler 1918 can be integral to or attached to pad 1907 which can be positioned between the abdominal cavity 1902 and the fascia.
- the pad 1907 can be positioned on top of the visceral peritoneal layer.
- the attached pad 1907 and/or pad 1925 will also collapse horizontally.
- the horizontal collapse can cause pad 1907 and/or pad 1925 to slide relative to the tissue layer over which pad 1907 and/or pad 1925 is positioned.
- the wound filler 1918 is attached to the pad 1907 positioned over the visceral peritoneal layer. As the wound filler 1918 collapses horizontally under the application of negative pressure, the horizontal collapse can thereby cause the attached pad 1907 to slide over the visceral peritoneal layer.
- the wound filler 1918 can be attached to the underlying pad at substantially all points of contact between the wound filler 1918 and the underlying pad. In other embodiments, the wound filler 1918 can attach to the underlying pad 1925 and/or pad 1907 at one or more attachment points. In one embodiment, the wound filler 1918 can be attached to the underlying pad 1925 and/or pad 1907 only at a center attachment point. As the wound filler 1918 collapses horizontally, the wound filler 1918 would slide horizontally relative to the underlying pad 1925 and/or pad 1907 due to the center attachment point. In some embodiments, the wound filler 1918 can be attached to the underlying pad 1925 and/or pad 1907 by one or more ribs extending down the center of the wound filler 1918. The one or more ribs can extend downward from the center of wound filler 1918 and connect to pad 1925 and/or pad 1907. Additionally, in some embodiments, the wound filler 1918 can be attached to pad 1925 and/or pad 1907 by an adhesive.
- a wound treatment system can be used in combination with the systems and methods described herein.
- Shown in Fig. 9B is a top view of a system utilizing a wound filler 1918 as described generally herein and a pad 1925.
- the shape of pad 1925 can also be circular and be without apertures or tissue anchors, for example.
- the number of drains can be in a range of 6- 10 that extend in a radial direction with uniform angular spacing between the drain elements.
- a preferred embodiment provides a pad or surgical drain device 1925 for promoting drainage of surgical wounds and wound closure.
- the drain device can include a plurality of drain tubes 1935 disposed on a substrate termed an "adhesion matrix,” which is designed to promote tissue adhesion within the wound space.
- the adhesion matrix has a conformable configuration and is made of a compliant material having planar surfaces that can bend to adapt to the shape of the wound space.
- the adhesion matrix contains a plurality of apertures 1927, or gaps in the matrix material, which allow tissue contact across the matrix, so as to promote adhesion and wound closure.
- a tissue surface on a first side of the matrix can directly contact a tissue surface on a second, or opposite, side of the matrix to promote rapid healing and stabilization of the wound.
- the number, size and distribution of the apertures 1927 extending through the matrix can be selected based on the geometry of the wound.
- the drain tubes can be positioned in a fan shaped array with a plurality of three or more tubes extending from a manifold. The matrix and/or the tubing can be cut or shaped by the user to conform to the shape of the wound.
- the matrix can also be used as a medication carrier to assist in the administration of a drug to a patient.
- the matrix can optionally include a layer of adhesive on at least a portion of any of its surfaces.
- the drain tubes can be removed from the device once drainage flow is sufficiently reduced, and the adhesion matrix can remain within the body, where it is degraded and absorbed over time, remaining in place to optimize tissue healing.
- the matrix can comprise a porous biodegradable polymer material. As the plurality of tubes extend from a single exit site into the wound with spaced apart distal ends, a user can readily remove all the tubes simultaneously from the wound.
- the pad 1925 can include a tissue anchoring system, whereby the device is mechanically attached to surrounding tissues by an array of surface barbs or hooks 1926, 1928 or other attachment mechanism as described herein.
- These surface structures can be located on any exposed surface of the adhesion matrix.
- the surrounding tissues can be pressed against the barbs or hooks to embed them within the tissue and anchor the device.
- the use of surface barbs or hooks can be used in combination with a surgical adhesive, providing a much stronger bond between tissue layers than the adhesive alone, and providing temporary adhesion while the adhesive sets.
- the structure of the hooks can have various forms depending on the tissue they are intended to bind. Longer hooks can be used for loosely bound tissues such as fat or connective tissue, while shorter hooks can be used for denser tissues such as muscle. Anchors with more rigid stems can be utilized to penetrate denser tissues.
- the system includes the drain device or pad coupled to a wound filler 1918 as described generally herein together with a vacuum source, such as a pump, and a tube connecting the vacuum source to the drain tubes of the drain device or pad.
- the system optionally also can include a fluid trap to collect drained fluid and a control unit to monitor and control the application of vacuum and the collection of fluid.
- Further components of the system can include a vacuum or pressure gauge, a flow meter, and a computer to monitor vacuum and flow and to regulate vacuum or flow. The pressure measurement can be used to control the level of applied pressure using a feedback control circuit.
- the wound filler 1918 can include the endoskeleton structure as described in International Application No.
- PCT/US2013/050698 may include, for example the stabilizing structures described with reference to Figures 14-25G, having external ribs extending from the outer surface and flexure arms or beams that have an intrinsic restoring force that varies as a function of position of each flexure element.
- the different flexure elements can have different restoring forces depending upon their position within the structure.
- the endoskeleton accommodates expansion to fill the wound cavity and will collapse in a well-defined manner in response to the collapse of the wound under negative pressure.
- foam or other filler material can be used within the flexure system.
- the endoskeleton can have a multilayered structure with the different layers collapsing along individual planes of the three dimensional structure within the wound without tilting of the structure. Any of the other embodiments of collapsible wound fillers described in International Application No. PCT/US2013/050698, titled “Negative Pressure Wound Closure Device," filed July 16, 2013 or elsewhere in this specification, may also be utilized.
- Figure 10 illustrates another embodiment where a wound closure element 1007 is positioned below a wound filler 1020, the wound closure element extending laterally beyond the wound filler 1020 such that the wound filler 1020 extends above or below the fascia.
- the wound closure element 1007 may be integral, attached to, or a separate element from the wound filler 1020. Furthermore, the features of the wound closure element may be incorporated into the lip 216 described above.
- the wound illustrated in Figure 10 has a wound opening 1001 that can have a generally circular or oval shape. The surgeon can use this opening to access tissue that must be removed to form a cavity 1005 that extends laterally.
- the wound closure element 1007 extends laterally to regions 1012, 1015 which can include tissue anchors 1014, 1016 that serve to attach regions 1012, 1015 to tissue flaps 1004, 1006 above the regions 1012, 1015, respectively, as well as the underlying tissue 1026.
- the anchors 928 can also extend in a lateral direction.
- the wound filler 1020 is in fluid communication with wound closure element 1007, and enables the application of negative pressure to the channels of regions 1012, 1015 that can be employed in the embodiment of Figure 10.
- the closure element can include apertures 927 that allow for tissue contact through regions 1012 and 1015 as these elements compress under negative pressure.
- the tissue anchors or attachment mechanisms 1014, 1016 can be provided on the top surface 218 and the bottom surface 219 of the lip, respectively, to secure the wound securing material 200 to the tissue.
- the bottom surface 218 of the lip faces into the wound cavity and/or viscera, while the top surface 218 of the lip is opposite the bottom surface 219 and closest to the dermal layers.
- the lip can extend under the fascia and be inserted between the fascia and the underlying peritoneal layer.
- the peritoneal layer is typically associated with abdominal fascia and lies below the abdominal fascia.
- the tissue anchors 1014 on the bottom surface 218 of the lip can extend into the peritoneal layer as the tissue anchors 1016 on the top surface 218 of the lip can extend into the fascia.
- the lip can be placed below both the fascia and peritoneal layer.
- the tissue anchors 1016 on the top surface 218 of the lip can pass through the peritoneal layer into the fascia to grip the fascia and the peritoneal layer and secure the lip to the wound cavity.
- the tissue anchors 1016 on the top surface 218 of the lip can attach to the peritoneal layer and secure the lip to the peritoneal layer.
- the lip, elongate layer, and/or fingers can extend beneath the deep fascia, subserous fascia, serous membrane, peritoneum, or any other layer between the dermal layers and the viscera as described herein.
- the attachment mechanisms (such as 701 , 702 described above) can be provided over an entire outer perimeter surface of the wound securing material 200, or on surfaces of the lip 216, the wound fillers, the pad 925 or wound closure element 1007, or other surfaces as described above.
- the attachment mechanisms 701 , 702 become buried within the tissue at the wound margins and secure the device 101 within the wound opening.
- the attachment mechanisms 701 , 702 can be spread out over the entire surface of the wound margins to provide sufficient strength in the grasping force.
- the wound securing material 200 can be designed to allow the wound closure device 101 to be easily placed but also easily removed and replaced with a new device 101 or other wound dressing as needed (e.g., 2-7 days later).
- the wound securing material 200 can be configured to have high grasping strength over at least a portion of its surface, but can be easily removed by, for example, pulling away at an edge.
- the wound securing material 200 can be designed to be removed from a wound without damaging the surrounding tissue.
- the attachment mechanisms 701 , 702 can be designed to accommodate various tissue applications, such as muscle, fat, skin and collagen, and various combinations of these.
- the attachment mechanisms 701 , 702 can also be designed to remain securely attached to particular tissues for a selected time period in certain embodiments.
- the attachment mechanisms 701 , 702 can also be formed using a resorbable material.
- a wound securing material 200 may comprise an elongate member as described herein having two sets of attachment mechanisms.
- the wound securing material 200 can have a first set 910 of outwardly- facing tissue-grasping elements or attachment mechanisms 912 that are designed to project into tissue. These tissue-grasping elements are on a tissue grasping surface of the wound securing material 200.
- a second set 904 of elements 906 project into the filler material to secure the wound securing material 200 to the filler material.
- the second anchor elements or attachment mechanisms 904 can be shaped to grasp the filler material such as with a distal hooked shape 906.
- the first group of anchor elements 910 adapted to grasp tissue can have a different shape and grasping force than the second anchor elements.
- barbs 912 can have bilateral prongs that tend to collapse upon insertion in tissue and yet expand when pulled in an opposite direction such that a certain pulling force can be applied to tissue.
- the prongs or cone shape anchor elements have a release force such that the barbs can be manually pulled from the tissue without causing injury.
- Figure 1 1B is an edge view of the device 101 showing the attachment mechanisms 926 projecting from the tissue grasping surface 924 on the periphery of the wound filler material 103.
- the wound filler material 103 can be integrally formed with the wound securing material 200 including a tissue grasping surface 924 with anchor elements or attachment mechanisms 926.
- the wound filler material does not contain a wound securing material 200 and the tissue grasping surface 924 with anchor elements or attachment mechanisms 926 is formed from the wound filler surface.
- the attachment mechanisms 926 can be provided over an entire outer perimeter surface of the filler material 103 spread out over the entire surface of the wound margins to provide sufficient strength in the grasping force.
- the tissue grasping surface and/or attachment mechanisms can also be formed using a resorbable material.
- the filler material 103 with the incorporated attachment mechanisms 926 can include all the features and descriptions of the attachment mechanism as described herein with reference to attachment mechanisms on the wound securing material 200.
- FIG. 1 C is a side view of a tissue grasping surface of the wound securing material 200, illustrating different tissue anchors or attachment mechanisms 601 , 602, 603, 604 for different types of tissue (Ti, T 2 ). Also illustrated is an example of the respective force profiles for the anchors or attachment mechanisms, including the maximum force applied to the tissue during vacuum closure (Fi) and the force required to remove the anchors from the tissue (F 2 ) without damaging the tissue. In one embodiment, the characteristics of the tissue anchors or attachment mechanisms vary to provide different force profiles across the interface between the wound closure device and the surrounding tissue. For example, for the upper tissue layer(s), Ti, the anchor 601 is designed to attach to collagen material, such as in the dermis.
- the anchor 601 has a different force profile (Fi and F 2 ) on the upper tissue layer(s), Ti, as shown in Figure 1 1C.
- the anchors 602, 603, 604 are designed to attach to fatty tissue of subcutaneous layer. Generally, a smaller force profile is needed to secure the anchors to this tissue.
- the characteristics of the anchors or attachment mechanisms, and their resulting force profiles, can vary by a number of parameters, such as the length of the anchor, the shape of the attachment mechanisms, the structure of grasping features, the material(s) used for the attachment mechanisms, the relative flexibility/rigidity of the attachment mechanisms, and the spacing/density of the attachment mechanisms.
- anchor 601 is significantly longer than anchors 602, 603, which in turn are longer than anchors 604.
- Figure 1 1C also illustrates varying the density of anchors, such as shown in 602, 603 and 604.
- Figure 1 1D illustrates three examples of different types of grasping features, including a barbed configuration 605, a staggered hook configuration 606, and a staggered barbed configuration 607.
- the anchoring or attachment process can be augmented by suturing the filler material or supporting endoskeleton to the tissue.
- the force profile can also be varied by controlling the vacuum force distribution in the filler material, such as by varying the pore size and/or pore density of the filler.
- the wound closure device of the invention can be provided in kits for closing different types of wounds (e.g., abdominal, fasciotomy, etc.).
- the tissue grasping surface can be optimized for different types of tissue such as collagen, fatty tissue, and muscle, depending on the structure of the tissue at the wound site.
- the tissue grasping surface grabs and pulls on the adjacent tissue, which is preferably the tissue around the wound margins, resulting in the displacement of the tissue thereby facilitating the closure of the wound.
- the force profile of the wound closure device is variable around the periphery of the wound.
- An exemplary embodiment is illustrated in Figure 12A, which shows the force profile (fi) exerted on the wound margins at a plurality of locations on the periphery of the wound.
- the largest fi is at the central region of the wound filler 102, where the wound opening is widest and the wound closure force is entirely or nearly entirely in the x-direction. Moving towards the top and bottom regions of the wound, the closure force (fi) is much smaller. One reason for this is because the wound opening is much smaller in these regions, and a much smaller force is needed to reapproximate the tissue.
- the inward force exerted in these regions includes components in both the x- and y-directions.
- a smaller force profile can be used to avoid the inward collapse of the tissue in the y-direction.
- Figure 12B as the wound closes and heals from an initial state (indicated by dotted lines) to a later state (indicated by solid lines), it can become elongated in the y-direction.
- the displacement of tissue anchors or attachment mechanisms 701a and 701b is exclusively in the x-direction and in the direction of the closure force (fi), while the displacement of tissue anchors or attachment mechanisms 703a, 703b is both inwards in the x-direction (in the direction of the closure force) and outwards in the y-direction (opposite the direction of the closure force).
- a smaller fi is preferable in these regions to provide more "play" between the attachment mechanisms and the surrounding tissue.
- the wound closure device can be configured so that it does not elongate, but rather does not change its length along the long axis 720.
- the variation in the force profile around the periphery of the wound closure device can be achieved in a variety of ways, such as varying the spacing/density of the tissue attachment mechanisms, the types of attachment mechanisms, length of attachment mechanisms, or configuration thereof, etc.
- attachment mechanisms or anchors 701a, 701b are longer and penetrate deeper into the tissue compared to attachment mechanisms or anchors 703 a, 703b.
- the force profile can also be varied by controlling the vacuum force distribution in the filler material, such as by varying the pore size and/or pore density of the filler.
- FIG. 13A a wound closure device 101 is placed within the wound opening so that the tissue grasping surface 1 104 with attachment mechanisms 1 106 are contacting the wound margin 203.
- FIG. 13B illustrates the wound 1200 following the application of a negative pressure to the wound closure device 101.
- the tissue anchor elements 1 106 grab the tissue margins 203 and cause displacement of the tissue margins 203 as the filler material 1 102 collapses.
- the filler material 1 102 collapses in the x- and y- directions in such a manner as to reapproximate the tissue at the wound margin 203.
- stabilizer elements 1 108 can be included in the wound filler material 1 102 in a crosshatched configuration of the help control the direction of tissue displacement during collapse.
- the largest amount of tissue displacement in this embodiment is in the central region of the wound 1200, where the opening is widest, and this displacement is primarily inward along the x-direction. Away from the central region (e.g., at the top and bottom of the wound as shown in Figures 13A and 13B), where the wound margins are closer together, less displacement in the x-direction is needed to reapproximate the tissue.
- the internal stabilizer elements 1 108 promote the collapse of the filler material in a manner that provides wound reapproximation.
- the crosshatched stabilizer elements 1 108 straighten out relative to one another, similar to an accordion gate. The largest displacement is in the central region of the filler 1 102, along the x-direction.
- the stabilizers 1 108 can inhibit inward collapse along the y-direction. As the stabilizers 1 108 straighten out, they can also facilitate elongation of the wound in the y-direction to allow proper tissue reapproximation.
- the inward collapse of the filler material along the y-direction is undesirable.
- the wound 1200 will tend to elongate in y-direction as the wound margins close in the x-direction.
- the wound filler can include a peripheral stabilizer element on the wound filler.
- the peripheral stabilizer element can be configured to expand and contract as necessary with the expansion and contraction of the wound filler material.
- the stabilizer element has sufficient flexibility to contract and expand in the x- and y-directions (i.e., along the periphery of the filler material 103), but has adequate rigidity along the z-direction (i.e. along the height of the filler) to inhibit collapse or tilting in this direction.
- the tissue grasping anchor elements or attachment mechanisms can be included on the peripheral stabilizer element, and project out from the periphery of the filler material. This can be as an alternative to, or in addition to, providing the anchor elements or attachment mechanisms on a separate wound securing material 200.
- the wound securing material can be formed of a material that is sufficiently stiff to hold the wound securing material and the wound filler that the wound securing material surrounds in place when placed in the wound.
- the wound filler and the surrounding wound securing material do not contain attachment mechanisms.
- the wound securing material can be formed of a sufficiently stiff that allows the wound securing material to be secured under the fascia or other tissue without the need for attachment mechanisms.
- the edges of the wound securing material may be rounded edges to avoid tissue trauma when inserted within the wound site.
- the elongate layer and lip described above may have edges that are not sharp, but instead are rounded.
- the wound securing material with rounded edges can contact and act on the surrounding tissue in contact with the material similar to embodiments described herein without rounded edges.
- the wound securing material with rounded edges can assist in the closure of the wound as effectively as wound closure devices with material that contains edges that are not rounded.
- FIGS 14-25G illustrate further embodiments of wound treatment devices and methods that may incorporate any of the apparatuses and methods hereinbefore described.
- the wound securing materials described above may be applied to the wound fillers, wound packers, and/or stabilizing structures described above to assist in positioning such devices in a wound.
- the wound closure devices are surrounded by a porous layer such as foam and/or an anchoring layer, such layers may be replaced with or incorporate features of the wound securing materials described above.
- Figure 14 illustrates an embodiment of a negative pressure treatment system 4100 that comprises a wound packer 4102 inserted into a wound 4101.
- the wound packer 4102 may comprise porous materials such as foam, and in some embodiments may comprise one or more embodiments of wound closure devices described in further detail in this section or elsewhere in this specification.
- the perimeter or top of any wound closure device inserted into the wound 4101 may also be covered with foam or other porous materials.
- a single drape 4104 or multiple drapes may be placed over the wound 4101 , and is preferably adhered or sealed to the skin on the periphery of the wound 4101 so as to create a fluid-tight seal.
- An aperture 4106 may be made through the drape 4104 which can be manually made or preformed into the drape 4104 so as to provide a fluidic connection from the wound 4101 to a source of negative pressure such as a pump 41 10.
- the fluidic connection between the aperture 4106 and the pump 41 10 is made via a conduit 4108.
- the conduit 4108 may comprise a RENASYS® Soft PortTM, manufactured by Smith & Nephew.
- the drape 4104 may not necessarily comprise an aperture 4106, and the fluidic connection to the pump 41 10 may be made by placing the conduit 4108 below the drape.
- multiple conduits 4108 may be used, fluidically connected via one or more apertures 4106.
- the drape 4104 may be provided with one or more corrugations or folds.
- the corrugations are aligned along the longitudinal axis of the wound, and as such may support closure of the wound by preferentially collapsing in a direction perpendicular to the longitudinal axis of the wound.
- Such corrugations may aid in the application of contractile forces parallel to the wound surface and in the direction of wound closure. Examples of such drapes may be found in Application Serial No. 12/922,1 18, titled “Vacuum Closure Device,” filed November 17, 2010 (published as US 201 1/0054365), which is hereby incorporated by reference in its entirety.
- the wound 4101 is prepared and cleaned.
- a non- or minimally- adherent organ protection layer (not illustrated) may be applied over any exposed viscera.
- the wound packer 4102 is then inserted into the wound, and is covered with the drape 4104 so as to form a fluid-tight seal.
- a first end of the conduit 4108 is then placed in fluidic communication with the wound, for example via the aperture 4106.
- the second end of the conduit 4108 is connected to the pump 41 10.
- the pump 41 10 may then be activated so as to supply negative pressure to the wound 4101 and evacuate wound exudate from the wound 4101.
- negative pressure may also aid in promoting closure of the wound 4101 , for example by approximating opposing wound margins.
- the strips in some embodiments have a rectangular or generally rectangular-shaped faces, wherein a length of the face is longer than the height of the face. In some embodiments, the length of the face may be more than 2 times, 4 times, 6 times, 8 times or 10 times greater than the height of the face.
- the term “horizontal,” when referring to a wound, indicates a direction or plane generally parallel to the skin surrounding the wound.
- the term “lateral,” when referring to a wound, generally refers to a direction in the horizontal plane perpendicular to the longitudinal direction.
- the terms “horizontal,” “vertical,” “longitudinal,” and “lateral” may also be used to describe the stabilizing structures and wound closure devices described throughout this specification. When describing these structures or devices, these terms should not be construed to require that the structures or devices necessarily be placed into a wound in a certain orientation, though in certain embodiments, it may be preferable to do so.
- FIGS 15A-F illustrate embodiments of a stabilizing structure 4200.
- the stabilizing structure may comprise a plurality of elongate strips 4202 arranged in parallel, whose longitudinal length can be aligned with the longitudinal axis when placed in a wound.
- the stabilizing structure can further comprise a plurality of intervening members 4204 connected to the elongate strips 4202 via joints 4206.
- the stabilizing structure 4200 can collapse in any manner described in this section or elsewhere in this specification with or without the application of negative pressure.
- the stabilizing structure may collapse significantly more in one plane than in another plane.
- the stabilizing structure can be comprised of any materials described in this section or elsewhere in this specification, including: flexible plastics such as silicone, polyurethane, rigid plastics such as polyvinyl chloride, semi-rigid plastics, semi-flexible plastics, biocompatible materials, composite materials, metals, and foam.
- the stabilizing structure 4200 and all stabilizing structures and wound closure devices described in this section or elsewhere in this specification can collapse on a variety of timescales in a dynamic fashion. In certain embodiments, the majority of the collapse may occur within the first few minutes upon application of negative pressure. However, after the initial collapse, the stabilizing structure or wound closure device may continue to collapse at a much slower rate, thereby applying increasing longitudinal tension over a long period of time and drawing the edges of the wound closer together. By slowly drawing the wound edges closer together over time, the stabilizing structure or wound closure device allows the surrounding healing tissue to remodel synergistically with the closure of the device or stabilizing structure. Slow, dynamic wound closure may allow the surrounding tissue to heal at an accelerated rate, because the collapsing structure or device slowly brings the edges of the wound closer together without stressing the newly formed or weakened tissue too quickly.
- the stabilizing structures described in this section or elsewhere in this specification can be placed into a wound for a period of time and then removed or replaced with another stabilizing structure.
- a stabilizing structure could be inserted into a wound for a period of time, promoting closure of the wound by drawing the edges closer together.
- the stabilizing structure can be replaced by a stabilizing structure of a different size or collapsibility, for example a stabilizing structure of a smaller size or decreased density. This process could be repeated over and over, thereby continuously drawing the edges of the wound together over time and allowing for continuing repair and remodeling of the surrounding tissue.
- the stabilizing structure is configured to remain in the wound for at least about less than 1 hour, at least about 1 hour, at least about 2 hours, at least about 4 hours, at least about 6 hours, at least about 8 hours, at least about 12 hours, at least about 24 hours, at least about 2 days, at least about 4 days, at least about 6 days, at least about 1 week, at least about 2 weeks, at least about 3 weeks, or more than 3 weeks.
- up to 90% of the collapse of the stabilizing structure or wound closure device may occur within the first few minutes upon application of negative pressure, while the remaining 10% of the collapse may occur slowly over a period of many minutes, hours, days, weeks, or months.
- up to about 80% of the collapse up to about 70%, up to about 60%, up to about 50%, up to about 40%, up to about 30%, up to about 20%, up to about 10%, or about 0% of the collapse will occur immediately within the first few minutes upon application of negative pressure while the remainder of the collapse occurs at a much slower rate such as over the course of many minutes, hours, days weeks, or months.
- the stabilizing structure can collapse at a variable rate.
- the entirety of the collapse occurs at a slowed rate, while in other embodiments the entirety of the collapse occurs almost immediately within the first few minutes.
- the collapse can occur at any rate and the rate can vary over time.
- the rate of collapse can be altered in a variable fashion by adding and/or removing portions of the structure or by controlling the application of negative pressure and irrigant fluid.
- the intersection of the intervening members 4204 and the elongate strips 4202 may define a plurality of cells 4210.
- the cells 4210 may be of any of the shapes and sizes described in this section or elsewhere in this specification.
- a cell may be in the shape of a square, a diamond, an oblong, an oval, and/or a parallelepiped.
- the joints 4206 are configured to allow the intervening members 4204 to collapse.
- the joints 4206 can be configured to allow the intervening members to collapse in any manner as described in this section or elsewhere in this specification in relation to other embodiments.
- the joints 4206 may be configured to allow or preferentially cause a first row of intervening members 4204 to collapse in one direction, while allowing or preferentially causing an adjacent row to collapse in another direction.
- the elongate strips 4202 may comprise alternating flexing segments 4212 and supporting segments 4214.
- the flexing segments 4212 may be constructed from a flexible or semi-flexible material such as silicone and/or polyurethane. However, any flexible or semi-flexible material may be suitable.
- the flexing segments 4212 can flex in any direction, allowing the stabilizing structure to collapse more readily in any direction, but particularly in the horizontal plane.
- the supporting segments 4214 can be constructed from a rigid or semi-rigid material such as polyvinyl chloride (PVC). However, any rigid or semi-rigid material may be suitable.
- the elongate strips 4202 comprise elongate strips of a first material such as silicone and/or polyurethane, with a plurality of elongate inserts of a second, more rigid material 4214 embedded into the first material.
- the flexing segments 4212 are the areas in the elongate strips 4202 where the more rigid inserts are not located.
- the supporting segments 4214 may be larger than the flexing segments 4212.
- the supporting segments 4214 can be approximately three times as large as the flexing segments 4212 (such as by spanning three cells 4210).
- the supporting segments 4214 may be the same size as the flexing segments 4212.
- the flexing segments 4212 can be larger than the supporting segments 4214.
- the lengths and widths of the individual segments of the elongate strips 4202 can be variable. For example, the height of the supporting segments 4214 can be reduced, such that they do not extend from approximately the top to approximately the bottom of the stabilizing structure 4200.
- a smaller supporting segment could encompass approximately half the height of the elongate strip 4202.
- the supporting segment 4214 could be located in the upper or in the lower portion of the elongate strip. Such embodiments may be accomplished by utilizing an insert of a second material that has a smaller height than the height of the first material forming the elongate strip 4202.
- the supporting segment does not alternate with the flexing segment 4212 and instead, the elongate strips 4202 are comprised entirely of supporting segments 4214 (e.g., a silicone strip or other material with an embedded more rigid insert extending the entire length thereof, or simply a more rigid material by itself).
- the entirety of the elongate strip 4202 can be comprised only of flexing segments 4212 (e.g., a strip made only of silicone or other more flexible material).
- the elongate strips 4202 may be manufactured from a female mold that may further encompass the entire stabilizing structure 4200.
- the supporting segments 4214 can be inserted into the female mold, followed by an injection of a flexible polymer such as silicone and/or polyurethane to encase the supporting segments 4214 within the flexible polymer frame.
- the supporting segments 4214 can be inserted into the mold in any desired manner or quantity, allowing for many potential variations of the stabilizing device.
- the supporting segments 4214 are insertable and/or removable from the elongate strips 4202, and may be inserted and/or removed to alter the coUapsibility of the stabilizing structure 4200.
- Supporting segments 4214 can be inserted and/or removed from the stabilizing structure 4200 after it has been placed in a wound to variably control the collapse of the stabilizing structure 4200.
- the elongate strips 4202 may form pockets that are open from one side (e.g., from the top) to allow insertion and removal of the supporting segments 4214.
- FIG. 15C-D illustrate in greater detail an embodiment of an individual supporting segment 4214.
- the supporting member 4214 may be a flat, plate-like structure having a rectangular shape, with a length greater than its height, and two parallel surfaces.
- the supporting segment can comprise at least one notch 4220, preferably located on the upper edge of the supporting segment.
- the notch or notches can be located on the bottom or the sides of the supporting segment.
- the top notch could have a corresponding bottom notch, or the notches could be located semirandomly on the top and bottom of the stabilizing structure.
- the notch could be configured so as to allow tearing of the supporting segment in a transecting line across the supporting segment.
- the notch or notches 4220 may advantageously provide flexibility to the structure.
- the notches 4220 may allow the stabilizing structure to flex more easily in the horizontal plane or in the vertical plane.
- the notches 4220 may further allow the stabilizing structure to twist in multiple planes.
- the notches 4220 may also improve fluid flow within the stabilizing structure 4200.
- the supporting segment does not contain a notch and the uppermost edge is flat.
- the notch 4220 can be located at other locations on the supporting segment, for example the bottom edge or the sides.
- the shape of the notch can be a rounded triangle as in Figures 15C-D or any other similar shape.
- the intervening members 4204 in some embodiments may comprise a first material 4216 with an embedded insert 4218 made of a more rigid material.
- the insert 4218 is placed within a female mold and a flexible polymer such as silicone and/or polyurethane is injected around the insert to entomb the insert 4218 within a flexible polymer frame.
- the inserts 4218 can be inserted into the mold in any desired manner or quantity, allowing for many potential variations of the stabilizing device.
- the first material 4216 may be in the form of a sleeve configured to receive the insert 4218. Further, the sleeve 4216 may be configured to allow for the removal of an insert 4218, such as by providing an opening in the top of the sleeve.
- the first material 4216 is constructed from a flexible or semi-flexible material such as silicone and/or polyurethane. However, any flexible or semi-flexible material may be suitable.
- the insert 4218 is constructed from a rigid or semi-rigid material such as polyvinyl chloride. However, any rigid or semi-rigid material may be suitable.
- Figure 15E illustrates a front view of insert 4218
- Figure 15F illustrates a side view of insert 4218
- the insert in one embodiment may be a flat, plate-like structure having a rectangular shape, with a height greater than its width, and two parallel surfaces.
- the insert can comprise an indent 4222.
- the indent is preferably located at the upper portion of the insert, however, the indent 4222 can be positioned on either side of the insert, or on the bottom.
- the indent 4222 can be configured such that it aids in allowing fluid to flow through the stabilizing structure by providing a flow path.
- the indent 4222 can improve flexibility of the stabilizing structure 4200 and be configured to allow for a more efficient collapse of the stabilizing structure 4200.
- the stabilizing structure 4200 of Figures 15A-B can be configured to include perforations or detachable sections that allow portions of the device to separate from the remainder of the device.
- perforations may be incorporated into the joints 4206 between various cells contained within the stabilizing structure 4200, allowing for the removal of individual rows or cells to alter the shape of the stabilizing structure 4200.
- the sections may be detached along perforations or lines in the elongate strips corresponding to the notches 4220.
- the inserts 4218 may be entombed within first material 4216 in a variable number of intervening members 4204 to control the shape and collapse of the stabilizing structure 4200. In other embodiments, the inserts 4218 may be inserted directly into sleeves comprised of first material 4216 within the intervening members 4204 to control the shape and collapse of the stabilizing structure 4200.
- the inserts 4218 can be present in at least about 5% of the intervening members, at least about 10% of the intervening members, at least about 15% of the intervening members, at least about 20% of the intervening members, at least about 25% of the intervening members , at least about 30% of the intervening members, at least about 35% of the intervening members, at least about 40% of the intervening members , at least about 45% of the intervening members, at least about 50% of the intervening members, at least about 55% of the intervening members, at least about 60% of the intervening members, at least about 65% of the intervening members, at least about 70% of the intervening members, at least about 75% of the intervening members, at least about 80% of the intervening members, at least about 85% of the intervening members, at least about 90% of the intervening members, at least about 95% of the intervening members, or about 100% of the intervening members.
- a variable number of supporting segments 4214 may be entombed within elongate strips 4202 to control the collapsibility of the stabilizing structure 4200. In other embodiments, a variable number of supporting segments may be inserted into a pocket contained within the elongate strips 4202 to control the collapsibility of the stabilizing structure.
- the supporting segments 4214 can be present in at least about 5% of the total length of the elongate strips, at least about 10%, at least about 15%, at least about 20%, at least about 25%, at least about 30%, at least about 35%, at least about 40%, at least about 45%, at least about 50% , at least about 55%, at least about 60%, at least about 65%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 95%, or about 100% of the total length of the elongate strips.
- the inserts 4218 or supporting segments 4214 may be inserted and/or removed over time to variably control the collapse of the stabilizing structure 4200.
- additional inserts 4218 may be removed over time, thus causing the stabilizing structure 4200 to collapse even further.
- Inserts can also be added to the stabilizing structure after it is inserted into a wound, thereby decreasing the collapsibility of the stabilizing structure 4200.
- the addition and/or removal of the inserts 4216 or supporting segments 4214 allows for variable control of the collapse of the stabilizing structure 4200.
- supporting segments 4214 can be inserted and removed from the elongated strips over time to provide variable control over the collapse of the stabilizing structure 4200.
- the flexibility of various sections of the stabilizing structure is enhanced by thinning of that section.
- the flexing segment 4212 can be constructed of a similar material to that used to construct supporting segment 4214.
- supporting segment 4212 since supporting segment 4212 is thicker than flexing segment 4212 it will not flex to the degree of flexion that may be experienced by flexing segment 4212.
- the entire stabilizing structure 4200 may be constructed from a single rigid or semi-rigid material, but made to have different rigid and flexible portions by thinning certain areas of the stabilizing structure 4200.
- the joints 4206 may be thinned to allow for greater flexibility as compared to the surrounding sections.
- thinning of a section of the stabilizing structure 4200 may allow the thinner portion to be more readily detached from the structure.
- FIGS 15G-15I illustrate another embodiment of a stabilizing structure 4200 similar to the stabilizing structure described above with respect to Figures 15A-15F.
- the stabilizing structure may have a length L and a width W that extend parallel to a horizontal plane, and a thickness T that may extend vertically and perpendicular to the horizontal plane.
- the length L and the width W may be greater than the thickness T so that the stabilizing structure forms a generally planar or flat body having an upper surface 4230 and a lower surface 4232 that may be parallel to each other.
- the thickness T of the structure may be constant between the upper and lower surfaces, or it may vary.
- the stabilizing structure of Figures 15G-15I may further comprise notches 4242 and 4244 in both the upper surface 4230 and lower surface 4232, respectively. These notches may extend through the elongate strips 4202 as well as through supporting segments 4214.
- the stabilizing structure of Figure 15G may define an outer perimeter that is general rectangular in shape, though other shapes are contemplated.
- the stabilizing structure has a first side 4234 and a second side 4236 opposite the first side.
- Figure 15H illustrates a side view of first side 4234. These sides 4234 and 4236 may be straight in shape and be parallel to each other. These sides also need not be parallel, and can have other shapes such as curved.
- the stabilizing structure may also have a third side 4238 and a fourth side 4240 opposite the third side.
- Figure 151 illustrates a side view of third side 4238.
- the third and fourth sides may have a zig-zag shape as shown, but may also have other shapes such as straight and curved.
- a soft polymer could be molded over the entire stabilizing structure 4200 to soften the feel of the device, thereby protecting the surrounding organs and/or other tissues.
- the soft polymer could be molded only over the bottom portion of the stabilizing device 4200, while in some embodiments the softer polymer can be molded over the top and/or the sides of the device.
- the soft polymer could be molded over particular edges of the stabilizing structure 4200, such as those on the bottom, sides, and/or top.
- the soft polymer could be molded over any side or combination of sides of the stabilizing structure 4200.
- the soft polymer may act like a softened rim surrounding the hard edges of the stabilizing structure 4200.
- FIG 16 illustrates an embodiment of an anchoring layer 4800 that may surround the stabilizing structures as described in this section or elsewhere in this specification.
- the ring 4800 can comprise a layer of tissue anchors 4802 configured to grip the surrounding edges of a wound.
- the tissue anchors can be hooks, barbs, prongs, or other structures that serve to attach to the tissue of a wound.
- the tissue anchors comprise hook and loop fasteners such as those used in Velcro technologies.
- the ring 4800 can be comprised of foam, such as those described previously or the ring can be comprised of a combination of a foam layer and a tissue anchor layer 4802.
- a lip 4804 may extend inward from the ring 4800 and serve to overlap the top and/or the bottom of a stabilizing structure as described in this section or elsewhere in this specification, thereby securing the ring 4800 around the stabilizing structure.
- FIG 17 is a photograph of a wound closure device 4900 comprising a stabilizing structure 4902 such as those described in this section or elsewhere in this specification, a foam layer 4904 such as those described in this section or elsewhere in this specification, and an anchoring layer 4906 comprising tissue anchors similar to the ring depicted in Figure 16.
- the wound closure device 4900 may be placed in a wound and sealed with a drape. Similar to the embodiments illustrated in Figures 15A-F, the stabilizing structure 4902 can collapse in any manner described in this section or elsewhere in this specification.
- the stabilizing structures and/or wound closure devices described in this section or elsewhere in this specification may be used in conjunction with methods or systems for the closure of a wound.
- one or more of the stabilizing structures or wound closure devices of any of the embodiments described in this section or elsewhere in this specification is placed into a wound.
- an organ protection layer may be provided in the wound before placement of the stabilizing structure.
- foam or other porous material may be placed in the wound along with the stabilizing structure or wound closure device, either below, above, or surrounding the stabilizing structure or wound closure device. Foam or other porous material may also surround the perimeter of the stabilizing structure or wound closure device.
- the stabilizing structure or wound closure device may be configured to collapse in any manner as described in this section or elsewhere in this specification, for example by having a particular size and shape, or by comprising a certain volume of foam or other porous material within the cells of the structure.
- the stabilizing structure or wound closure device may further be altered in any manner described in this section or elsewhere in this specification so as to better accommodate the shape of the wound.
- the stabilizing structure or wound closure device can be sealed by a fluid-tight drape.
- the fluid-tight drape can comprise a port configured for the application of negative pressure. A source of negative pressure may then be connected to the port and negative pressure may be applied to the wound.
- the stabilizing structure or wound closure device may be replaced over time by stabilizing structures or wound closure devices of various shapes and sizes as desired to best promote wound healing.
- FIGS 18A-D are photographs of a wound closure device 5000 according to another embodiment.
- the wound closure device 5000 comprises a stabilizing structure 5002 which may be similar to the structures described in Figures 15A-I, or may comprise any of the stabilizing structures described elsewhere in this specification.
- the stabilizing structure 5002 is surrounded by a porous layer 5004 such as a layer of foam, and the porous layer is surrounded by an anchoring layer 5006 comprising tissue anchors such as those anchors produced by Velcro industries, various barbs and/or various hooks.
- the tissue anchors are similar to the rings depicted in Figures 16-17.
- the porous layer may be in the form of a ribbon.
- the stabilizing structure 5002, porous layer 5004 and anchoring layer 5006 may be provided as separate components to be attached by the practitioner in use, or they may be pre-attached to each other.
- the stabilizing structure 5002 can collapse in any manner described elsewhere in this specification, for example, horizontally.
- the wound closure device 5000 When the wound closure device 5000 is implanted, the surrounding tissues can be pressed against the tissue anchors to embed them within the tissue and anchor the device.
- the wound closure device 5000 may be placed in a wound and sealed with a drape.
- the embodiments further described in this section comprise an anchor layer that surrounds a porous layer, other embodiments may omit the porous layer, such that the anchoring layer directly surrounds or is attached to the stabilizing structure.
- the anchoring layer 5006 comprises an elongate strip of material comprising a plurality of tissue anchors extending from a base layer 5007, wherein the tissue anchors can have different shapes and sizes as described elsewhere in the specification.
- the tissue anchors may extend from a first planar side of the elongate strip, and the second planar side of the elongate strip may comprise an adhesive covered by an adhesive backing layer.
- the structure of the anchors can have various forms depending on the tissue they are intended to bind. Longer anchors can be used for loosely bound tissues such as fat or connective tissue, while shorter anchors can be used for denser tissues such as muscle.
- anchors depending upon the shape of the anchor, shorter anchors may be more desirable for softer, fatty tissue, while longer anchors are utilized for denser tissues.
- Anchors with more rigid stems can be utilized to penetrate denser tissues.
- anchors can have bilateral prongs that tend to collapse upon insertion in tissue and yet expand when pulled in an opposite direction such that a certain pulling force can be applied to tissue.
- the characteristics of the anchors or attachment mechanisms, and their resulting force profiles, can vary by a number of parameters, such as the length of the anchor, the shape of the attachment mechanisms, the structure of grasping features, the material(s) used for the attachment mechanisms, the relative flexibility/rigidity of the attachment mechanisms, and the spacing/density of the attachment mechanisms.
- the anchors may have various lengths for optimal penetration of the surrounding tissue.
- the length of the anchors may be at most about .01mm, at most about .1mm, at most about .2mm, at most about .5mm, at most about 1mm, at most about 2 mm, at most about 3mm, at most about 5mm, at most about 10mm, at most about 20mm, at most about 30mm, at most about 40mm, at most about 50mm, at most about 75mm, at most about 100mm, or more than 100mm.
- FIG 18B is a photograph of a closer view of the anchoring layer 5006 of the wound closure device 5002 depicted in Figure 18A.
- the anchoring layer may consist of a first band of longer anchors 5008 configured to surround the porous layer 5004 and stabilizing structure 5002, and a second band of shorter anchors 5010 configured to surround the porous layer 5004 and stabilizing structure 5002.
- the first band 5008 may be disposed above the second band 5010.
- the different bands may have different anchor lengths and shapes, as disclosed herein this section and elsewhere in the specification.
- the anchors are selected for the appropriate tissue types.
- the first band 5008 may comprise longer anchors, desirable for penetration into the denser fascia, and thus may be positioned towards the bottom of the device.
- the second band 5010 comprises shorter double hooks, desirable for penetration into denser tissue.
- suitable tissue anchors include the hook and loop configuration of Velcro, barbs, hooks, spikes, pegs, arrowheads, or any suitable shape.
- surfaces include textured surfaces, such as roughened sandpaper-like surfaces, or nano-textured surfaces that may facilitate tissue adhesion.
- the use of surface anchors can be used in combination with a surgical adhesive, providing a much stronger bond between tissue layers than the adhesive alone, and providing temporary adhesion while the adhesive sets.
- the surgical adhesive can be added to the anchors themselves.
- the surgical adhesive may simply be applied between the anchors to coat at least a portion of the anchoring layer.
- the anchors may be replaced with a surgical adhesive, and the surgical adhesive may act to anchor the device to the surrounding wound.
- the anchors may be constructed from a variety of materials, including any materials disclosed elsewhere in the specification, such as: synthetic or natural polymers, metals, ceramics, or other suitable materials.
- the anchors may be constructed from biodegradable materials such as biodegradable synthetic or natural polymers.
- biodegradable synthetic polymers include: polyesters such as polylactic acid or polyglycolic acid, polyanhydrides, and linear polymers with biodegradable linkages.
- the anchors may be constructed of biodegradable biological materials, such as autografts, allografts, and/or xenografts.
- Figure 18C is a photograph of an embodiment of a wound closure device 5000, similar to the wound closure devices of Figures 18A-B. However, in this orientation the first band 5008 of anchors is towards the bottom of the device, while the second band of anchors 5010 is towards the top. As described above, the bands of anchors may be arrayed in any desired manner.
- Figure 18D is a top view of an embodiment of a wound closure device 5000, similar to the wound closure devices of Figures 18A-C.
- the shape of the anchoring layer is not limited to the ring shape of Figures 17-18D.
- the anchoring layer is wrapped around the entirety of the stabilizing device, i.e. the top, bottom, and sides.
- the anchoring layer is only around a portion of the perimeter of the stabilizing structure.
- the anchoring layer is only attached to discrete portions of the stabilizing structure as needed.
- the anchoring layer covers at most about 5%, at most about 10%, at most about 20%, at most about 30%, at most about 50%, at most about 75%, and at most about 100% of the outside of the stabilizing structure.
- the bands of different tissue anchors can be organized in a vertical direction, while in other embodiments, they may be organized in a horizontal direction. They may also be organized in either the horizontal and vertical directions when considered in the xy plane, i.e. facing downward into the wound.
- the different types of anchors may be interspersed with one another, rather than organized into discrete bands of specific types of anchors.
- the longer anchors may be surrounded by smaller anchors and vice-versa.
- the anchors may be organized randomly across the anchoring layer or in other suitable patterns.
- the anchoring layer may be disposed on the inner faces of the stabilizing structure.
- the anchoring layer may cover at most about 5%, at most about 10%, at most about 20%, at most about 30%, at most about 50%, at most about 75%, and at most about 100% of the interior surfaces of the stabilizing structure.
- the entire anchoring layer may be comprised of only one type of anchor, for example the entirety of the anchoring layer may be comprised of the longer hooks 5008 or the shorter hooks 5010 as depicted in Figure 18B.
- Some embodiments may call for the anchors to be color coded.
- the anchors on the bottom may be made to be one color while the anchors on the top may be another so as to identify the proper orientation of the stabilizing structure in the wound.
- Figures 19-23D are photographs and illustrations depicting embodiments of a method for the treatment of a wound that utilizes a wound closure device comprising a stabilizing structure as described herein this section and elsewhere in the specification.
- numbers have been added to each step in Figures 23A-D to allow the reader to more easily follow these steps of the method.
- the steps can be performed in any order, and any numbering system is for clarity only. Further, in some embodiments, different steps of this method may be excluded. In other embodiments, additional steps may be added to the method based on methods described herein this section and elsewhere in the specification.
- the porous layers and structures described in this section may be of any material or structure described elsewhere in the specification, such as foam.
- Figure 19 depicts an embodiment of an open wound 5100 prior to treatment with a wound closure device as will be described in much greater detail below.
- the open wound of Figure 19 is similar to the wounds described elsewhere in the specification, particularly as relates to Figure 14. In some instances, as described elsewhere in the specification, such a wound may be produced via a surgical incision or other means.
- Figure 20 depicts an embodiment of an initial step in a method for the treatment of an open wound 5100 with a wound closure device.
- the wound may be cleaned with a pad 5502 and the skin 5504 prepared for application of a wound closure device, such as those described in relation to Figures 15A- 18D and Figures 23A-23C.
- FIG. 21 depicts an embodiment of an early step in a method for the treatment of an open wound 5100.
- a tissue protection layer 5506 may be placed over the wound to protect the underlying tissues from the rigors of negative pressure wound therapy or other potential harms. Accordingly, certain embodiments provide for a tissue protection layer 5506 which may be cut to size to be placed over the wound site 5100.
- the tissue protection layer 5506 can be a material which will not adhere to the wound site or to the exposed viscera in close proximity.
- Such a tissue protection layer may be constructed from any suitable material such as a biocompatible polymer.
- tissue protection layers manufactured by Smith & Nephew and sold under the brand RENASYS® may act as tissue protection layers and be placed over the abdominal cavity and/or wound bed 5100 and tucked over the peritoneal gutter.
- materials such as the fluoroplymer polytetrafluoroethylene (PTFE) may be applicable as these materials are generally non-adherent and used in surgical grafts.
- the tissue protection layer is permeable.
- the tissue protection layer 5506 can be provided with openings, such as holes, slits, or channels, to allow the removal of fluids from the wound site 5100 or the transmittal of negative pressure to the wound site 5100.
- the tissue protection layer may be used over non-abdominal wounds on other areas of the body, such as the leg, arm, shoulder, or back.
- FIGs 22A-C illustrate embodiments of possible initial steps in a method for the treatment of an open wound. However, as described above, the steps need not be performed in this order and may be performed in any order.
- two pieces of a porous material such as foam, a bottom piece 5102 and a top piece 51 16 are selected so as to approximate the size of the wound 5100.
- the top piece and the bottom piece are of identical thickness.
- top piece 51 16 may be at least twice as thick, at least four times as thick, at least 10 times as thick or more than ten times as thick as bottom piece 5102.
- Figure 22B illustrates an embodiment of additional steps in a method for the treatment of an open wound.
- Bottom piece 5102 may be shaped via cutting or other suitable means to the shape of the wound and subsequently placed into the wound 5100, as shown in Figure 22C and depicted further below in Figure 23 A.
- a foam layer 5102 (for example, a 15 mm layer of foam) is placed in the wound bed 5100.
- a stabilizing structure 5104 similar to the stabilizing structures disclosed in Figures 15A-I or any other stabilizing structure described elsewhere in the specification, is shaped to the size of the wound via cutting or other suitable means.
- the matrix may be shaped in such a manner as to ensure that the matrix has flat, longitudinal sides.
- the stabilizing structure 5104 may be placed in the wound to determine the accuracy of the shaping step.
- a foam layer 5106 in the shape of a ribbon, is attached to the outer edge of the stabilizing structure 5104 via an adhesive backing tape or other suitable means.
- the foam layer 5106 may be used to partially or completely surround the perimeter of the stabilizing structure 5104. Excess ribbon can simply be removed from the backing tape and discarded. To allow the backing layer to properly adhere to the stabilizing structure, the foam layer may be held in place for an excess of 30 seconds.
- Step 7 of Figure 23B shows the next step of an embodiment of the method, wherein an anchoring layer 5108 comprising a first band of longer anchors 51 10 and a second band of shorter anchors 51 12 is attached to the foam layer 5106.
- the anchoring layer 5108 may be shaped to the size of the perimeter of the stabilizing structure 5104 and adhered to the foam layer 5106 via the removal of an adhesive backing layer covering an adhesive surface on a side of the elongate layer opposite the anchors.
- the anchoring layer may partially or completely surround the foam layer. To allow the anchoring layer to properly adhere to the stabilizing structure, the anchoring layer may be held in place for a period of time, for example in excess of 30 seconds.
- the entire wound closure device 51 14 may be placed into the wound 5100, as displayed in step 8 of Figure 23B.
- the device can be deformed slightly inwardly or horizontally to facilitate entrance into the wound site.
- the device may be squeezed slightly during insertion and then release upon contact with the walls of the wound.
- the wound closure device 51 14 may be placed such that the longitudinal sides of the matrix align with the longitudinal axis of the wound 5100.
- anchors 51 12 it may be preferable to orient the shorter second anchors 51 12 towards the top of the wound and the longer first anchors 51 10 towards the bottom of the wound so that the shorter anchors 51 12 may engage the fatty tissue of the wound.
- the anchors may also have the same length.
- the anchors may be color coded, to direct a use to a particular orientation of the stabilizing structure.
- the anchors also need not cover the entire outer perimeter of the stabilizing structure.
- anchors are provided only on the first side 4234 and second side 4236 of the stabilizing structure (for an embodiment such as illustrated in Figure 15G).
- FIG. 23 C contains photographs of step 9 and 10 of a method of wound closure and treatment.
- another foam layer 51 16 (for example, a 10 mm layer of foam) is placed on top of the wound closure device 51 14.
- a bridging portion of foam 51 18 may be placed in intimate contact with the foam layer 51 16 at the edge of the wound.
- the bridging portion of foam 51 18 may extend over intact skin, with a piece of drape 5120 placed between it and the intact skin.
- a suction port 5122 may be connected to the bridging portion 51 18 with a section of drape 5120 between.
- the bridging portion 51 18 and suction port 5122 may be placed on the wound during a different step, for example during steps 1 and 2 as depicted in Figure 23A.
- the device may be covered by one or more drapes 5120.
- a hole may be made in the drape covering the bridging portion of foam, and a suction port 5122 may be placed over the hole.
- a protective layer 5124 on the top surface of the one or more drapes may be removed after the drapes 5120 are applied.
- negative pressure may be applied to the wound through the drape from a vacuum source. The negative pressure can cause the stabilizing structure to collapse horizontally as described elsewhere in this specification.
- the tissue anchors adhered to the stabilizing structure through the porous layer engage tissue of the wound and may facilitate closure of the wound.
- Figures 25A-25C provide further illustrations of an upper foam layer 51 16 being placed in a wound, followed by placing a bridging portion 51 18 and placing one or more drapes or wound covers 5120.
- Figures 25D-25G illustrate an embodiment of several steps in a method for the treatment and closure of a wound. As illustrated in Figure 25D, a suction port 5122 is separated from a release liner 5126 and later applied to a wound as depicted in Figures 23A-24.
- Figure 25E illustrates a canister 5128 being inserted into a negative pressure wound therapy device 5130 in preparation for the collection of wound exudate.
- Figure 25F illustrates the snap connection between the tubing connected to the suction port and the tubing connected to the negative pressure wound therapy device 5130. Once the connection has been made, negative pressure wound treatment may begin as depicted in Figure 25G.
- a wound filler configured to collapse horizontally within a wound
- a securing material configured to surround the wound filler, the securing material comprising:
- a lip extending outwardly from elongate layer, wherein the lip is capable of being positioned beneath the fascia of a patient;
- a wound cover configured to be placed over a wound.
- a method of treating a wound using the apparatus of any one of Embodiments 1 -15 comprising applying negative pressure to the wound through the wound cover positioned over the wound with the wound filler positioned within the wound, wherein the wound filler is surrounded by the elongate layer and the lip is positioned beneath the fascia; and wherein the wound filler collapses horizontally under negative pressure.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Surgical Instruments (AREA)
- Packaging Of Annular Or Rod-Shaped Articles, Wearing Apparel, Cassettes, Or The Like (AREA)
Abstract
Description
Claims
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2902776A CA2902776C (en) | 2013-03-13 | 2014-03-12 | Wound treatment apparatus and use thereof |
MX2015011803A MX369065B (en) | 2013-03-13 | 2014-03-12 | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure. |
US14/774,689 US10124098B2 (en) | 2013-03-13 | 2014-03-12 | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure |
EP18169232.8A EP3372209A1 (en) | 2013-03-13 | 2014-03-12 | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure |
EP14723917.2A EP2968016B1 (en) | 2013-03-13 | 2014-03-12 | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure |
AU2014248519A AU2014248519B2 (en) | 2013-03-13 | 2014-03-12 | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure |
BR112015021854A BR112015021854A2 (en) | 2013-03-13 | 2014-03-12 | negative pressure wound closure device and systems and methods of use in treating negative pressure wound |
CN201480027156.7A CN105188622A (en) | 2013-03-13 | 2014-03-12 | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure |
JP2016501735A JP6407954B2 (en) | 2013-03-13 | 2014-03-12 | Negative pressure wound closure device and system and method of use in wound treatment with negative pressure |
RU2015142873A RU2015142873A (en) | 2013-03-13 | 2014-03-12 | DEVICE AND SYSTEMS FOR CLOSING A Wound USING NEGATIVE PRESSURE, AND METHODS FOR APPLICATION IN TREATING A WAN USING NEGATIVE PRESSURE |
ZA2015/06245A ZA201506245B (en) | 2013-03-13 | 2015-08-26 | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure |
US16/177,189 US11419767B2 (en) | 2013-03-13 | 2018-10-31 | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure |
AU2019201930A AU2019201930A1 (en) | 2013-03-13 | 2019-03-20 | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure. |
AU2020213413A AU2020213413A1 (en) | 2013-03-13 | 2020-08-07 | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361780660P | 2013-03-13 | 2013-03-13 | |
US61/780,660 | 2013-03-13 | ||
US201361891857P | 2013-10-16 | 2013-10-16 | |
US61/891,857 | 2013-10-16 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/774,689 A-371-Of-International US10124098B2 (en) | 2013-03-13 | 2014-03-12 | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure |
US16/177,189 Continuation US11419767B2 (en) | 2013-03-13 | 2018-10-31 | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2014165275A1 true WO2014165275A1 (en) | 2014-10-09 |
WO2014165275A9 WO2014165275A9 (en) | 2014-12-11 |
Family
ID=50721876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2014/025059 WO2014165275A1 (en) | 2013-03-13 | 2014-03-12 | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure |
Country Status (10)
Country | Link |
---|---|
US (2) | US10124098B2 (en) |
EP (2) | EP2968016B1 (en) |
JP (1) | JP6407954B2 (en) |
CN (2) | CN113730099A (en) |
AU (3) | AU2014248519B2 (en) |
BR (1) | BR112015021854A2 (en) |
CA (1) | CA2902776C (en) |
MX (2) | MX369065B (en) |
RU (1) | RU2015142873A (en) |
WO (1) | WO2014165275A1 (en) |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015061352A2 (en) | 2013-10-21 | 2015-04-30 | Smith & Nephew, Inc. | Negative pressure wound closure device |
US9226737B2 (en) | 2011-02-04 | 2016-01-05 | University Of Massachusetts | Negative pressure wound closure device |
US9421132B2 (en) | 2011-02-04 | 2016-08-23 | University Of Massachusetts | Negative pressure wound closure device |
WO2017019810A1 (en) * | 2015-07-27 | 2017-02-02 | Noleus Technologies Inc. | Apparatuses and methods for improving post-operative recovery from surgery |
WO2017106576A1 (en) * | 2015-12-15 | 2017-06-22 | University Of Massachusetts | Negative pressure wound closure devices and methods |
US9820888B2 (en) | 2006-09-26 | 2017-11-21 | Smith & Nephew, Inc. | Wound dressing |
US9844472B2 (en) | 2012-05-22 | 2017-12-19 | Smith & Nephew Plc | Wound closure device |
WO2018044949A1 (en) | 2016-08-30 | 2018-03-08 | Smith & Nephew, Inc. | Wound closure devices |
WO2018044944A1 (en) | 2016-08-30 | 2018-03-08 | Smith & Nephew, Inc. | Negative pressure wound closure device |
WO2018060144A1 (en) | 2016-09-27 | 2018-04-05 | Smith & Nephew Plc | Wound closure devices with dissolvable portions |
US9962295B2 (en) | 2012-07-16 | 2018-05-08 | Smith & Nephew, Inc. | Negative pressure wound closure device |
WO2018085457A1 (en) | 2016-11-02 | 2018-05-11 | Smith & Nephew Inc. | Wound closure devices |
WO2018108785A1 (en) | 2016-12-16 | 2018-06-21 | Smith & Nephew Plc | Negative pressure wound closure device |
US10070994B2 (en) | 2012-05-22 | 2018-09-11 | Smith & Nephew Plc | Apparatuses and methods for wound therapy |
US10117782B2 (en) | 2012-05-24 | 2018-11-06 | Smith & Nephew, Inc. | Devices and methods for treating and closing wounds with negative pressure |
US10124098B2 (en) | 2013-03-13 | 2018-11-13 | Smith & Nephew, Inc. | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure |
WO2018229012A1 (en) | 2017-06-14 | 2018-12-20 | Smith & Nephew Plc | Collapsible sheet for wound closure and method of use |
WO2018231878A1 (en) | 2017-06-14 | 2018-12-20 | Smith & Nephew, Inc. | Fluid removal management and control of wound closure in wound therapy |
WO2018229009A1 (en) | 2017-06-13 | 2018-12-20 | Smith & Nephew Plc | Wound closure device and method of use |
WO2018229011A1 (en) | 2017-06-14 | 2018-12-20 | Smith & Nephew Plc | Collapsible structure for wound closure and method of use |
US10159771B2 (en) | 2013-03-14 | 2018-12-25 | Smith & Nephew Plc | Compressible wound fillers and systems and methods of use in treating wounds with negative pressure |
US10179073B2 (en) | 2014-01-21 | 2019-01-15 | Smith & Nephew Plc | Wound treatment apparatuses |
WO2019020544A1 (en) | 2017-07-27 | 2019-01-31 | Smith & Nephew Plc | Customizable wound closure device and method of use |
US10201642B2 (en) | 2014-01-21 | 2019-02-12 | Smith & Nephew Plc | Collapsible dressing for negative pressure wound treatment |
WO2019030136A1 (en) | 2017-08-07 | 2019-02-14 | Smith & Nephew Plc | Wound closure device with protective layer and method of use |
US10220125B2 (en) | 2012-02-03 | 2019-03-05 | Smith & Nephew Plc | Apparatuses and methods for wound therapy |
US10814049B2 (en) | 2015-12-15 | 2020-10-27 | University Of Massachusetts | Negative pressure wound closure devices and methods |
WO2021059126A1 (en) * | 2019-09-24 | 2021-04-01 | Kci Licensing, Inc. | Dressing system for use on deep wounds with reduced in-growth and extended wear time |
US11135351B2 (en) | 2016-08-30 | 2021-10-05 | Smith & Nephew Plc | Systems and methods for applying reduced pressure therapy |
US11324876B2 (en) | 2017-06-13 | 2022-05-10 | Smith & Nephew Plc | Collapsible structure and method of use |
US11375923B2 (en) | 2017-08-29 | 2022-07-05 | Smith & Nephew Plc | Systems and methods for monitoring wound closure |
US11395873B2 (en) | 2017-06-14 | 2022-07-26 | Smith & Nephew, Inc. | Control of wound closure and fluid removal management in wound therapy |
US11439539B2 (en) | 2015-04-29 | 2022-09-13 | University Of Massachusetts | Negative pressure wound closure device |
US11471586B2 (en) | 2015-12-15 | 2022-10-18 | University Of Massachusetts | Negative pressure wound closure devices and methods |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018237206A2 (en) * | 2017-06-21 | 2018-12-27 | University Of Massachusetts | Negative pressure wound closure devices and methods |
CN105662830B (en) * | 2016-03-02 | 2018-05-18 | 卢雯 | Kowtow back of the body sputum elimination machine |
AU2017292881B2 (en) | 2016-07-08 | 2022-03-17 | Convatec Technologies Inc. | Flexible negative pressure system |
EP3634519B1 (en) | 2017-06-07 | 2023-05-31 | 3M Innovative Properties Company | Systems, apparatuses, and methods for negative-pressure treatment with reduced tissue in-growth |
CN110709038B (en) | 2017-06-07 | 2022-09-02 | 3M创新知识产权公司 | Composite dressing for improving granulation growth and reducing maceration by negative pressure therapy |
WO2018226328A1 (en) * | 2017-06-07 | 2018-12-13 | Kci Licensing, Inc. | Tissue interface incorporating multiple layers |
US11207217B2 (en) | 2017-06-07 | 2021-12-28 | Kci Licensing, Inc. | Methods for manufacturing and assembling dual material tissue interface for negative-pressure therapy |
JP2020523078A (en) | 2017-06-07 | 2020-08-06 | ケーシーアイ ライセンシング インコーポレイテッド | Composite dressing for promoting granulation and reducing maceration by negative pressure treatment |
US20180353334A1 (en) | 2017-06-07 | 2018-12-13 | Kci Licensing, Inc. | Tissue Contact Interface |
EP3634332B1 (en) | 2017-06-07 | 2022-07-27 | 3M Innovative Properties Company | Assembly features and methods for a peel-and-place dressing for use with negative-pressure treatment |
US10695227B2 (en) | 2017-06-07 | 2020-06-30 | Kci Licensing, Inc. | Methods for manufacturing and assembling dual material tissue interface for negative-pressure therapy |
WO2018226707A1 (en) | 2017-06-07 | 2018-12-13 | Kci Licensing, Inc. | Composite dressings for improved granulation reduced maceration with negative-pressure treatment |
JP7356358B2 (en) | 2017-06-07 | 2023-10-04 | スリーエム イノベイティブ プロパティズ カンパニー | Multilayer wound filler for long-term wear |
EP3684312B1 (en) * | 2017-09-20 | 2023-08-23 | Coloplast A/S | Wound care device for debriding wounds |
EP3706689A4 (en) * | 2017-11-08 | 2021-12-01 | University Of Massachusetts | Post-operative hybrid dressing to optimize skin-grafting procedures in reconstructive surgery |
IL256675A (en) * | 2017-12-31 | 2018-02-28 | Technion Res & Development Found Ltd | Methods and compositions for prevention and treatment of pressure ulcers |
ES2719501A1 (en) * | 2018-01-10 | 2019-07-10 | Servei De Salut De Les Illes Balears Ibsalut | Device for hepatic packing (Machine-translation by Google Translate, not legally binding) |
WO2020014178A1 (en) * | 2018-07-12 | 2020-01-16 | Kci Licensing, Inc. | Abdominal dressing with user selection of fascial closure force profile |
CN112955100A (en) * | 2018-10-17 | 2021-06-11 | 凯希特许有限公司 | Peel-off and placement dressing with closed cell contact layer |
US20200155359A1 (en) * | 2018-11-08 | 2020-05-21 | Kci Licensing, Inc. | Wound dressing with semi-rigid support to increase disruption using perforated dressing and negative pressure wound therapy |
JP2022530337A (en) * | 2019-04-22 | 2022-06-29 | ケーシーアイ ライセンシング インコーポレイテッド | A transparent dressing that can be peeled off and applied for negative pressure therapy |
US20230131447A1 (en) * | 2019-05-10 | 2023-04-27 | Seracettin EGIN | A two-way vacuum assisted closure system |
EP3969071A1 (en) * | 2019-05-13 | 2022-03-23 | KCI Licensing, Inc. | Dressing including outlet connection fluid buffer |
RU2720831C1 (en) * | 2019-05-31 | 2020-05-13 | Государственное бюджетное учреждение здравоохранения "Научно-исследовательский институт - краевая клиническая больница N 1 имени профессора С.В. Очаповского" Министерства здравоохранения Краснодарского края (ГБУЗ "НИИ-ККБ N 1 им. проф. Очаповского" Минздрава Краснодарского края) | Method of vacuum dressing application |
EP3983028A1 (en) * | 2019-06-17 | 2022-04-20 | KCI Licensing, Inc. | Abdominal negative-pressure therapy dressing with closed-loop force management control |
KR102628722B1 (en) * | 2019-06-20 | 2024-01-24 | 쿠오후앙 양 | Fluid retention/retention pad |
WO2021009712A1 (en) * | 2019-07-17 | 2021-01-21 | Kci Licensing, Inc. | Wound dressing with multiple treatment zones |
EP4031082B1 (en) * | 2019-09-05 | 2023-06-21 | KCI Licensing, Inc. | Long-term wear tissue interfaces for high-closure force negative- pressure therapy dressings |
CN114887138B (en) * | 2022-05-11 | 2024-01-16 | 陈林涛 | Clinical surface of a wound degassing unit that uses of department of general surgery |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004018020A1 (en) * | 2002-08-21 | 2004-03-04 | Hill-Rom Services, Inc. | Wound packing for preventing wound closure |
US20040162512A1 (en) * | 2003-02-19 | 2004-08-19 | 3M Innovative Properties Company | Conformable wound dressing |
US20070118096A1 (en) * | 2005-11-21 | 2007-05-24 | Smith Joshua D | Wound care system |
US7524315B2 (en) | 2002-10-28 | 2009-04-28 | Smith & Nephew Plc | Apparatus for aspirating, irrigating and cleansing wounds |
US20090306609A1 (en) | 2005-04-27 | 2009-12-10 | Smith & Nephew Plc | Wound treatment apparatus and method |
WO2010075180A2 (en) * | 2008-12-24 | 2010-07-01 | Kci Licenssing, Inc. | Reduced-pressure wound treatment systems and methods employing manifold structures |
US7753894B2 (en) | 2004-04-27 | 2010-07-13 | Smith & Nephew Plc | Wound cleansing apparatus with stress |
US20110054365A1 (en) | 2008-03-13 | 2011-03-03 | Smith & Nephew Plc | Vacuum closure device |
US20110213287A1 (en) | 2010-02-26 | 2011-09-01 | Smith & Nephew, Inc. | Systems and methods for using negative pressure wound therapy to manage open abdominal wounds |
US20110282309A1 (en) | 2010-04-27 | 2011-11-17 | Smith & Nephew Plc | Wound dressing and method of use |
US20120209227A1 (en) | 2011-02-04 | 2012-08-16 | Raymond Dunn | Negative pressure wound closure device |
Family Cites Families (493)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1006716A (en) | 1911-07-17 | 1911-10-24 | Charles T Bloomer | Egg-box partition. |
US3014483A (en) | 1959-10-26 | 1961-12-26 | Avco Corp | Surgical bridge for supporting sutures |
US3194239A (en) | 1963-01-16 | 1965-07-13 | Cornelius J P Sullivan | Suture provided with radiopaque free metal |
US3578003A (en) | 1969-04-01 | 1971-05-11 | Lucille G Everett | Portable platform and shelter |
US3789851A (en) | 1971-07-01 | 1974-02-05 | H Leveen | Wound splints |
US3812616A (en) | 1972-06-26 | 1974-05-28 | L Koziol | Portable greenhouse |
JPS5330068B2 (en) | 1973-04-16 | 1978-08-24 | ||
US4000845A (en) | 1975-10-20 | 1977-01-04 | Clevepak Corporation | Partition assembly and partition strips therefor |
JPS5636960A (en) | 1979-08-31 | 1981-04-10 | Matsuda Ika Kogyo | Suturing gut for medical treatment |
SE429197B (en) | 1981-10-14 | 1983-08-22 | Frese Nielsen | SAR TREATMENT DEVICE |
US4467805A (en) | 1982-08-25 | 1984-08-28 | Mamoru Fukuda | Skin closure stapling device for surgical procedures |
DK149601C (en) | 1984-01-23 | 1987-02-02 | Coloplast As | PRESSURELY BANDAGE |
US4637819A (en) | 1985-05-31 | 1987-01-20 | The Procter & Gamble Company | Macroscopically expanded three-dimensional polymeric web for transmitting both dynamically deposited and statically contacted fluids from one surface to the other |
JPS6257560A (en) | 1985-09-06 | 1987-03-13 | 中興化成工業株式会社 | Medical suturing yarn |
US4815468A (en) | 1987-01-09 | 1989-03-28 | Annand David S | Sutureless closure |
US4771482A (en) | 1987-07-17 | 1988-09-20 | Shlenker Robin R T | Glove for inhibiting the spread of contagious diseases and method of using the same |
US5176663A (en) | 1987-12-02 | 1993-01-05 | Pal Svedman | Dressing having pad with compressibility limiting elements |
JP2719671B2 (en) | 1989-07-11 | 1998-02-25 | 日本ゼオン株式会社 | Wound dressing |
US5409472A (en) | 1989-08-03 | 1995-04-25 | Smith & Nephew Plc | Adhesive polymeric foam dressings |
US5264218A (en) | 1989-10-25 | 1993-11-23 | C. R. Bard, Inc. | Modifiable, semi-permeable, wound dressing |
US5860978A (en) | 1990-09-25 | 1999-01-19 | Innovasive Devices, Inc. | Methods and apparatus for preventing migration of sutures through transosseous tunnels |
US7229959B1 (en) | 1990-11-27 | 2007-06-12 | The American National Red Cross | Supplemented fibrin matrix delivery systems |
SU1818103A1 (en) | 1991-06-21 | 1993-05-30 | Tsnii Travmatologii I Ortopedi | Device for treatment of contaminated wounds |
US7198046B1 (en) | 1991-11-14 | 2007-04-03 | Wake Forest University Health Sciences | Wound treatment employing reduced pressure |
US5636643A (en) | 1991-11-14 | 1997-06-10 | Wake Forest University | Wound treatment employing reduced pressure |
US5368930A (en) | 1991-11-15 | 1994-11-29 | Samples; C. Robert | Thin elastomeric article having increasing puncture resistance |
US5514105A (en) | 1992-01-03 | 1996-05-07 | The Procter & Gamble Company | Resilient plastic web exhibiting reduced skin contact area and enhanced fluid transfer properties |
FR2691923B1 (en) | 1992-06-04 | 1994-09-09 | Europ Propulsion | Honeycomb structure in thermostructural composite material and its manufacturing process. |
US5376067A (en) | 1992-10-28 | 1994-12-27 | Daneshvar; Yousef | Pressure bandages and dressings |
US5368910A (en) | 1993-04-02 | 1994-11-29 | The Procter & Gamble Company | Macroscopically expanded plastic web having improved fluid drainage |
US5332149A (en) | 1993-06-25 | 1994-07-26 | Rock-Tenn Company | Glued flap partition for visible container |
US5584859A (en) | 1993-10-12 | 1996-12-17 | Brotz; Gregory R. | Suture assembly |
US5423857A (en) | 1993-11-02 | 1995-06-13 | Ethicon, Inc. | Three piece surgical staple |
AU701055B2 (en) | 1993-11-18 | 1999-01-21 | Procter & Gamble Company, The | Web for absorbent articles having a textured wearer-contacting surface |
US6500112B1 (en) | 1994-03-30 | 2002-12-31 | Brava, Llc | Vacuum dome with supporting rim and rim cushion |
US5695777A (en) | 1994-05-10 | 1997-12-09 | Medtronic, Inc. | Absorptive wound dressing for wound healing promotion |
ES2223977T3 (en) | 1994-08-22 | 2005-03-01 | Kci Licensing, Inc. | CONTAINER. |
US5512041A (en) | 1994-10-07 | 1996-04-30 | Scott Health Care | Wound dressing for promoting moist wound healing |
GB9515807D0 (en) | 1995-08-02 | 1995-10-04 | Cantwell Evelyna D | Topical hyperbaric bandage |
US5562107A (en) | 1995-09-27 | 1996-10-08 | Hollister Incorporated | Reclosable wound cover |
GB9523253D0 (en) | 1995-11-14 | 1996-01-17 | Mediscus Prod Ltd | Portable wound treatment apparatus |
US6287322B1 (en) | 1995-12-07 | 2001-09-11 | Loma Linda University Medical Center | Tissue opening locator and everter and method |
US5853863A (en) | 1996-07-03 | 1998-12-29 | Higher Dimension Research, Inc. | Puncture, pierce, and cut resistant fabric |
US7771402B2 (en) | 1996-07-11 | 2010-08-10 | PulseCare Medical | Wound irrigation containment arrangement |
US5960497A (en) | 1997-08-22 | 1999-10-05 | Kci-Rik Acquisition, Corp. | Pressure relieving pad with graduated pillars |
US8353948B2 (en) | 1997-01-24 | 2013-01-15 | Celonova Stent, Inc. | Fracture-resistant helical stent incorporating bistable cells and methods of use |
WO1998046300A1 (en) | 1997-04-14 | 1998-10-22 | Biosurgical Corporation | Fluid applicator for dispensing measured quantities with use of controlled suction |
DE19722075C1 (en) | 1997-05-27 | 1998-10-01 | Wilhelm Dr Med Fleischmann | Medication supply to open wounds |
DE19731040A1 (en) | 1997-07-19 | 1999-01-21 | Christian Mueller | Device and method for fixing and / or compressing and / or taking impressions of bodies (parts) |
US7214202B1 (en) | 1997-07-28 | 2007-05-08 | Kci Licensing, Inc. | Therapeutic apparatus for treating ulcers |
US6080168A (en) | 1997-08-28 | 2000-06-27 | Levin; John M. | Compression pad for laparoscopic/thorascopic surgery |
GB9719520D0 (en) | 1997-09-12 | 1997-11-19 | Kci Medical Ltd | Surgical drape and suction heads for wound treatment |
IL122994A (en) | 1998-01-19 | 2001-12-23 | Wisebands Ltd | Suture tightening device for closing wounds and a method for its use |
GB9822341D0 (en) | 1998-10-13 | 1998-12-09 | Kci Medical Ltd | Negative pressure therapy using wall suction |
US6291050B1 (en) | 1998-10-30 | 2001-09-18 | The Procter & Gamble Company | Topsheet systems for absorbent articles exhibiting improved hydrophilicity gradients |
US6767334B1 (en) | 1998-12-23 | 2004-07-27 | Kci Licensing, Inc. | Method and apparatus for wound treatment |
DE19901134C2 (en) | 1999-01-14 | 2002-11-21 | Wilhelm Fleischmann | dressing material |
US6641575B1 (en) | 1999-01-26 | 2003-11-04 | Neal M. Lonky | Surgical vacuum instrument for retracting, extracting, and manipulating tissue |
US6086591A (en) | 1999-01-29 | 2000-07-11 | Smith & Nephew, Inc. | Soft tissue anchor |
DK1163019T3 (en) | 1999-03-25 | 2008-03-03 | Metabolix Inc | Medical devices and applications of polyhydroxyalkanoate polymers |
NZ514480A (en) | 1999-04-02 | 2005-05-27 | Kci Licensing Inc | Vacuum assisted closure system with heating and cooling provision |
RU2247548C2 (en) | 1999-04-02 | 2005-03-10 | Кей Си Ай ЛАЙСЕНСИНГ, Инк. | Vacuum system for closing wounds by applying means introduced for healing the wound |
US6994702B1 (en) | 1999-04-06 | 2006-02-07 | Kci Licensing, Inc. | Vacuum assisted closure pad with adaptation for phototherapy |
US6695823B1 (en) | 1999-04-09 | 2004-02-24 | Kci Licensing, Inc. | Wound therapy device |
GB9909301D0 (en) | 1999-04-22 | 1999-06-16 | Kci Medical Ltd | Wound treatment apparatus employing reduced pressure |
US6991643B2 (en) | 2000-12-20 | 2006-01-31 | Usgi Medical Inc. | Multi-barbed device for retaining tissue in apposition and methods of use |
KR100767140B1 (en) | 1999-10-29 | 2007-10-15 | 삼소나이트 코포레이션 | Direct forming of non-textile fabric elements from thermoplastic pellets or the like |
GB9926538D0 (en) | 1999-11-09 | 2000-01-12 | Kci Medical Ltd | Multi-lumen connector |
FR2801188B1 (en) | 1999-11-22 | 2002-11-08 | Didier Detour | DEVICE FOR THE NON-TRAUMATIC CLOSURE, WITHOUT SUTURE, OF THE OPEN EDGES OF A WOUND OF THE MAMMALIAN SKIN |
NO995755L (en) | 1999-11-24 | 2001-05-25 | Greger Loenne | Frame and method for suturing a wound |
US7153312B1 (en) | 1999-12-02 | 2006-12-26 | Smith & Nephew Inc. | Closure device and method for tissue repair |
US6794554B2 (en) | 2000-02-01 | 2004-09-21 | Ferris Pharmaceuticals, Inc. | Wound packing material |
US6566575B1 (en) | 2000-02-15 | 2003-05-20 | 3M Innovative Properties Company | Patterned absorbent article for wound dressing |
US6548727B1 (en) | 2000-02-17 | 2003-04-15 | 3M Innovative Properties Company | Foam/film composite medical articles |
US6977323B1 (en) | 2000-02-17 | 2005-12-20 | 3M Innovative Properties Company | Foam-on-film medical articles |
US6712830B2 (en) | 2000-03-15 | 2004-03-30 | Esplin Medical Inventions, L.L.C. | Soft tissue anchor |
GB0011202D0 (en) | 2000-05-09 | 2000-06-28 | Kci Licensing Inc | Abdominal wound dressing |
CA2409331C (en) | 2000-05-19 | 2010-07-13 | Coapt Systems, Inc. | Tissue approximation device and a method of using it |
US20040010275A1 (en) | 2000-05-19 | 2004-01-15 | Daniel Jacobs | Multi-point tissue tension distribution device and method, a custom-fittable variation |
US7156862B2 (en) | 2000-05-19 | 2007-01-02 | Coapt Systems, Inc. | Multi-point tension distribution system device and method of tissue approximation using that device to improve wound healing |
US6645226B1 (en) | 2000-05-19 | 2003-11-11 | Coapt Systems, Inc. | Multi-point tension distribution system device and method of tissue approximation using that device to improve wound healing |
US20050119694A1 (en) | 2000-05-19 | 2005-06-02 | Jacobs Daniel I. | Remotely anchored tissue fixation device and method |
US7172615B2 (en) | 2000-05-19 | 2007-02-06 | Coapt Systems, Inc. | Remotely anchored tissue fixation device |
US6485503B2 (en) | 2000-05-19 | 2002-11-26 | Coapt Systems, Inc. | Multi-point tissue tension distribution device, a brow and face lift variation, and a method of tissue approximation using the device |
ES2295182T3 (en) | 2000-07-18 | 2008-04-16 | Coloplast A/S | ONE APOSITO. |
US6767356B2 (en) | 2000-09-01 | 2004-07-27 | Angiolink Corporation | Advanced wound site management systems and methods |
US7066182B1 (en) | 2000-09-27 | 2006-06-27 | 3M Innovative Properties Company | Conformable adhesive wound closures |
GB0025068D0 (en) | 2000-10-12 | 2000-11-29 | Browning Healthcare Ltd | Apparatus and method for treating female urinary incontinence |
US20060205995A1 (en) | 2000-10-12 | 2006-09-14 | Gyne Ideas Limited | Apparatus and method for treating female urinary incontinence |
US6855135B2 (en) | 2000-11-29 | 2005-02-15 | Hill-Rom Services, Inc. | Vacuum therapy and cleansing dressing for wounds |
US6685681B2 (en) | 2000-11-29 | 2004-02-03 | Hill-Rom Services, Inc. | Vacuum therapy and cleansing dressing for wounds |
US6503208B1 (en) | 2000-12-05 | 2003-01-07 | Holtech Medical | Method and apparatus for the measurement of intra-abdominal pressure |
US7700819B2 (en) | 2001-02-16 | 2010-04-20 | Kci Licensing, Inc. | Biocompatible wound dressing |
US7070584B2 (en) | 2001-02-20 | 2006-07-04 | Kci Licensing, Inc. | Biocompatible wound dressing |
US6776769B2 (en) | 2001-03-05 | 2004-08-17 | Joseph Smith | Anatomically configured tubular body of woven or knitted fabric for pressure support of articulating joint |
US7645269B2 (en) | 2001-04-30 | 2010-01-12 | Kci Licensing, Inc. | Gradient wound treatment system and method |
WO2002091999A2 (en) | 2001-05-09 | 2002-11-21 | Geron Corporation | Treatment for wounds |
AU2002315027A1 (en) | 2001-05-15 | 2002-11-25 | Children's Medical Center Corporation | Methods and apparatus for application of micro-mechanical forces to tissues |
GB0115054D0 (en) | 2001-06-20 | 2001-08-15 | Recuperatio Ltd | Fluid transfer device |
JP2004533890A (en) | 2001-07-06 | 2004-11-11 | トリカーディア,エル.エル.シー. | Antiarrhythmic device and method of using same |
US20040161805A1 (en) | 2001-07-13 | 2004-08-19 | Heylen Godelieve Irma Christine | Cardiovascular safety assay |
WO2003013406A1 (en) | 2001-08-03 | 2003-02-20 | Asahi Kasei Life & Living Corporation | Color masking component for use with feminine sanitary pad and the like |
US6592608B2 (en) | 2001-12-07 | 2003-07-15 | Biopsy Sciences, Llc | Bioabsorbable sealant |
US7004915B2 (en) | 2001-08-24 | 2006-02-28 | Kci Licensing, Inc. | Negative pressure assisted tissue treatment system |
US6787682B2 (en) | 2001-11-05 | 2004-09-07 | Hollister Incorporated | Absorbent foam wound dressing |
US8105580B2 (en) | 2001-12-07 | 2012-01-31 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to promote wound healing |
US6958432B2 (en) | 2001-12-14 | 2005-10-25 | Kimberly-Clark Worldwide, Inc. | Disposable absorbent article |
US6726668B2 (en) | 2001-12-14 | 2004-04-27 | Kimberly-Clark Worldwide, Inc. | Disposable absorbent article |
US20030120249A1 (en) | 2001-12-20 | 2003-06-26 | Wulz Andrea Susan | Absorbent article having an insert providing for improved fluid distribution |
US7723560B2 (en) | 2001-12-26 | 2010-05-25 | Lockwood Jeffrey S | Wound vacuum therapy dressing kit |
US6645330B2 (en) | 2002-01-03 | 2003-11-11 | Paragon Trade Brands, Inc. | Method of making disposable absorbent article having graphics using ultrasonic thermal imaging |
KR100964762B1 (en) | 2002-02-08 | 2010-06-21 | 구르샤란 싱 차나 | Improved surgical devices and methods of use |
DE10209122B4 (en) | 2002-03-01 | 2006-04-13 | Fleischmann, Wilhelm, Dr.med. | Instrument for tissue dilation of the skin |
US6953111B2 (en) | 2002-03-22 | 2005-10-11 | Yoshida Sports, Inc. | Protective structure for a travel case |
US8241308B2 (en) | 2002-04-24 | 2012-08-14 | Boston Scientific Scimed, Inc. | Tissue fastening devices and processes that promote tissue adhesion |
US7910789B2 (en) | 2002-05-07 | 2011-03-22 | Polyremedy, Inc. | Method for treating wound, dressing for use therewith and apparatus and system for fabricating dressing |
US8407065B2 (en) | 2002-05-07 | 2013-03-26 | Polyremedy, Inc. | Wound care treatment service using automatic wound dressing fabricator |
EP1513456B1 (en) | 2002-06-14 | 2006-10-11 | Loma Linda University Medical Center | Vascular wound closure device |
GB2389794A (en) | 2002-06-19 | 2003-12-24 | Johnson & Johnson Medical Ltd | Wound dressing with variable shape |
US7164360B2 (en) | 2002-08-14 | 2007-01-16 | Mark Schiebler | Multi-use linkage device |
US7381211B2 (en) | 2002-08-21 | 2008-06-03 | Kci Licensing, Inc. | Medical closure screen device and method |
US8062331B2 (en) | 2002-08-21 | 2011-11-22 | Kci Licensing, Inc. | Internal and external medical closure screen systems and methods |
US7351250B2 (en) | 2002-08-21 | 2008-04-01 | Kci Licensing, Inc. | Circumferential medical closure device and method |
US7413571B2 (en) | 2002-08-21 | 2008-08-19 | Kci Licensing, Inc. | Flexible medical closure screen and method |
US7846141B2 (en) | 2002-09-03 | 2010-12-07 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
US7815616B2 (en) | 2002-09-16 | 2010-10-19 | Boehringer Technologies, L.P. | Device for treating a wound |
US7625362B2 (en) | 2003-09-16 | 2009-12-01 | Boehringer Technologies, L.P. | Apparatus and method for suction-assisted wound healing |
US7189238B2 (en) | 2002-09-25 | 2007-03-13 | Linvatec Corporation | Soft tissue anchor |
US7367342B2 (en) | 2002-12-02 | 2008-05-06 | Life Support Technologies, Inc. | Wound management systems and methods for using the same |
US7612248B2 (en) | 2002-12-19 | 2009-11-03 | 3M Innovative Properties Company | Absorbent medical articles |
US6951553B2 (en) | 2002-12-31 | 2005-10-04 | Kci Licensing, Inc | Tissue closure treatment system and method with externally-applied patient interface |
US7976519B2 (en) | 2002-12-31 | 2011-07-12 | Kci Licensing, Inc. | Externally-applied patient interface system and method |
US6883531B1 (en) | 2003-01-14 | 2005-04-26 | Brian H. Perttu | Tip-up tent |
JP4002847B2 (en) | 2003-01-31 | 2007-11-07 | 松下電器産業株式会社 | Level conversion circuit with automatic delay adjustment function |
US7112177B2 (en) | 2003-03-04 | 2006-09-26 | Wolfe Tory Medical, Inc. | Apparatus for monitoring intra-abdominal pressure |
US20070255167A1 (en) | 2004-03-01 | 2007-11-01 | Wolfe Tory Medical, Inc. | Apparatus for monitoring intra-abdominal pressure |
US20060135921A1 (en) | 2003-04-04 | 2006-06-22 | Wiercinski Robert A | Porous particulate collagen sponges |
US7617762B1 (en) | 2003-06-23 | 2009-11-17 | Gary Dean Ragner | Flexible hydraulic muscle |
JP4795234B2 (en) | 2003-07-22 | 2011-10-19 | ケーシーアイ ライセンシング インク | Negative pressure wound dressing |
US20050020899A1 (en) | 2003-07-25 | 2005-01-27 | Rubicor Medical, Inc. | Post-biopsy cavity treatmetn implants and methods |
US7942866B2 (en) | 2003-08-28 | 2011-05-17 | Boehringer Technologies, L.P. | Device for treating a wound |
US7361184B2 (en) | 2003-09-08 | 2008-04-22 | Joshi Ashok V | Device and method for wound therapy |
NL1025938C2 (en) | 2003-09-17 | 2005-03-18 | Broockeville Corp N V | Wound drainage device. |
US7022890B2 (en) | 2003-09-22 | 2006-04-04 | Ferris Pharmaceuticals | Wound dressing suitable for insertion in nasal passages |
GB0325129D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus in situ |
GB0325130D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with scaffold |
GB0518804D0 (en) | 2005-09-15 | 2005-10-26 | Smith & Nephew | Exudialysis tissue cleanser |
GB0325120D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with actives |
US7252870B2 (en) | 2003-12-31 | 2007-08-07 | Kimberly-Clark Worldwide, Inc. | Nonwovens having reduced Poisson ratio |
US7128735B2 (en) | 2004-01-02 | 2006-10-31 | Richard Scott Weston | Reduced pressure wound treatment appliance |
US20050222613A1 (en) | 2004-02-05 | 2005-10-06 | Edwin Ryan | Wound closure device and method for vitrectomy |
GB0403969D0 (en) | 2004-02-24 | 2004-03-31 | Huntleigh Technology Plc | Tissue treatment device |
US8100887B2 (en) | 2004-03-09 | 2012-01-24 | Bluesky Medical Group Incorporated | Enclosure-based reduced pressure treatment system |
US7754937B2 (en) | 2004-03-18 | 2010-07-13 | Boehringer Technologies, L.P. | Wound packing material for use with suction |
US7942838B2 (en) | 2004-03-22 | 2011-05-17 | Farrow Medical Innovations, Inc. | Compression garment |
US7776028B2 (en) | 2004-04-05 | 2010-08-17 | Bluesky Medical Group Incorporated | Adjustable overlay reduced pressure wound treatment system |
US8062272B2 (en) | 2004-05-21 | 2011-11-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US7708724B2 (en) | 2004-04-05 | 2010-05-04 | Blue Sky Medical Group Incorporated | Reduced pressure wound cupping treatment system |
US7909805B2 (en) | 2004-04-05 | 2011-03-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US7951124B2 (en) | 2004-04-13 | 2011-05-31 | Boehringer Technologies, Lp | Growth stimulating wound dressing with improved contact surfaces |
GB0508531D0 (en) | 2005-04-27 | 2005-06-01 | Smith & Nephew | Sai with ultrasound |
US8529548B2 (en) | 2004-04-27 | 2013-09-10 | Smith & Nephew Plc | Wound treatment apparatus and method |
GB0424046D0 (en) | 2004-10-29 | 2004-12-01 | Smith & Nephew | Apparatus |
GB0409291D0 (en) | 2004-04-27 | 2004-06-02 | Smith & Nephew | Apparatus with stress |
JP2007537830A (en) | 2004-05-17 | 2007-12-27 | アプライド ティッシュ テクノロジーズ エルエルシー | Wound chamber with remote access portal |
US20060020269A1 (en) | 2004-07-20 | 2006-01-26 | Eric Cheng | Device to aid in stone removal and laser lithotripsy |
US7364145B2 (en) | 2004-09-08 | 2008-04-29 | Equipment Solutions, Inc | High stiffness flexure |
US7455681B2 (en) | 2004-09-13 | 2008-11-25 | Wound Care Technologies, Llc | Wound closure product |
US8491503B2 (en) | 2004-09-29 | 2013-07-23 | Covidien Lp | Intrauterine pressure catheter interface cable system |
US8790632B2 (en) | 2004-10-07 | 2014-07-29 | Actamax Surgical Materials, Llc | Polymer-based tissue-adhesive form medical use |
US8052671B2 (en) | 2004-10-11 | 2011-11-08 | Abviser Medical, Llc | Intra-abdominal pressure monitoring device and method |
US9358318B2 (en) | 2004-10-20 | 2016-06-07 | Ethicon, Inc. | Method of making a reinforced absorbable multilayered hemostatic wound dressing |
US20060257457A1 (en) | 2004-10-20 | 2006-11-16 | Gorman Anne J | Method for making a reinforced absorbable multilayered hemostatic wound dressing |
US7315183B2 (en) | 2004-11-22 | 2008-01-01 | Texas Instruments Incorporated | Single-supply voltage translator input having low supply current |
DE202004018245U1 (en) * | 2004-11-24 | 2005-07-07 | Riesinger, Birgit | Drainage device for treating wounds using reduced pressure has absorption body with layer(s) of textile section enriched with super-absorbents enclosed by liquid transmissive sleeve; absorbed wound secretions remain in absorption body |
USD544092S1 (en) | 2004-12-03 | 2007-06-05 | Kci Licensing, Inc. | Wearable negative pressure wound care appliance |
JP4560415B2 (en) | 2005-01-20 | 2010-10-13 | ユニ・チャーム株式会社 | Absorbent articles |
EP1843709B1 (en) | 2005-02-04 | 2016-04-06 | AMS Research, LLC | Needle design for male transobturator sling |
GB2423019A (en) | 2005-02-09 | 2006-08-16 | Ind Ltd Ak | Wound dressing and wound treatment system including the wound dressing |
DE102005007016A1 (en) | 2005-02-15 | 2006-08-24 | Fleischmann, Wilhelm, Dr.med. | Device for the treatment of wounds |
US8961733B2 (en) | 2005-02-15 | 2015-02-24 | Pinwrest Development Group, Llc | Method of improving the impact-protective properties of a conformable substrate |
US20060259074A1 (en) | 2005-02-22 | 2006-11-16 | Brian Kelleher | Methods and devices for anchoring to soft tissue |
WO2006110197A2 (en) | 2005-03-03 | 2006-10-19 | Icon Medical Corp. | Polymer biodegradable medical device |
DE102005014420A1 (en) | 2005-03-24 | 2006-09-28 | Inmeditec Medizintechnik Gmbh | Vacuum therapy device |
US8415523B2 (en) | 2005-04-16 | 2013-04-09 | Aalnex, Inc. | Secondary wound dressings for securing primary dressings and managing fluid from wounds, and methods of using same |
US8067662B2 (en) * | 2009-04-01 | 2011-11-29 | Aalnex, Inc. | Systems and methods for wound protection and exudate management |
US7438705B2 (en) | 2005-07-14 | 2008-10-21 | Boehringer Technologies, L.P. | System for treating a wound with suction and method detecting loss of suction |
US20110077605A1 (en) | 2005-07-14 | 2011-03-31 | Boehringer Technologies, L.P. | Pump system for negative pressure wound therapy |
CA2613983A1 (en) | 2005-07-14 | 2007-02-15 | C.R. Bard, Inc. | Intra-abdominal pressure monitoring system |
US7857806B2 (en) | 2005-07-14 | 2010-12-28 | Boehringer Technologies, L.P. | Pump system for negative pressure wound therapy |
US7503910B2 (en) | 2006-02-01 | 2009-03-17 | Carmeli Adahan | Suctioning system, method and kit |
US20070027414A1 (en) | 2005-07-28 | 2007-02-01 | Integra Lifesciences Corporation | Laminar construction negative pressure wound dressing including bioabsorbable material |
US20070027475A1 (en) | 2005-08-01 | 2007-02-01 | Ancel Surgical R&D, Inc. | Scaled suture thread |
US20070032755A1 (en) | 2005-08-02 | 2007-02-08 | Medica-Rents Co., Ltd. | Method and apparatus for treating a wound |
US7608066B2 (en) | 2005-08-08 | 2009-10-27 | Innovative Therapies, Inc. | Wound irrigation device pressure monitoring and control system |
CN101257875A (en) | 2005-09-06 | 2008-09-03 | 泰科保健集团有限合伙公司 | Self contained wound dressing with micropump |
AU2006287461A1 (en) | 2005-09-07 | 2007-03-15 | Tyco Healthcare Group L.P. | Self contained wound dressing apparatus |
WO2007030598A2 (en) | 2005-09-07 | 2007-03-15 | Tyco Healthcare Group Lp | Wound dressing with vacuum reservoir |
DE602006020488D1 (en) | 2005-10-05 | 2011-04-14 | Univ Loma Linda Med | Vascular wound closure device |
JP2007126341A (en) | 2005-11-07 | 2007-05-24 | Toshiba Corp | Anisotropic porous material |
DE202005019670U1 (en) | 2005-12-14 | 2006-04-27 | Riesinger, Birgit | Wound treatment device with elastically deformable negative pressure generating element |
US7622629B2 (en) * | 2005-12-15 | 2009-11-24 | Aalnex, Inc. | Wound shield for exudate management |
US7863495B2 (en) * | 2006-01-12 | 2011-01-04 | Aalnex, Inc. | Dressing substrate |
US20100081983A1 (en) | 2005-12-23 | 2010-04-01 | Biosara Corporation | Wound guard bandage |
US7605299B2 (en) | 2005-12-23 | 2009-10-20 | Biosara Corporation | Wound guard bandage |
WO2007087810A2 (en) | 2006-02-02 | 2007-08-09 | Coloplast A/S | A suction method and a wound suction system |
JP4719278B2 (en) | 2006-02-06 | 2011-07-06 | ケーシーアイ ライセンシング インコーポレイテッド | Adapter for applying negative pressure wound therapy to tissue sites |
CA2641485C (en) * | 2006-02-07 | 2015-04-07 | Tyco Healthcare Group Lp | Surgical wound dressing |
EP1988814B1 (en) | 2006-03-01 | 2014-07-02 | Boss Instruments, Ltd. | Surgical retractor frame system |
AU2006342253B2 (en) | 2006-04-13 | 2013-01-24 | Solventum Intellectual Properties Company | Medical closure screen installation systems and methods |
AU2007241496A1 (en) | 2006-04-25 | 2007-11-01 | Coloplast A/S | An adhesive wafer |
US20100028407A1 (en) | 2006-04-27 | 2010-02-04 | University Of Louisville Research Foundation, Inc. | Layered bio-adhesive compositions and uses thereof |
US7615036B2 (en) | 2006-05-11 | 2009-11-10 | Kalypto Medical, Inc. | Device and method for wound therapy |
US7779625B2 (en) | 2006-05-11 | 2010-08-24 | Kalypto Medical, Inc. | Device and method for wound therapy |
US7837706B2 (en) | 2006-05-31 | 2010-11-23 | Boston Scientific Scimed, Inc. | Tissue attachment device, system, and method |
WO2007143179A2 (en) | 2006-06-02 | 2007-12-13 | Bengtson Bradley P | Assemblies, systems, and methods for vacuum assisted internal drainage during wound healing |
US8551075B2 (en) | 2006-06-02 | 2013-10-08 | Kci Medical Resources | Assemblies, systems, and methods for vacuum assisted internal drainage during wound healing |
WO2007142688A1 (en) | 2006-06-02 | 2007-12-13 | Bengtson Bradley P | Assemblies, systems, and methods for vacuum assisted internal drainage during wound healing |
CA2657042A1 (en) | 2006-07-07 | 2008-01-10 | Boehringer Technologies, L.P. | Growth stimulating wound dressing with improved contact surfaces |
US20080041401A1 (en) | 2006-08-15 | 2008-02-21 | Casola Robert P | Computer adjusted pressure wound care devices, systems & methods |
EP2068798A4 (en) | 2006-08-30 | 2009-12-16 | Southeastern Medical Technolog | Methods, compositions and apparatuses to treat wounds with pressures altered from atmospheric |
CN101511277B (en) | 2006-09-19 | 2013-05-22 | 凯希特许有限公司 | Reduced pressure treatment system having blockage clearing and dual-zone pressure protection capabilities |
US7491541B2 (en) | 2006-09-21 | 2009-02-17 | Kci Licensing, Inc. | Method for quantitation of collagen in tissue |
CA2664677C (en) | 2006-09-26 | 2016-01-26 | T.J. Smith & Nephew, Limited | Lattice dressing |
GB0903032D0 (en) | 2009-02-24 | 2009-04-08 | Smith & Nephew | Drapeable wound dressing |
US9820888B2 (en) | 2006-09-26 | 2017-11-21 | Smith & Nephew, Inc. | Wound dressing |
WO2008039223A1 (en) | 2006-09-26 | 2008-04-03 | Boehringer Technologies L.P. | Pump system for negative pressure wound therapy |
WO2008040020A2 (en) | 2006-09-28 | 2008-04-03 | Puricore, Inc. | Apparatus and method for wound, cavity, and bone treatment |
US20080243096A1 (en) | 2006-10-05 | 2008-10-02 | Paul Svedman | Device For Active Treatment and Regeneration of Tissues Such as Wounds |
CA2663826C (en) | 2006-10-13 | 2012-07-03 | Kci Licensing Inc. | Reduced pressure delivery system having a manually-activated pump for providing treatment to low-severity wounds |
KR100788356B1 (en) | 2006-10-26 | 2008-01-02 | 동부일렉트로닉스 주식회사 | Level shifter having a single voltage source and capable of shifting between wide difference of voltage levels |
US20080103462A1 (en) | 2006-10-30 | 2008-05-01 | Stuart Wenzel | Wound healing patch with integral passive vacuum and electrostimulation |
US8353931B2 (en) | 2006-11-02 | 2013-01-15 | Covidien Lp | Long term bioabsorbable barbed sutures |
US7931774B2 (en) | 2006-11-06 | 2011-04-26 | 3M Innovative Properties Company | Acrylic adhesives containing an amine plasticizer |
US8030534B2 (en) | 2006-11-28 | 2011-10-04 | Boehringer Technologies, L.P. | Tunnel dressing for use with negative pressure wound therapy system |
KR20090082914A (en) | 2006-11-30 | 2009-07-31 | 메델라 홀딩 아게 | Device for treating wounds |
RU62504U1 (en) | 2006-12-07 | 2007-04-27 | Юрий Павлович Савченко | MEDIUM DRAINING DEVICE |
WO2008104609A1 (en) | 2007-03-01 | 2008-09-04 | Coloplast A/S | Pressure-distributing elements for use with negative pressure therapy |
US8057446B2 (en) | 2007-05-01 | 2011-11-15 | The Brigham And Women's Hospital, Inc. | Wound healing device |
KR20120037514A (en) | 2007-05-10 | 2012-04-19 | 케이씨아이 라이센싱 인코포레이티드 | Reduced pressure wound dressing having a wound contact surface with columnar protrusions |
US8062315B2 (en) | 2007-05-17 | 2011-11-22 | Portaero, Inc. | Variable parietal/visceral pleural coupling |
EP2157948B1 (en) | 2007-05-24 | 2017-02-15 | Applied Tissue Technologies Llc | Wound treatment device employing negative pressure |
US7858835B2 (en) | 2007-06-27 | 2010-12-28 | Tyco Healthcare Group Lp | Foam control for synthetic adhesive/sealant |
GB0715259D0 (en) | 2007-08-06 | 2007-09-12 | Smith & Nephew | Canister status determination |
GB0712737D0 (en) | 2007-07-02 | 2007-08-08 | Smith & Nephew | Apparatus |
USD602583S1 (en) | 2007-07-02 | 2009-10-20 | Smith & Nephew Plc | Device for applying negative pressure to a wound |
GB0712736D0 (en) | 2007-07-02 | 2007-08-08 | Smith & Nephew | Apparatus |
GB0712757D0 (en) | 2007-07-02 | 2007-08-08 | Smith & Nephew | Pressure control |
US9408954B2 (en) | 2007-07-02 | 2016-08-09 | Smith & Nephew Plc | Systems and methods for controlling operation of negative pressure wound therapy apparatus |
GB0715211D0 (en) | 2007-08-06 | 2007-09-12 | Smith & Nephew | Apparatus |
IN2010KN00792A (en) | 2007-08-03 | 2015-08-28 | Nicast Ltd | |
US20090043268A1 (en) | 2007-08-06 | 2009-02-12 | Eddy Patrick E | Wound treatment system and suction regulator for use therewith |
CN101112326A (en) | 2007-09-05 | 2008-01-30 | 李旭辉 | Skin wound stitching instrument |
US20090099519A1 (en) | 2007-09-07 | 2009-04-16 | Albert Einstein Healthcare Network | Advanced abdominal dressing for the treatment of the postoperative hypothermic patients with an open abdomen |
US9023001B2 (en) | 2007-09-12 | 2015-05-05 | Heal-Ex, Llc | Systems and methods for providing a debriding wound vacuum |
US20090069904A1 (en) | 2007-09-12 | 2009-03-12 | Applied Medical Research | Biomaterial including micropores |
US8197506B2 (en) | 2007-09-14 | 2012-06-12 | Kenneth Burke | Wound closing device |
EP2185637B1 (en) | 2007-09-19 | 2013-04-03 | SurModics, Inc. | Biocompatible foams, systems, and methods |
EP2203137B1 (en) | 2007-10-11 | 2016-02-24 | Spiracur, Inc. | Closed incision negative pressure wound therapy device |
JP2011500272A (en) | 2007-10-23 | 2011-01-06 | ボリンジャー・テクノロジーズ・エル・ピー | Thin film wound covering, suction wound treatment system using thin film wound covering, method of using thin film wound covering, and method of manufacturing thin film wound covering |
US8746662B2 (en) | 2007-10-23 | 2014-06-10 | Elisna S.A.R.L. | Foam spring for pillows, cushions, mattresses or the like and method for manufacturing such a foam spring |
TWI340653B (en) | 2007-11-09 | 2011-04-21 | Ind Tech Res Inst | Detachable pump and the negative pressure wound therapy system using the same |
US9408755B2 (en) | 2007-11-13 | 2016-08-09 | Medela Holding Ag | Wound drainage dressing |
EP2214590B1 (en) | 2007-11-19 | 2016-08-31 | Massachusetts Institute of Technology | Adhesive articles |
CA2705896C (en) | 2007-11-21 | 2019-01-08 | Smith & Nephew Plc | Wound dressing |
HUE049431T2 (en) | 2007-11-21 | 2020-09-28 | Smith & Nephew | Wound dressing |
GB0722820D0 (en) | 2007-11-21 | 2008-01-02 | Smith & Nephew | Vacuum assisted wound dressing |
GB0724044D0 (en) | 2007-12-08 | 2008-01-16 | Smith & Nephew | Wound packing members |
GB0723872D0 (en) | 2007-12-06 | 2008-01-16 | Smith & Nephew | Apparatus for topical negative pressure therapy |
GB0723874D0 (en) | 2007-12-06 | 2008-01-16 | Smith & Nephew | Dressing |
US20130096518A1 (en) | 2007-12-06 | 2013-04-18 | Smith & Nephew Plc | Wound filling apparatuses and methods |
GB0723876D0 (en) | 2007-12-06 | 2008-01-16 | Smith & Nephew | Apparatus and method for topical negative pressure therapy |
WO2009093116A1 (en) | 2008-01-25 | 2009-07-30 | The University Of Cape Town | Wound dressing system and method |
WO2009099559A2 (en) | 2008-02-01 | 2009-08-13 | Synthes Usa, Llc | Porous biocompatible polymer material and methods |
US8273105B2 (en) | 2008-02-20 | 2012-09-25 | Tyco Healthcare Group Lp | Compound barb medical device and method |
CN102036692A (en) | 2008-02-22 | 2011-04-27 | 西洛诺瓦生物科学公司 | Multi-functional wound dressing matrices and related methods |
US8449508B2 (en) | 2008-03-05 | 2013-05-28 | Kci Licensing, Inc. | Dressing and method for applying reduced pressure to and collecting and storing fluid from a tissue site |
US20090227938A1 (en) | 2008-03-05 | 2009-09-10 | Insitu Therapeutics, Inc. | Wound Closure Devices, Methods of Use, and Kits |
BRPI0906095A2 (en) | 2008-03-05 | 2016-06-21 | Kci Licensing Inc | reduced pressure dressing to apply a reduced pressure treatment to a tissue site, method for collecting fluid in a bandage positioned at a tissue site and a reduced pressure dressing adapted to deliver a reduced pressure to a tissue site. |
US8298200B2 (en) | 2009-06-01 | 2012-10-30 | Tyco Healthcare Group Lp | System for providing continual drainage in negative pressure wound therapy |
US20110087261A1 (en) | 2008-03-11 | 2011-04-14 | Umc Utrecht Holding B.V. | Device and Method for Transseptal Puncturing |
AU2009223037A1 (en) | 2008-03-12 | 2009-09-17 | Smith & Nephew Plc | Negative pressure dressing and method of using same |
CA2723364A1 (en) | 2008-04-01 | 2009-11-12 | Ohio Medical Corporation | Wound treatment system |
CN102076269B (en) | 2008-05-16 | 2015-01-28 | 伊西康有限责任公司 | Coded heterofunctional sutures and methods |
AU2009251810B2 (en) | 2008-05-27 | 2013-03-28 | Smith & Nephew, Inc. | Negative pressure wound therapy device |
EP2829287B1 (en) | 2008-05-30 | 2019-07-03 | KCI Licensing, Inc. | Reduced-pressure, linear-wound treatment system |
AU2012261793B2 (en) | 2008-05-30 | 2014-11-06 | Solventum Intellectual Properties Company | Wound dressing with inflatable bladders |
CN103417332B (en) | 2008-05-30 | 2015-10-07 | 凯希特许有限公司 | Super-absorbent, reduced-pressure wound dressing and system |
CA2725569C (en) | 2008-05-30 | 2014-11-25 | Kci Licensing, Inc. | Reduced-pressure, linear wound closing bolsters and systems |
AU2013206230B2 (en) | 2008-05-30 | 2016-05-12 | Solventum Intellectual Properties Company | Reduced-pressure dressing assemblies for use in applying a closing force |
GB2461048C (en) | 2008-06-18 | 2012-11-21 | Jake Timothy | Improved wound dressing |
GB0811572D0 (en) | 2008-06-24 | 2008-07-30 | Smith & Nephew | Negitive pressure wound theraphy device |
EP2140888A1 (en) | 2008-07-04 | 2010-01-06 | Bayer MaterialScience AG | Layered compound, intended as wound dressing, containing a polyurethane foam layer, an absorbent layer and a covering layer |
EP2300069B1 (en) | 2008-07-08 | 2017-12-13 | Smith & Nephew, Inc | Portable negative pressure wound therapy device |
US20100022990A1 (en) | 2008-07-25 | 2010-01-28 | Boehringer Technologies, L.P. | Pump system for negative pressure wound therapy and improvements thereon |
US7777522B2 (en) | 2008-07-31 | 2010-08-17 | Freescale Semiconductor, Inc. | Clocked single power supply level shifter |
US8454990B2 (en) | 2008-08-01 | 2013-06-04 | Milliken & Company | Composite article suitable for use as a wound dressing |
US20100036333A1 (en) | 2008-08-06 | 2010-02-11 | Schenk Iii Albert A | Fluid level sensor for a container of a negative pressure wound treatment system |
DK2309961T3 (en) | 2008-08-08 | 2018-03-12 | Smith & Nephew Inc | Wound dressing of continuous fibers |
US9271706B2 (en) | 2008-08-12 | 2016-03-01 | Covidien Lp | Medical device for wound closure and method of use |
RU2011107119A (en) | 2008-09-18 | 2012-10-27 | КейСиАй Лайсензинг, Инк. (US) | SYSTEMS AND METHODS OF DELIVERY THERAPY |
EP2326295B2 (en) | 2008-09-18 | 2021-09-01 | KCI Licensing, Inc. | Multi-layer dressings, systems, and methods for applying reduced pressure at a tissue site |
EP2346414A2 (en) | 2008-09-20 | 2011-07-27 | Steven Craig Anderson | Apparatus and method for tissue adhesion |
MX2011003466A (en) | 2008-10-03 | 2011-04-21 | Kci Licensing Inc | System and method for using micro-electro-mechanical systems (mems) to heal wounds. |
EP2179749B1 (en) | 2008-10-23 | 2012-08-08 | Paul Hartmann AG | Polyurethane gel foams |
RU2011114218A (en) | 2008-10-29 | 2012-12-10 | КейСиАй ЛАЙСЕНЗИНГ, ИНК. | OPEN CAVITY THERAPY DEVICES AND SYSTEMS REDUCED PRESSURE |
BRPI0916062A2 (en) | 2008-11-07 | 2019-09-24 | Kci Licensing Inc | reduced pressure wound treatment system for patient wound care, wound closure dressing, wound treatment method, and wound closure dressing method |
RU2011114003A (en) | 2008-11-18 | 2012-12-27 | КейСиАй ЛАЙСЕНЗИНГ, ИНК. | COMPOSED LOW-PRESSURE HIGHWAYS |
JP5680544B2 (en) | 2008-11-25 | 2015-03-04 | スパイラキュア インコーポレイテッド | Device for delivering reduced pressure to the body surface |
US8721629B2 (en) | 2008-12-02 | 2014-05-13 | Kci Licensing, Inc. | System and method for mechanical closure of wounds |
US20100150991A1 (en) | 2008-12-15 | 2010-06-17 | Bernstein Brent H | Combination Wound Therapy |
CN101744688A (en) | 2008-12-18 | 2010-06-23 | 财团法人工业技术研究院 | Injury nursing device |
US8529528B2 (en) | 2008-12-24 | 2013-09-10 | Kci Licensing, Inc. | Reduced-pressure wound treatment systems and methods employing microstrain-inducing manifolds |
US8486032B2 (en) | 2008-12-24 | 2013-07-16 | Kci Licensing, Inc. | Reduced-pressure treatment systems and methods employing debridement mechanisms |
CA2745676A1 (en) | 2008-12-31 | 2010-07-08 | Kci Licensing, Inc. | System for providing fluid flow to nerve tissues |
GB0900423D0 (en) | 2009-01-12 | 2009-02-11 | Smith & Nephew | Negative pressure device |
CN102378606A (en) | 2009-02-02 | 2012-03-14 | Bsn医疗有限责任公司 | Wound dressing, method for the production thereof, and use thereof for dressing wounds |
WO2010091282A2 (en) | 2009-02-05 | 2010-08-12 | Tht Consulting, Llc | Flexible structural apparatus, spring, wound covering, and methods |
GB0902368D0 (en) | 2009-02-13 | 2009-04-01 | Smith & Nephew | Wound packing |
WO2010104983A2 (en) | 2009-03-10 | 2010-09-16 | The Johns Hopkins University | Biological tissue connection and repair devices and methods of using same |
US20100256672A1 (en) | 2009-04-01 | 2010-10-07 | Weinberg Medical Physics Llc | Apparatus and method for wound weaving and healing |
US8444614B2 (en) | 2009-04-10 | 2013-05-21 | Spiracur, Inc. | Methods and devices for applying closed incision negative pressure wound therapy |
CA2757841C (en) | 2009-04-10 | 2018-06-12 | Spiracur, Inc. | Methods and devices for applying closed incision negative pressure wound therapy |
DE102009019646B4 (en) | 2009-04-30 | 2015-04-30 | Lohmann & Rauscher Gmbh | Wound covering and method of manufacture |
US9039783B2 (en) | 2009-05-18 | 2015-05-26 | Baxter International, Inc. | Method for the improvement of mesh implant biocompatibility |
US20100298866A1 (en) | 2009-05-19 | 2010-11-25 | Tyco Healthcare Group Lp | Wound closure system and method of use |
US20120130327A1 (en) | 2009-05-20 | 2012-05-24 | Marquez Canada Juan | Perfecting of the improved vacuum dressing and the use thereof in vacuum-assisted therapy |
ES1070675Y (en) | 2009-05-20 | 2010-01-14 | Canada Juan Marquez | IMPROVED VACUUM TANK APPLICABLE AS POSTOPERATIVE COMPRESSION TREATMENT |
SE533843C2 (en) | 2009-06-15 | 2011-02-08 | Moelnlycke Health Care Ab | Wound pad comprising a body of compressed open cell foam material |
BRPI1012740A2 (en) | 2009-06-15 | 2016-03-22 | Damascus Armour Dev Pty Ltd | martensitic shielding steel alloy with high ballistic strength |
WO2010147930A1 (en) | 2009-06-16 | 2010-12-23 | 3M Innovative Properties Company | Conformable medical dressing with self supporting substrate |
US8469936B2 (en) | 2009-07-15 | 2013-06-25 | Kci Licensing, Inc. | Reduced-pressure dressings, systems, and methods employing desolidifying barrier layers |
WO2011043863A2 (en) | 2009-08-13 | 2011-04-14 | Michael Simms Shuler | Methods and dressing systems for promoting healing of injured tissue |
DE102009039336B4 (en) | 2009-08-29 | 2023-07-13 | Paul Hartmann Ag | Vacuum therapy device with pressure sensor |
FR2949688B1 (en) | 2009-09-04 | 2012-08-24 | Sofradim Production | FABRIC WITH PICOTS COATED WITH A BIORESORBABLE MICROPOROUS LAYER |
US20110059291A1 (en) | 2009-09-07 | 2011-03-10 | Boyce Christopher M | Structured materials with tailored isotropic and anisotropic poisson's ratios including negative and zero poisson's ratios |
US20110066096A1 (en) | 2009-09-11 | 2011-03-17 | Pal Svedman | Device for traction wound closure |
IN2012DN03120A (en) | 2009-09-17 | 2015-09-18 | Zipline Medical Inc | |
CN201519362U (en) | 2009-09-17 | 2010-07-07 | 宋九宏 | Superficial wound surface negative-pressure close drainage system |
US20110082480A1 (en) | 2009-10-01 | 2011-04-07 | Tyco Healthcare Group Lp | Wound closure device including pivotable claws |
US20110106027A1 (en) | 2009-11-05 | 2011-05-05 | Tyco Healthcare Group Lp | Chemically Coated Screen for Use with Hydrophobic Filters |
WO2011057175A1 (en) | 2009-11-09 | 2011-05-12 | 3M Innovative Properties Company | Medical articles and methods of making using miscible composition |
US9398943B2 (en) | 2009-11-30 | 2016-07-26 | Covidien Lp | Ventral hernia repair with barbed suture |
DK2515961T3 (en) | 2009-12-22 | 2019-07-15 | Smith & Nephew Inc | APPARATUS AND METHODS FOR NEGATIVE PRESSURE WOUND THERAPY |
DE102009060596A1 (en) | 2009-12-23 | 2011-06-30 | Paul Hartmann Aktiengesellschaft, 89522 | Connection device for use in the vacuum treatment of wounds |
WO2011090410A1 (en) | 2010-01-19 | 2011-07-28 | Sca Hygiene Products Ab | Absorbent article comprising an absorbent porous foam |
WO2011091169A1 (en) | 2010-01-20 | 2011-07-28 | University Of Rochester | Nerve and blood vessel repair systems |
US9770368B2 (en) | 2010-01-20 | 2017-09-26 | Kci Licensing, Inc. | Foam wound inserts with regions of higher and lower densities, wound dressings, and methods |
US8500776B2 (en) | 2010-02-08 | 2013-08-06 | Covidien Lp | Vacuum patch for rapid wound closure |
WO2011109704A1 (en) | 2010-03-04 | 2011-09-09 | The Trustees Of The University Of Pennsylvania Center For Technology Transfer | Antimicrobial cationic stereoids and methods of use |
JP5871822B2 (en) | 2010-03-10 | 2016-03-01 | オスディーサイン アーベー | Implants and methods for correcting tissue defects |
US8721606B2 (en) | 2010-03-11 | 2014-05-13 | Kci Licensing, Inc. | Dressings, systems, and methods for treating a tissue site |
US8430867B2 (en) | 2010-03-12 | 2013-04-30 | Kci Licensing, Inc. | Reduced-pressure dressing connection pads, systems, and methods |
US8454580B2 (en) | 2010-03-12 | 2013-06-04 | Kci Licensing, Inc. | Adjustable reduced-pressure wound coverings |
US8882730B2 (en) | 2010-03-12 | 2014-11-11 | Kci Licensing, Inc. | Radio opaque, reduced-pressure manifolds, systems, and methods |
US8814842B2 (en) | 2010-03-16 | 2014-08-26 | Kci Licensing, Inc. | Delivery-and-fluid-storage bridges for use with reduced-pressure systems |
DE102010012521A1 (en) | 2010-03-17 | 2011-09-22 | Aesculap Ag | Medical kit for use in vacuum sealing therapy |
RU2559184C2 (en) | 2010-03-23 | 2015-08-10 | Ухань Всд Медикал Сайенс Энд Текхнолоджи Ко., Лтд. | Medical device for vacuum closed drainage |
US8758799B2 (en) | 2010-03-24 | 2014-06-24 | Covidien Lp | Therapeutic implant |
US8758800B2 (en) | 2010-03-24 | 2014-06-24 | Covidien Lp | Therapeutic implant |
KR101782188B1 (en) | 2010-03-24 | 2017-09-26 | 바스프 에스이 | Ultrathin fluid-absorbent cores |
US9427506B2 (en) | 2010-03-31 | 2016-08-30 | Kci Licensing, Inc. | System and method for locating fluid leaks at a drape using sensing techniques |
GB201006986D0 (en) | 2010-04-27 | 2010-06-09 | Smith & Nephew | Wound dressing |
GB201006985D0 (en) | 2010-04-27 | 2010-06-09 | Smith & Nephew | Wound dressing |
GB201006988D0 (en) | 2010-04-27 | 2010-06-09 | Smith & Nephew | Suction port |
GB201008347D0 (en) | 2010-05-19 | 2010-07-07 | Smith & Nephew | Wound protection |
US8623047B2 (en) | 2010-04-30 | 2014-01-07 | Kci Licensing, Inc. | System and method for sealing an incisional wound |
US20110282365A1 (en) | 2010-05-14 | 2011-11-17 | Ahmad Robert Hadba | Surgical Implants |
EP2394617B1 (en) | 2010-06-10 | 2013-12-11 | MedSkin Solutions Dr. Suwelack AG | Layer-like perforated biomatrices |
CN103002844B (en) | 2010-06-14 | 2016-08-31 | 奇普林医药公司 | For the method and apparatus suppressing cicatrization |
US9198987B2 (en) | 2010-06-25 | 2015-12-01 | Kci Licensing, Inc. | Systems and methods for imaging sinuses |
US8585665B2 (en) | 2010-07-01 | 2013-11-19 | Prospera Technologies Llc | Transmissive dressing for negative pressure wound therapy |
US9211175B2 (en) | 2010-07-08 | 2015-12-15 | Covidien Lp | Self-detachable medical devices |
WO2012006625A2 (en) | 2010-07-09 | 2012-01-12 | Velomedix, Inc. | Method and apparatus for pressure measurement |
US9265665B2 (en) | 2010-07-19 | 2016-02-23 | Kci Licensing, Inc. | Inflatable off-loading wound dressing assemblies, systems, and methods |
US8679153B2 (en) | 2010-07-30 | 2014-03-25 | Andrew Dennis | Method and apparatus for surgically closing an open abdomen |
US10751221B2 (en) | 2010-09-14 | 2020-08-25 | Kpr U.S., Llc | Compression sleeve with improved position retention |
RU2599326C2 (en) | 2010-09-20 | 2016-10-10 | СМИТ ЭНД НЕФЬЮ ПиЭлСи | Negative pressure device |
GB201015656D0 (en) | 2010-09-20 | 2010-10-27 | Smith & Nephew | Pressure control apparatus |
CA2814823A1 (en) | 2010-10-15 | 2012-04-19 | The Procter & Gamble Company | Absorbent article having surface visual texture |
US8758314B2 (en) | 2010-10-20 | 2014-06-24 | Kci Licensing, Inc. | Reduced-pressure systems, devices, and methods for treating a tissue site that includes a fistula |
US9220499B2 (en) | 2010-10-28 | 2015-12-29 | Covidien Lp | Wound closure device including barbed pins |
EP3574929B1 (en) | 2010-11-17 | 2023-06-07 | 3M Innovative Properties Company | Systems for managing reduced pressure at a plurality of wound sites |
JP5761966B2 (en) | 2010-11-18 | 2015-08-12 | 学校法人 久留米大学 | Negative pressure treatment loading material |
WO2012148472A2 (en) | 2010-11-19 | 2012-11-01 | President And Fellows Of Harvard College | Soft robotic actuators |
GB201020005D0 (en) | 2010-11-25 | 2011-01-12 | Smith & Nephew | Composition 1-1 |
DE102010052336A1 (en) | 2010-11-25 | 2012-05-31 | Paul Hartmann Ag | Wound dressing for the negative pressure therapy |
BR112013012785A2 (en) | 2010-11-25 | 2020-10-20 | Bluestar Silicones France Sas | composition i - ii and products and uses thereof |
CN102038575B (en) | 2010-12-06 | 2012-09-19 | 陈德华 | Wound filling dressing for closed negative pressure drainage of surgical wound as well as preparation method |
TW201223512A (en) | 2010-12-06 | 2012-06-16 | Kang Na Hsiung Entpr Co Ltd | Absorbent hygiene product |
US9440010B2 (en) | 2010-12-07 | 2016-09-13 | Kci Licensing, Inc. | Drape having microstrain inducing projections for treating a wound site |
ES2748519T3 (en) | 2010-12-08 | 2020-03-17 | Convatec Technologies Inc | Wound exudate system accessory |
TWI465263B (en) | 2010-12-10 | 2014-12-21 | Ind Tech Res Inst | Medical dressing and negative pressure wound therapy apparatus using the same |
US8613733B2 (en) | 2010-12-15 | 2013-12-24 | Kci Licensing, Inc. | Foam dressing with integral porous film |
US20120157826A1 (en) | 2010-12-15 | 2012-06-21 | Christopher Brian Locke | Method for the Remote Detection of Wound Interface Materials Inside the Body |
RU2016111981A (en) | 2010-12-22 | 2018-11-27 | Смит Энд Нефью, Инк. | DEVICE AND METHOD FOR TREATING RAS WITH NEGATIVE PRESSURE |
US9375208B2 (en) | 2010-12-30 | 2016-06-28 | Covidien Lp | Wound closure device |
US8637726B2 (en) | 2011-01-02 | 2014-01-28 | Omnitek Partners Llc | Shape and pressure adjustable dressing |
US9615975B2 (en) | 2011-01-02 | 2017-04-11 | Omnitek Partners Llc | Shape and pressure adjustable dressing |
US8608775B2 (en) | 2011-01-24 | 2013-12-17 | Covidien Lp | Two part tape adhesive for wound closure |
US9421132B2 (en) | 2011-02-04 | 2016-08-23 | University Of Massachusetts | Negative pressure wound closure device |
US9107990B2 (en) | 2011-02-14 | 2015-08-18 | Kci Licensing, Inc. | Reduced-pressure dressings, systems, and methods for use with linear wounds |
US8785714B2 (en) | 2011-02-28 | 2014-07-22 | Celanese International Corporation | Alkali neutralizing acquisition and distribution structures for use in personal care articles |
US9278166B2 (en) | 2011-03-02 | 2016-03-08 | Medline Industries, Inc. | Method and apparatus pertaining to a medical drape having a suction port |
US20120253302A1 (en) | 2011-04-04 | 2012-10-04 | Tyco Healthcare Group Lp | Negative Pressure Wound Therapy Dressing |
DE102011001832A1 (en) | 2011-04-06 | 2012-10-11 | Birgit Riesinger | Wound care article with targeted deformable shell |
GB2489947B (en) | 2011-04-11 | 2018-12-12 | Adv Med Solutions Ltd | Wound dressing |
WO2012142473A1 (en) | 2011-04-15 | 2012-10-18 | University Of Massachusetts | Surgical cavity drainage and closure system |
US8968760B2 (en) | 2011-04-27 | 2015-03-03 | Covidien Lp | Attachment of a biomaterial to tissue |
GB201108229D0 (en) | 2011-05-17 | 2011-06-29 | Smith & Nephew | Tissue healing |
EP3299041B1 (en) | 2011-05-27 | 2021-05-19 | 3M Innovative Properties Company | Systems and methods for delivering fluid to a wound therapy dressing |
EP2717936B1 (en) | 2011-06-07 | 2016-10-12 | Smith & Nephew PLC | Apparatus for the treatment of wounds |
US20130012891A1 (en) | 2011-07-05 | 2013-01-10 | Yossi Gross | Skin-treatment and drug-delivery devices |
JP6208124B2 (en) | 2011-07-14 | 2017-10-04 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Wound dressing and method for producing the wound dressing |
WO2013012381A1 (en) | 2011-07-19 | 2013-01-24 | Shieldheart Medtech Ab | Stabilizer, barrier disc and wound dressing comprising stabilizer, method for controlling the position of a wound dressing or barrier disc, and method for facilitating drainage from a wound dressing or barrier disc in negative pressure wound treatment |
JP2013027450A (en) | 2011-07-27 | 2013-02-07 | Panasonic Corp | Dish washing and drying machine |
JP5883248B2 (en) | 2011-07-27 | 2016-03-09 | 京セラ株式会社 | Wireless communication system, wireless base station, and wireless communication method |
DE202011108805U1 (en) | 2011-09-02 | 2012-09-03 | BLüCHER GMBH | wound dressing |
PL2567682T5 (en) | 2011-09-09 | 2018-06-29 | Paul Hartmann Ag | Abdominal wound dressing with application aid |
DE102011112795A1 (en) | 2011-09-09 | 2013-03-14 | Paul Hartmann Ag | Device for simulating a wound on the open abdomen |
EP2758086B1 (en) | 2011-09-20 | 2018-05-23 | KCI Licensing, Inc. | Tissue treatment systems and methods having a non-tactile-stimulus-activated, macroscopically-deforming material |
US9393354B2 (en) | 2011-11-01 | 2016-07-19 | J&M Shuler Medical, Inc. | Mechanical wound therapy for sub-atmospheric wound care system |
GB2504873B (en) | 2011-11-01 | 2015-10-14 | Brightwake Ltd | Wound dressings, and yarn useful therein |
US8993831B2 (en) | 2011-11-01 | 2015-03-31 | Arsenal Medical, Inc. | Foam and delivery system for treatment of postpartum hemorrhage |
US9084845B2 (en) | 2011-11-02 | 2015-07-21 | Smith & Nephew Plc | Reduced pressure therapy apparatuses and methods of using same |
CA2850956C (en) | 2011-11-11 | 2020-06-02 | Kci Licensing, Inc. | Reduced-pressure, tunnel-wound dressings, systems, and methods |
CN103917255B (en) | 2011-11-18 | 2016-09-28 | 凯希特许有限公司 | There is tissue therapy system and the method for the perforated substrate of band constricted zone and extended region |
US9204801B2 (en) | 2011-11-21 | 2015-12-08 | Kci Licensing, Inc. | Systems, devices, and methods for identifying portions of a wound filler left at a tissue site |
US20150159066A1 (en) | 2011-11-25 | 2015-06-11 | Smith & Nephew Plc | Composition, apparatus, kit and method and uses thereof |
DE102011055782A1 (en) | 2011-11-28 | 2013-05-29 | Birgit Riesinger | WOUND CARE DEVICE FOR TREATING WOUNDS USING ATMOSPHERIC UNDERPRESSURE |
FR2983347B1 (en) | 2011-11-28 | 2014-07-25 | Commissariat Energie Atomique | DIODE ARRAY DEVICE HAVING ACCESS RESISTORS AND IMPROVED STABILITY |
GB201120693D0 (en) | 2011-12-01 | 2012-01-11 | Convatec Technologies Inc | Wound dressing for use in vacuum therapy |
DE102012001752A1 (en) | 2012-01-30 | 2013-08-01 | Wilhelm Kannengießer | Healing support device for treating wound after amputation, has funnel-like, V-shaped part and container connected by removable elastic connecting sleeve, tube attached at container above outlet, and pump producing low pressure in container |
EP3708196A1 (en) | 2012-03-12 | 2020-09-16 | Smith & Nephew PLC | Reduced pressure apparatus and methods |
CN202568632U (en) | 2012-05-04 | 2012-12-05 | 王宏坤 | Bag-shaped vacuum wound dressing |
MX2014014266A (en) | 2012-05-22 | 2015-06-23 | Smith & Nephew | Apparatuses and methods for wound therapy. |
EP2852419B1 (en) | 2012-05-22 | 2019-11-20 | Smith & Nephew plc | Wound closure device |
US10117782B2 (en) | 2012-05-24 | 2018-11-06 | Smith & Nephew, Inc. | Devices and methods for treating and closing wounds with negative pressure |
CN104411340B (en) | 2012-05-29 | 2016-09-07 | 3M创新有限公司 | Absorbent article including the foam of polymers and intermediate with superabsorbents |
EP2855722A1 (en) | 2012-05-31 | 2015-04-08 | Zimmer, Inc. | Anisotropic porous scaffolds and method of making anisotropic porous scaffolds |
US10130520B2 (en) | 2012-07-16 | 2018-11-20 | Smith & Nephew, Inc. | Negative pressure wound closure device |
BR112015000933B1 (en) | 2012-07-16 | 2021-10-19 | University Of Massachusetts | NEGATIVE PRESSURE INJURY CLOSING DEVICE |
EP2882392B1 (en) | 2012-08-08 | 2019-03-20 | Smith & Nephew PLC | Bespoke wound treatment apparatuses and methods for use in negative pressure wound therapy |
JP6298468B2 (en) | 2012-10-16 | 2018-03-20 | サーモディクス,インコーポレイテッド | Wound filling device and method |
CN103071197A (en) | 2013-01-29 | 2013-05-01 | 绍兴福清卫生用品有限公司 | Negative pressure wound dressing capable of flushing wound and using method for same |
JP2014168573A (en) | 2013-03-04 | 2014-09-18 | Nitto Denko Corp | Film dressing with sweating visual recognition function and through hole |
RU2015142873A (en) | 2013-03-13 | 2017-04-19 | Смит Энд Нефью Инк. | DEVICE AND SYSTEMS FOR CLOSING A Wound USING NEGATIVE PRESSURE, AND METHODS FOR APPLICATION IN TREATING A WAN USING NEGATIVE PRESSURE |
WO2014158526A1 (en) | 2013-03-14 | 2014-10-02 | Kci Licensing, Inc. | Negative pressure therapy with dynamic profile capability |
AU2014229749B2 (en) | 2013-03-14 | 2018-09-20 | Smith & Nephew Plc | Compressible wound fillers and systems and methods of use in treating wounds with negative pressure |
US9737649B2 (en) | 2013-03-14 | 2017-08-22 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
US10695226B2 (en) | 2013-03-15 | 2020-06-30 | Smith & Nephew Plc | Wound dressing and method of treatment |
WO2014178945A1 (en) | 2013-05-02 | 2014-11-06 | Vomaris Innovations, Inc. | Expandable wound dressings |
US20140343517A1 (en) | 2013-05-16 | 2014-11-20 | Oakwell Distribution, Inc, | Negative Pressure Foot Bandage |
CN103691010B (en) | 2013-06-04 | 2016-09-14 | 武汉维斯第医用科技股份有限公司 | Multi-layered foamed dressing for negative-pressure sealed drainage and preparation method thereof |
EP2815731A1 (en) | 2013-06-18 | 2014-12-24 | Mölnlycke Health Care AB | Fluid transport dressing |
WO2015002986A1 (en) | 2013-07-01 | 2015-01-08 | Nike Innovate C.V. | Modular impact protection system for athletic wear |
CN105530898B (en) | 2013-07-16 | 2020-02-28 | 史密夫及内修公开有限公司 | Apparatus for wound therapy |
CN103405846B (en) | 2013-07-17 | 2016-02-03 | 苏州爱得科技发展有限公司 | Medical pad pasting negative pressure drainage device |
EP2830042A1 (en) | 2013-07-26 | 2015-01-28 | AIRBUS HELICOPTERS DEUTSCHLAND GmbH | Sandwich type load bearing panel |
WO2015023515A1 (en) | 2013-08-13 | 2015-02-19 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
CN203408163U (en) | 2013-08-14 | 2014-01-29 | 朱新生 | Novel compound foam material negative-pressure absorption device |
US9936937B2 (en) | 2013-08-20 | 2018-04-10 | Brigham Young University | Surgical retractor |
DE102013014295A1 (en) | 2013-08-22 | 2015-02-26 | Johnson & Johnson Medical Gmbh | Surgical implant |
US9986772B2 (en) | 2013-09-13 | 2018-06-05 | Djo, Llc | Disposable padded tape |
US10004646B2 (en) | 2013-10-04 | 2018-06-26 | Dristi, LLC | Methods for using polymer foam absorbent materials in wound dressings |
WO2015061352A2 (en) | 2013-10-21 | 2015-04-30 | Smith & Nephew, Inc. | Negative pressure wound closure device |
US20150164174A1 (en) | 2013-12-16 | 2015-06-18 | J. Stephen West | Helmet with external protective scales |
CN110974539A (en) | 2014-01-21 | 2020-04-10 | 史密夫及内修公开有限公司 | Collapsible dressing for negative pressure wound therapy |
CN106456376B (en) | 2014-01-21 | 2020-12-15 | 史密夫及内修公开有限公司 | Wound treatment device |
CN106457748A (en) | 2014-01-24 | 2017-02-22 | 墨尔本皇家理工大学 | Structured porous metamaterial |
GB2524510B (en) | 2014-03-25 | 2020-02-19 | Brightwake Ltd | Wound dressing impregnated with honey |
EP3791837B1 (en) | 2014-05-09 | 2024-07-17 | Solventum Intellectual Properties Company | Disruptive dressing for use with negative pressure and fluid instillation |
CN106456848B (en) | 2014-05-09 | 2020-03-06 | 凯希特许有限公司 | Debridement dressings for use with negative pressure and fluid instillation |
CN111134959B (en) | 2014-05-09 | 2022-08-16 | 3M创新知识产权公司 | Dressing with a shrink layer for a linear tissue site |
DE102014106518A1 (en) | 2014-05-09 | 2015-11-12 | Paul Hartmann Ag | Foam wound dressing for negative pressure therapy |
IE86941B1 (en) | 2014-05-27 | 2018-12-12 | Sugrue Michael | Dual and negative pressure wound therapy dressings for the prevention and management of tissue fluid, seroma and lymphoedema |
EP3666237B1 (en) | 2014-06-18 | 2023-11-01 | Smith & Nephew plc | Wound dressing |
US20150374561A1 (en) | 2014-06-27 | 2015-12-31 | The Procter & Gamble Company | Heterogeneous mass containing foam |
WO2016018448A1 (en) | 2014-07-31 | 2016-02-04 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
EP2995289A1 (en) | 2014-09-10 | 2016-03-16 | The Procter and Gamble Company | Multi-level cell forming structures and their use in disposable consumer products |
USD805039S1 (en) | 2015-01-29 | 2017-12-12 | Layer Zero Power Systems, Inc. | Cover |
EP3288509B1 (en) | 2015-04-29 | 2022-06-29 | Smith & Nephew, Inc | Negative pressure wound closure device |
WO2016179245A1 (en) | 2015-05-04 | 2016-11-10 | The Florida State University Research Foundation, Inc. | Negative poisson ratio piezoresistive sensor and method of manufacture |
EP3297697B1 (en) | 2015-05-18 | 2022-05-11 | Smith & Nephew plc | Negative pressure wound therapy apparatus |
WO2017063036A1 (en) | 2015-10-12 | 2017-04-20 | Rmit University | Wound filler for negative pressure wound therapy |
US10814049B2 (en) | 2015-12-15 | 2020-10-27 | University Of Massachusetts | Negative pressure wound closure devices and methods |
US10575991B2 (en) | 2015-12-15 | 2020-03-03 | University Of Massachusetts | Negative pressure wound closure devices and methods |
WO2018237206A2 (en) | 2017-06-21 | 2018-12-27 | University Of Massachusetts | Negative pressure wound closure devices and methods |
US11471586B2 (en) | 2015-12-15 | 2022-10-18 | University Of Massachusetts | Negative pressure wound closure devices and methods |
SE540964C2 (en) | 2016-08-23 | 2019-01-29 | Halao Ab | Wound dressing with inflatable structures |
EP3506865B1 (en) | 2016-08-30 | 2021-10-06 | Smith & Nephew plc | Systems for applying reduced pressure therapy |
EP3506867A1 (en) | 2016-08-30 | 2019-07-10 | Smith&Nephew, Inc. | Negative pressure wound closure device |
JP2019531846A (en) | 2016-08-30 | 2019-11-07 | スミス アンド ネフュー インコーポレイテッド | Wound closure device |
-
2014
- 2014-03-12 RU RU2015142873A patent/RU2015142873A/en not_active Application Discontinuation
- 2014-03-12 US US14/774,689 patent/US10124098B2/en active Active
- 2014-03-12 JP JP2016501735A patent/JP6407954B2/en active Active
- 2014-03-12 CA CA2902776A patent/CA2902776C/en active Active
- 2014-03-12 BR BR112015021854A patent/BR112015021854A2/en not_active IP Right Cessation
- 2014-03-12 EP EP14723917.2A patent/EP2968016B1/en active Active
- 2014-03-12 WO PCT/US2014/025059 patent/WO2014165275A1/en active Application Filing
- 2014-03-12 MX MX2015011803A patent/MX369065B/en active IP Right Grant
- 2014-03-12 EP EP18169232.8A patent/EP3372209A1/en not_active Withdrawn
- 2014-03-12 CN CN202110914060.4A patent/CN113730099A/en active Pending
- 2014-03-12 AU AU2014248519A patent/AU2014248519B2/en active Active
- 2014-03-12 CN CN201480027156.7A patent/CN105188622A/en active Pending
-
2015
- 2015-09-07 MX MX2019012837A patent/MX2019012837A/en unknown
-
2018
- 2018-10-31 US US16/177,189 patent/US11419767B2/en active Active
-
2019
- 2019-03-20 AU AU2019201930A patent/AU2019201930A1/en not_active Abandoned
-
2020
- 2020-08-07 AU AU2020213413A patent/AU2020213413A1/en not_active Abandoned
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004018020A1 (en) * | 2002-08-21 | 2004-03-04 | Hill-Rom Services, Inc. | Wound packing for preventing wound closure |
US7524315B2 (en) | 2002-10-28 | 2009-04-28 | Smith & Nephew Plc | Apparatus for aspirating, irrigating and cleansing wounds |
US20040162512A1 (en) * | 2003-02-19 | 2004-08-19 | 3M Innovative Properties Company | Conformable wound dressing |
US7753894B2 (en) | 2004-04-27 | 2010-07-13 | Smith & Nephew Plc | Wound cleansing apparatus with stress |
US20090306609A1 (en) | 2005-04-27 | 2009-12-10 | Smith & Nephew Plc | Wound treatment apparatus and method |
US20070118096A1 (en) * | 2005-11-21 | 2007-05-24 | Smith Joshua D | Wound care system |
US20110054365A1 (en) | 2008-03-13 | 2011-03-03 | Smith & Nephew Plc | Vacuum closure device |
WO2010075180A2 (en) * | 2008-12-24 | 2010-07-01 | Kci Licenssing, Inc. | Reduced-pressure wound treatment systems and methods employing manifold structures |
US20110213287A1 (en) | 2010-02-26 | 2011-09-01 | Smith & Nephew, Inc. | Systems and methods for using negative pressure wound therapy to manage open abdominal wounds |
WO2011106722A1 (en) * | 2010-02-26 | 2011-09-01 | Smith & Nephew, Inc. | Systems and methods for using negative pressure wound therapy to manage open abdominal wounds |
US20110282309A1 (en) | 2010-04-27 | 2011-11-17 | Smith & Nephew Plc | Wound dressing and method of use |
US20120209227A1 (en) | 2011-02-04 | 2012-08-16 | Raymond Dunn | Negative pressure wound closure device |
Cited By (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11701263B2 (en) | 2006-09-26 | 2023-07-18 | Smith & Nephew, Inc. | Wound dressing |
US10548776B2 (en) | 2006-09-26 | 2020-02-04 | Smith & Nephew, Inc. | Wound dressing |
US9820888B2 (en) | 2006-09-26 | 2017-11-21 | Smith & Nephew, Inc. | Wound dressing |
US10405861B2 (en) | 2011-02-04 | 2019-09-10 | University Of Massachusetts | Negative pressure wound closure device |
US9421132B2 (en) | 2011-02-04 | 2016-08-23 | University Of Massachusetts | Negative pressure wound closure device |
US9301742B2 (en) | 2011-02-04 | 2016-04-05 | University Of Massachusetts | Negative pressure wound closure device |
US9226737B2 (en) | 2011-02-04 | 2016-01-05 | University Of Massachusetts | Negative pressure wound closure device |
US11166726B2 (en) | 2011-02-04 | 2021-11-09 | University Of Massachusetts | Negative pressure wound closure device |
US10220125B2 (en) | 2012-02-03 | 2019-03-05 | Smith & Nephew Plc | Apparatuses and methods for wound therapy |
US10070994B2 (en) | 2012-05-22 | 2018-09-11 | Smith & Nephew Plc | Apparatuses and methods for wound therapy |
US9844472B2 (en) | 2012-05-22 | 2017-12-19 | Smith & Nephew Plc | Wound closure device |
US10702420B2 (en) | 2012-05-22 | 2020-07-07 | Smith & Nephew Plc | Wound closure device |
US11559439B2 (en) | 2012-05-22 | 2023-01-24 | Smith & Nephew Plc | Wound closure device |
US10117782B2 (en) | 2012-05-24 | 2018-11-06 | Smith & Nephew, Inc. | Devices and methods for treating and closing wounds with negative pressure |
US11241337B2 (en) | 2012-05-24 | 2022-02-08 | Smith & Nephew, Inc. | Devices and methods for treating and closing wounds with negative pressure |
US11083631B2 (en) | 2012-07-16 | 2021-08-10 | University Of Massachusetts | Negative pressure wound closure device |
US11564843B2 (en) | 2012-07-16 | 2023-01-31 | University Of Massachusetts | Negative pressure wound closure device |
US10130520B2 (en) | 2012-07-16 | 2018-11-20 | Smith & Nephew, Inc. | Negative pressure wound closure device |
US9962295B2 (en) | 2012-07-16 | 2018-05-08 | Smith & Nephew, Inc. | Negative pressure wound closure device |
US11419767B2 (en) | 2013-03-13 | 2022-08-23 | University Of Massachusetts | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure |
US10124098B2 (en) | 2013-03-13 | 2018-11-13 | Smith & Nephew, Inc. | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure |
US11097044B2 (en) | 2013-03-14 | 2021-08-24 | Smith & Nephew Plc | Compressible wound fillers and systems and methods of use in treating wounds with negative pressure |
US10159771B2 (en) | 2013-03-14 | 2018-12-25 | Smith & Nephew Plc | Compressible wound fillers and systems and methods of use in treating wounds with negative pressure |
WO2015061352A2 (en) | 2013-10-21 | 2015-04-30 | Smith & Nephew, Inc. | Negative pressure wound closure device |
US10660992B2 (en) | 2013-10-21 | 2020-05-26 | Smith & Nephew, Inc. | Negative pressure wound closure device |
AU2014340232B2 (en) * | 2013-10-21 | 2019-07-11 | Smith & Nephew Inc. | Negative pressure wound closure device |
WO2015061352A3 (en) * | 2013-10-21 | 2015-09-24 | Smith & Nephew, Inc. | Negative pressure wound closure device |
US11344665B2 (en) | 2014-01-21 | 2022-05-31 | Smith & Nephew Plc | Collapsible dressing for negative pressure wound treatment |
US10179073B2 (en) | 2014-01-21 | 2019-01-15 | Smith & Nephew Plc | Wound treatment apparatuses |
US11103385B2 (en) | 2014-01-21 | 2021-08-31 | Smith & Nephew Plc | Wound treatment apparatuses |
US10201642B2 (en) | 2014-01-21 | 2019-02-12 | Smith & Nephew Plc | Collapsible dressing for negative pressure wound treatment |
US11439539B2 (en) | 2015-04-29 | 2022-09-13 | University Of Massachusetts | Negative pressure wound closure device |
EP4209201A1 (en) | 2015-04-29 | 2023-07-12 | Smith & Nephew, Inc. | Negative pressure wound closure device |
AU2016298953B2 (en) * | 2015-07-27 | 2020-12-10 | Noleus Technologies Inc. | Apparatuses and methods for improving post-operative recovery from surgery |
WO2017019810A1 (en) * | 2015-07-27 | 2017-02-02 | Noleus Technologies Inc. | Apparatuses and methods for improving post-operative recovery from surgery |
US10960113B2 (en) | 2015-07-27 | 2021-03-30 | Noleus Technologies, Inc. | Apparatuses and methods for improving post-operative recovery from surgery |
US10575991B2 (en) | 2015-12-15 | 2020-03-03 | University Of Massachusetts | Negative pressure wound closure devices and methods |
US10814049B2 (en) | 2015-12-15 | 2020-10-27 | University Of Massachusetts | Negative pressure wound closure devices and methods |
EP3389508A4 (en) * | 2015-12-15 | 2019-06-19 | University of Massachusetts | Negative pressure wound closure devices and methods |
WO2017106576A1 (en) * | 2015-12-15 | 2017-06-22 | University Of Massachusetts | Negative pressure wound closure devices and methods |
US11471586B2 (en) | 2015-12-15 | 2022-10-18 | University Of Massachusetts | Negative pressure wound closure devices and methods |
WO2018044949A1 (en) | 2016-08-30 | 2018-03-08 | Smith & Nephew, Inc. | Wound closure devices |
WO2018044944A1 (en) | 2016-08-30 | 2018-03-08 | Smith & Nephew, Inc. | Negative pressure wound closure device |
EP4085884A1 (en) | 2016-08-30 | 2022-11-09 | Smith & Nephew, Inc. | Wound closure devices |
US11135351B2 (en) | 2016-08-30 | 2021-10-05 | Smith & Nephew Plc | Systems and methods for applying reduced pressure therapy |
WO2018060144A1 (en) | 2016-09-27 | 2018-04-05 | Smith & Nephew Plc | Wound closure devices with dissolvable portions |
US11096832B2 (en) | 2016-09-27 | 2021-08-24 | Smith & Nephew Plc | Wound closure devices with dissolvable portions |
US11617684B2 (en) | 2016-11-02 | 2023-04-04 | Smith & Nephew, Inc. | Wound closure devices |
WO2018085457A1 (en) | 2016-11-02 | 2018-05-11 | Smith & Nephew Inc. | Wound closure devices |
WO2018108785A1 (en) | 2016-12-16 | 2018-06-21 | Smith & Nephew Plc | Negative pressure wound closure device |
US11324876B2 (en) | 2017-06-13 | 2022-05-10 | Smith & Nephew Plc | Collapsible structure and method of use |
US12082999B2 (en) | 2017-06-13 | 2024-09-10 | Smith & Nephew Plc | Wound closure device and method of use |
US11872110B2 (en) | 2017-06-13 | 2024-01-16 | Smith & Nephew Plc | Wound closure device and method of use |
WO2018229009A1 (en) | 2017-06-13 | 2018-12-20 | Smith & Nephew Plc | Wound closure device and method of use |
WO2018231878A1 (en) | 2017-06-14 | 2018-12-20 | Smith & Nephew, Inc. | Fluid removal management and control of wound closure in wound therapy |
US12082998B2 (en) | 2017-06-14 | 2024-09-10 | Smith & Nephew Plc | Collapsible structure for wound closure and method of use |
WO2018229012A1 (en) | 2017-06-14 | 2018-12-20 | Smith & Nephew Plc | Collapsible sheet for wound closure and method of use |
WO2018229011A1 (en) | 2017-06-14 | 2018-12-20 | Smith & Nephew Plc | Collapsible structure for wound closure and method of use |
US11583623B2 (en) | 2017-06-14 | 2023-02-21 | Smith & Nephew Plc | Collapsible structure for wound closure and method of use |
US11123476B2 (en) | 2017-06-14 | 2021-09-21 | Smith & Nephew, Inc. | Fluid removal management and control of wound closure in wound therapy |
US11938002B2 (en) | 2017-06-14 | 2024-03-26 | Smith & Nephew, Inc. | Control of wound closure and fluid removal management in wound therapy |
US11395873B2 (en) | 2017-06-14 | 2022-07-26 | Smith & Nephew, Inc. | Control of wound closure and fluid removal management in wound therapy |
US11690948B2 (en) | 2017-06-14 | 2023-07-04 | Smith & Nephew, Inc. | Fluid removal management and control of wound closure in wound therapy |
US11724020B2 (en) | 2017-06-14 | 2023-08-15 | Smith & Nephew Plc | Collapsible sheet for wound closure and method of use |
US12005180B2 (en) | 2017-06-14 | 2024-06-11 | Smith & Nephew Plc | Collapsible sheet for wound closure and method of use |
US12097096B2 (en) | 2017-07-27 | 2024-09-24 | Smith & Nephew Plc | Customizable wound closure device and method of use |
WO2019020544A1 (en) | 2017-07-27 | 2019-01-31 | Smith & Nephew Plc | Customizable wound closure device and method of use |
US11607344B2 (en) | 2017-07-27 | 2023-03-21 | Smith & Nephew Plc | Customizable wound closure device and method of use |
US11590030B2 (en) | 2017-08-07 | 2023-02-28 | Smith & Nephew Plc | Wound closure device with protective layer and method of use |
WO2019030136A1 (en) | 2017-08-07 | 2019-02-14 | Smith & Nephew Plc | Wound closure device with protective layer and method of use |
US11375923B2 (en) | 2017-08-29 | 2022-07-05 | Smith & Nephew Plc | Systems and methods for monitoring wound closure |
WO2021059126A1 (en) * | 2019-09-24 | 2021-04-01 | Kci Licensing, Inc. | Dressing system for use on deep wounds with reduced in-growth and extended wear time |
Also Published As
Publication number | Publication date |
---|---|
WO2014165275A9 (en) | 2014-12-11 |
US20190231944A1 (en) | 2019-08-01 |
EP3372209A1 (en) | 2018-09-12 |
MX2015011803A (en) | 2016-07-07 |
AU2019201930A1 (en) | 2019-04-11 |
AU2020213413A1 (en) | 2020-09-03 |
RU2015142873A (en) | 2017-04-19 |
JP6407954B2 (en) | 2018-10-17 |
EP2968016B1 (en) | 2018-07-11 |
US20160022885A1 (en) | 2016-01-28 |
MX369065B (en) | 2019-10-28 |
AU2014248519B2 (en) | 2018-12-20 |
AU2014248519A2 (en) | 2016-07-21 |
CN105188622A (en) | 2015-12-23 |
JP2016512105A (en) | 2016-04-25 |
CA2902776C (en) | 2023-03-07 |
US10124098B2 (en) | 2018-11-13 |
CA2902776A1 (en) | 2014-10-09 |
MX2019012837A (en) | 2019-11-28 |
RU2015142873A3 (en) | 2018-02-28 |
CN113730099A (en) | 2021-12-03 |
EP2968016A1 (en) | 2016-01-20 |
US11419767B2 (en) | 2022-08-23 |
BR112015021854A2 (en) | 2017-07-18 |
AU2014248519A1 (en) | 2015-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11419767B2 (en) | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure | |
AU2019246851B2 (en) | Negative pressure wound closure device | |
US11344665B2 (en) | Collapsible dressing for negative pressure wound treatment | |
EP3534856A1 (en) | Wound closure devices | |
EP3506867A1 (en) | Negative pressure wound closure device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201480027156.7 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14723917 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2014723917 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2902776 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2015/011803 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2014248519 Country of ref document: AU Date of ref document: 20140312 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14774689 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2016501735 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2015142873 Country of ref document: RU Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112015021854 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112015021854 Country of ref document: BR Kind code of ref document: A2 Effective date: 20150908 |